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ABSTRACT 
Type 2 diabetes mellitus (T2D) is a metabolic disorder of fuel homeostasis 
characterised by hyperglycaemia and altered lipid metabolism caused by islet β-cells 
being unable to secrete adequate insulin in response to varying degrees of 
overnutriton, inactivity, obesity, and insulin resistance. β-cell dysfunction is the 
hallmark pathophysiological step in the progression of this disease. The worldwide 
prevalence rates of T2D are rapidly increasing owing to rising levels of obesity and 
sedentary lifestyles. Studies now point to T2D as being a disorder of the innate 
immune system as it is highly correlated with obesity and low grade inflammation. 
Circulating levels of proinflammatory cytokines are used as indicators for diagnosis 
of T2D. Toll-like receptors (TLRs) are pattern-recognition receptors that play a 
crucial role in the innate immune system, which detects the presence and the nature 
of pathogenic microbial infection, and thus provides the first line of host defence. In 
order to assess the effects of activation of the innate immune system on β-cell 
function we set up an in vitro model where we studied the effects of TLR activation 
on the insulin secreting β-cell line MIN6. Activation of MIN6 cells with TLR 
ligands altered not only insulin secretion and synthesis, but also the inflammatory 
status of the cell. Interestingly TLR4 the receptor for bacterial LPS, and TLR5 the 
receptor for bacterial flagellin had very different effects on MIN6 cells, with TLR5 
activation seeming to play a protective role. Furthermore in order to explore how β-
cells interact with macrophage, whose infiltration of the pancreas is a hallmark of 
T2D, we used an in vitro model where we conditioned J774A.1 macrophage with 
MIN6 β-cell supernatants prior to activation. Conditioned macrophages acquired a 
regulatory phenotype and were less responsive to TLR activation with decreased 
production of pro-inflammatory cytokines, chemokines and immune cell surface 
markers, whilst maintaining their ability to phagocytose. This effect was transient 
and normal phenotype returned once the macrophages were removed from the β-cell 
supernatants thus showing that these cells secrete mediators involved in this 
response. As T2D and low grade inflammation are inextricably linked we used an in 
vivo model of DSS-induced colitis to induce inflammation in the gut and saw 
increased numbers of macrophage in the pancreas of diseased animals. 
Our findings show that TLR activation has not only the ability to alter insulin 
signalling in MIN6 β-cells, but also their inflammatory status. Of note is the role of 
TLR5 activation in protecting β-cells. Furthermore we have shown that β-cells can 
produce factors that change and shape macrophage response, this ability is possibly 
altered in the setting of T2D. Finally we have provided a mechanistic link between 
low grade inflammation in the gut and macrophage infiltration of the pancreas.  
 
 
 
 
 
 
xi 
 
ABBREVIATIONS  
AP-1  activator protein 1 
APC   allophycocyanin  
BMMØ  bone marrow-derived macrophage  
BSA   bovine serum albumin  
CD   cluster of differentiation  
DAMP  damage associated molecular pattern 
DMEM  Dulbecco’s modified eagle medium  
DNA   deoxyribonucleic acid  
dNTP   deoxyribonucleotide triphosphates  
DSS   dextran sulphate sodium  
EDTA  ethylenediaminetetraacetic acid  
ELISA  enzyme-linked immunosorbent assay  
ER  endoplasmic reticulum 
FACS   fluorescence activated cell sorting  
FBS   foetal bovine serum  
FCS   foetal calf serum  
FITC   fluorescein isothiocyanate  
FSC   forward scatter  
IL   interleukin  
IR  insulin receptor 
IRS  insulin receptor substrate 
IκB  inhibitor of kappa B  
LPS   lipopolysaccharide  
MAPK  mitogen-activated protein kinase 
xii 
 
MCP   monocyte chemoattractant protein  
M-CSF  macrophage colony stimulating factor  
MHC   major histocompatibility complex  
MIP   macrophage inflammatory protein  
MØ   macrophage  
MyD88 myeloid differentiation primary response gene 88  
NF-κB  nuclear factor kappa-light-chain-enhancer of activated B cells 
NO   nitric oxide  
PAMP  pathogen-associated molecular pattern  
PBS   phosphate buffered saline   
PE  phycoerythrin 
PI3K  phosphatidylinositol-4,5-bisphosphate 3-kinase 
PRR   pattern recognition receptor  
qPCR   quantitative real time polymerase chain reaction  
RNA   ribonucleic acid  
RPMI   Roswell Park Memorial Institute medium  
RT   room temperature  
SSC   side scatter  
T2D  type 2 diabetes 
TLR   Toll-like receptor  
TNF   tumour necrosis factor   
TRIF  TIR-domain-containing adapter-inducing interferon-β 
 
 
 
xiii 
 
PUBLICATIONS 
TLR5 plays a protective role in the insulin secreting pancreatic β-cell line MIN6 
(2014) 
McEvoy FA, Kristek M, Collins LE, Decourcey J, Lynch M, Holthofer H, Loscher 
CE  (manuscript in preparation) 
Soluble factors from colonic epithelial cells contribute to gut homeostasis by 
modulating macrophage phenotype (2014) 
Kristek M, Collins LE, DeCourcey J, McEvoy FA, Loscher CE  
Innate Immunity, Manuscript ID INI-13-0125, resubmitted following revisions 
(2014) 
Conjugated linoleic acid suppresses dendritic cell activation and subsequent 
Th17 responses. (2014) 
Draper E, DeCourcey J, Higgins SC, Canavan M, McEvoy FA, Lynch M, Keogh B, 
Reynolds C, Roche HM, Mills KH, Loscher CE  
Journal of Nutritional Biochemistry 25(7):741-9   
 
 
 
 
 
 
 
 
xiv 
 
PRESENTATIONS 
 
Irish Society of Immunology Annual Meeting, Dublin, October 2010 
Modulation of Pancreatic β Cell Function Following TLR Ligation  
Fiona Mc Evoy, Harry Holthofer and Christine E. Loscher 
 
(Bio)Pharmaceuticals and Pharmacological Sciences Research Day, Dublin, 
January 2011 
Modulation of Pancreatic β Cell Function Following Exposure to TLR Ligands and 
Cytokines - Poster 
Fiona Mc Evoy, Harry Holthofer and Christine E. Loscher
 
 
School of Biotechnology Annual Research Day, Dublin, January 2011 
Modulation of Pancreatic β Cell Function Following Exposure to TLR Ligands and 
Cytokines - Poster 
Fiona Mc Evoy, Harry Holthofer and Christine E. Loscher 
 
Irish Society of Immunology Annual Meeting, Galway, September 2011 
TLR5 activation in pancreatic β-cells modulates secretion of Insulin and 
inflammatory mediators - Poster 
Fiona Mc Evoy, Harry Holthofer and Christine E. Loscher 
 
American Association of Immunologists Annual Meeting, Boston, May 2012 
Modulation of the Inflammatory and Metabolic Profile of Pancreatic β-cells 
Following TLR Ligation – Poster & Oral 
Fiona Mc Evoy, Harry Holthofer and Christine E. Loscher 
Source The Journal of Immunology, 2012, 188, 61.5 
 
 
 
1 
 
 
 
 
 
Chapter 1 
General Introduction 
 
 
 
 
 
 
 
  
2 
 
1 Introduction  
Type 2 Diabetes (T2D) is a multifactorial metabolic disorder characterised by 
chronic hyper-glycaemia, insulin resistance and a relative insulin secretion deficit. 
The estimated worldwide prevalence of diabetes was 285 million (6.4%) in 2010, 
and this value is predicted to rise to around 439 million (7.7%) by 2030 (Shaw et al. 
2010). Type 2 Diabetes is the predominant form and accounts for at least 90% of the 
cases (González et al. 2009). This increase in T2D is inextricably linked to changes 
towards a western lifestyle (high-energy diets with reduced physical activity) in 
developing countries and the rise in prevalence of overweight and obesity (Colagiuri 
2010). Insulin resistance affects the action of insulin in each of its major target 
tissues leading to increased circulating fatty acids and the hyper-glycaemia of 
diabetes. Although obesity often leads to insulin resistance, only a subset of obese, 
genetically susceptible insulin resistant individuals progress to type-2 diabetes (Kahn 
et al. 2006). In both animal models and humans with T2D the triggering factor is β-
cell failure, which involves a decrease in β-cell mass and deterioration of key β-cell 
functions such as glucose-stimulated insulin secretion (GSIS). The leading 
hypothesized mechanisms to explain insulin resistance and islet β-cell dysfunction in 
T2D have been oxidative stress, endoplasmic reticulum stress, amyloid deposition in 
the pancreas, ectopic lipid deposition in the muscle, liver and pancreas and 
lipotoxicity and glucotoxicity. All of these stresses can be caused by over-nutrition, 
and each of these cellular stresses is also thought to be exacerbated by or associated 
with inflammation (Donath & Shoelson 2011) giving fuel to the concept that 
activation of innate immunity may underlie the pathophysiology of T2D.  
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The immune system is a collection of highly regulated processes designed to 
promote protective immunity against insults from pathogenic organisms. These 
highly regulated processes (both adaptive and innate immune systems) encompass 
both stimulatory and regulatory pathways aimed at turning on and off appropriate 
responses designed to resolve the infection without causing long-term damage to the 
host. Regulatory mechanisms have evolved to down-regulate and control the 
immune response and tissue inflammation, however inflammation sometimes fails to 
subside and this unresolved inflammation may become chronic. Recently, many 
notable discoveries have provided evidence to support the concept of immune 
system involvement in obesity and the development of T2D. Cross-sectional and 
prospective studies have described elevated circulating levels of acute-phase proteins 
(such as C-reactive protein (CRP), fibrinogen, haptoglobin) and sialic acid as well as 
cytokines and chemokines in patients with T2D (Pickup et al. 1997; Herder et al. 
2005). Furthermore, elevated levels of IL-1β, IL-6 and CRP are predictive of T2D 
(Spranger et al. 2003; Pradhan et al. 2001). Not only have proinflammatory 
cytokines been shown to have the ability to promote insulin resistance by interfering 
with insulin signalling (Hotamisligil et al. 1994), they have also been shown to have 
a direct detrimental effect on β-cell function and viability (Wachlin et al. 2003). 
Tissue inflammation has also been detected in the islets of patients with T2D, along 
with increased cytokines and chemokines (Ehses et al. 2007). Of note, patients with 
T2D and every animal model of T2D investigated to date, display immune cell 
infiltration of the islets (Ehses et al. 2007). Islet tissue sections from patients with 
T2D also show fibrosis which is found in conjunction with amyloid deposits and this 
also argues for an inflammatory response in islets as fibrosis is a hallmark symptom 
of chronic inflammation. A recent report shows that human islet amyloid polypeptide 
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(IAPP) which itself has been linked to the pathogenesis of T2D induces the secretion 
of IL-1β by bone marrow-derived macrophages, suggesting that IAPP may 
contribute to islet inflammation (Masters et al. 2010). Further evidence for roles of 
inflammation in T2D comes from clinical trials using either small molecule anti-
inflammatory approaches or biological agents that target specific proinflammatory 
cytokine pathways to improve parameters of glucose control, such as glycated 
haemoglobin levels (HbA1c). The most promising approaches thus far include the 
selective blockade of IL-1-Receptor 1 activation with either IL-1R antagonists or 
specific antibodies (Dinarello et al. 2012), and inhibition of the NF-κB pathway with 
salicylate derivatives such as saisalate (Fleischman et al. 2008). Both approaches 
seem to lower blood glucose levels and improve β-cell secretory function and insulin 
sensitivity as well as reducing evidence of systemic inflammation. These proof-of-
concept studies validate the potential approach of targeting of inflammatory 
mediators as a treatment for T2D and also support a causative role for the immune 
system and inflammation in the pathogenesis of this disease. 
 
1.2 The Pancreas 
The pancreas is an organ in the digestive and endocrine system of vertebrates. The 
mature pancreas is composed of morphologically and functionally distinct endocrine 
and exocrine components. The exocrine region is formed by acinar and ductal cells, 
making up to 95–99% of the pancreas. They produce digestive enzymes such as bile, 
and electrolytes, which help in nutrient digestion and absorption in the 
gastrointestinal tract. The endocrine cells form aggregates scattered throughout the 
exocrine pancreas in the form of islets of Langerhans (Morrison 1937). The 
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endoderm-derived islets are oval in shape, highly vascularized by an extensive 
endothelial network and innervated by sympathetic, parasympathetic and sensory 
nerves (Ahrén 2000).  
The islets contain five principle endocrine cell types defined by the hormone they 
secrete. These include insulin-producing β-cells, glucagon-producing α-cells, 
somatostatin-producing δ-cells, ghrelin-producing ε-cells and pancreatic 
polypeptide-producing PP-cells (Brissova et al. 2005). In rodents, each islet is made 
up of 70–80% β-cells, 5% δ-cells and 15–20% α-cells or PP-cells in the dorsal or 
ventral pancreas respectively (Elayat et al. 1995). However, studies on human islets 
have shown that this proportion of β-cells and non-β-cells is different from that in 
rodents, and that β-cells constitute approximately 55% of the islet cell mass and α-
cells up to 35% (Brissova et al. 2005). The secretion of islet hormones is highly 
regulated and collectively maintains glucose homeostasis through actions on many 
peripheral tissues such as liver, muscle and adipose tissue. Non endocrine cells are 
also part of an islet. These include nerves, dendritic cells, macrophages, fibroblasts 
and vascular cells such as endothelial cells (Eberhard & Lammert 2009). 
 
1.3 Insulin 
Pancreatic β-cells in the islet of Langerhans are the sole source of insulin, the main 
hormonal regulator of glycaemia, thus the β-cell is a metabolic hub connecting 
nutrient metabolism and the endocrine system. Insulin is a small protein of 
approximately 5.8 kDa, the monomeric structure of which was first discovered by x-
ray crystallography in 1926 (Scott 1934). The monomeric insulin consists of the 21 
amino acid residue “A” chain and 30 amino acid residue “B” chain. The two chains 
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are bound together in their quaternary structure by two disulfide bridges. The 
secondary structure of both chains is mostly alpha helical. Insulin is created as a 
single peptide chain, which is looped around, bonded to itself by covalent disulfide 
bonds between cysteine residues (Brange & Langkjoer 1993). In addition, a third 
disulfide bridge between two amino acids in the “A” chain helps stabilize its tertiary 
structure (Brange & Langkjoer 1993). Humans have a single copy of the insulin 
gene, but rodents have two non-allelic insulin genes (insulin I and II). They differ in 
their number of introns and chromosomal locations (Soares et al. 1985).  
 
1.3.1 Insulin Biosynthesis 
The secreted insulin consists of 51 amino acids with a molecular weight of 5.8 kDa 
however the insulin gene encodes a 110 amino acid precursor known as 
preproinsulin. Cytosolic ribonucleoprotein signal recognition particles (SRP) 
facilitate preproinsulin translocation across the rough endoplasmic reticulum (ER) 
membrane into the lumen. This process occurs via the peptide-conducting channel 
(Chan et al. 1976), where the signal peptide from preproinsulin is cleaved by a signal 
peptidase to yield proinsulin (Patzelt et al. 1978). Proinsulin then undergoes folding 
and formation of three disulfide bonds (Huang & Arvan 1995), the folded proinsulin 
is then transported from the ER to the Golgi apparatus where proinsulin enters 
immature secretory vesicles and is cleaved to yield insulin and C-peptide. Insulin 
and C-peptide are then stored in these secretory granules together with islet amyloid 
polypeptide and less abundant β-cell secretory products (Steiner 2008). Although 
controlled by multiple factors, glucose metabolism is the most important 
physiological event that stimulates insulin gene transcription and mRNA translation 
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(Steiner 2008). Insulin biosynthesis is regulated at both transcriptional and 
translational levels. In a mouse β-cell there are approximately 13,000 insulin 
granules (Leiter et al. 1979) however this content is known to be highly dynamic. 
Insulin accumulates in the presence of nutrients and decreases in response to nutrient 
depletion. The ability of β-cells to quickly respond to cellular signals is due to 
transcriptional regulation. A number of sequence elements within the promoter 
region of the insulin gene, named A, C, E, Z, and CRE elements determine the 
localization of insulin within β-cells and also serve as binding sites for several β-cell 
transcription factors to regulate insulin gene expression (Hay & Docherty 2006). An 
example of one such transcription is pancreatic duodenal homeobox 1 (PDX-1) 
which binds to the A element. Not only is it a key regulator of insulin gene 
expression it also plays a central role in pancreatic β-cell development, function and 
survival (Fujimoto & Polonsky 2009). Complete deficiency of PDX-1 is associated 
with pancreatic agenesis (Jonsson et al. 1994) and partial deficiency leads to severe 
β-cell dysfunction, and increases β-cell death and diabetes both in rodent and human 
(Stoffers et al. 1998; Hani et al. 1999; W M Macfarlane et al. 1999). Chronic 
hyperglycaemia and dyslipidaemia, which are major features of T2D, cause β-cell 
dysfunction via reduced PDX-1 expression (W M Macfarlane et al. 1999).  
 
1.3.2 Regulation of Insulin Secretion 
Insulin is a crucial hormone required for normal metabolism. In healthy subjects, 
insulin release is exquisitely exact in order to meet the metabolic demand. 
Specifically, β-cells sense changes in plasma glucose concentration and respond by 
releasing corresponding amounts of insulin. 
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1.3.2.1 Carbohydrate Metabolism and Insulin Secretion 
 Insulin can respond to many nutrients in the blood circulation, including glucose, 
other monosaccharides, amino acids, and fatty acids, however glucose is 
evolutionarily the primary stimuli for insulin release, because it is a principal food 
component and can accumulate immediately after food ingestion and thus will be the 
focus of this section. The β-cell glucose transporter (GLUT1 (SCL2A1) in humans 
and GLUT2 in rodents) senses the glucose concentration and transports it into the β-
cell (De Vos et al. 1995; McCulloch et al. 2011; Rorsman & Braun 2013). The Km of 
these GLUT1 and GLUT2 transporters for glucose is high (6 and 11 mM 
respectively), indicating that they are only active at high extracellular glucose, as 
observed in postprandial conditions (Newsholme et al. 2014). Following uptake 
glucose is phosphorylated into glucose-6-phosphate by the high Km glucokinase 
(GK) which constitutes the flux determining step for glycolysis (Nilsson et al. 1996; 
Newgard & McGarry 1995). Unlike other hexokinases, GK is not inhibited by its 
product glucose-6-phosphate and maintains high glycolytic flux in the presence of 
elevated glucose, coupling carbohydrate sensing to insulin secretion in the β-cell 
(Newsholme et al. 2014). Alterations in the activity of important glycolytic enzymes 
such as GK can modulate GSIS, and thus can lead to impaired glucose metabolism 
and insulin secretion (Gloyn et al. 2005; Osbak et al. 2009).  
Following glucose uptake, glycolytic degradation to pyruvate generates ATP which 
is an important stimulus-secretion coupling factor. Pyruvate sits at a critical 
branching point in glucose metabolism in β-cells as it can be metabolized in the 
cytosol by lactate dehydrogenase (LDH) or enter mitochondria to be metabolized by 
pyruvate dehydrogenase (PDH) or pyruvate carboxylase (PC) (Komatsu et al. 2013). 
As pancreatic β-cells express low levels of LDH it is not thought to play a role in 
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GSIS (Sekine et al. 1994; Patterson et al. 2014). PC facilitates the production of 
oxaloacetate from pyruvate. Oxaloacetate is then converted to malate by 
mitochondrial malate dehydrogenase and enters the cytosol from the mitochondria. 
Malic enzyme 1 (ME1) regenerates pyruvate from malate while simultaneously 
creating NADPH and increasing ATP levels. Pyruvate can the re-enter the 
mitochondria to continue the process, generating more NADH and increasing ATP 
levels (Jitrapakdee et al. 2010; Newsholme et al. 2014). The metabolism of pyruvate 
by pyruvate dehydrogenase leads to the generation of acetyl CoA which can then 
condense with oxaloacetate to form citrate, activating the tricarboxylic acid (TCA) 
cycle allowing it to be transferred from the mitochondria to the cytosol via the citrate 
carrier. Citrate is then converted back to acetyl CoA and oxaloacetate and ME1 
generates NADPH and ATP as described above (Newsholme et al. 2014; Maechler 
2013). Unsurprisingly, studies have shown that siRNA knockdown of PC in murine 
models reduces β-cell GSIS and proliferation (Patterson et al. 2014; Hasan et al. 
2008) while enhanced expression increases GSIS (Xu et al. 2008).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
The increased production of ATP increases the intracellular ratio of ATP/ADP 
(Ghosh et al. 1991). ATP binds ATP sensitive K
+
 channels
 
(KATP) channels on the β-
cell membrane, probably concomitant with phosphorylation of KATP channel, closes 
the channels. As the KATP channel is the primary determinant of the membrane 
potential of the β-cells, closure of these channels results in depolarization of the β-
cell membrane (Tarasov et al. 2004). When the β-cell membrane potential reaches –
30 to –40 mV, the voltage-sensitive calcium channels open leading to an influx of 
calcium ions. This increase of intracellular calcium ions triggers the exocytosis of 
insulin granules (Ohara-Imaizumi & Nagamatsu 2006). In  addition, increased Ca
2+ 
 
then activates voltage-sensitive K
+
 channels, thereby restoring the resting potential to 
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–70 to -60 mV and increasing the concentration of cytoplasmic free calcium (Ohara-
Imaizumi & Nagamatsu 2006). Inagaki et al first identified the KATP channel in β-
cells as a tetra-octamer composed of four sulfonylurea receptor 1 (SUR1) and 
inwardly rectifying K
+
 channel 6.2 subunits (Kir6.2) (Inagaki et al. 1995; Inagaki et 
al. 1997). SUR1 is the target of insulin secretagogues, such as sulfonylurea (SU) and 
glinide used in the treatment of T2D, such that the channel is closed on binding of 
SU or glinide to the SUR1, enhancing insulin secretion.  An acute elevation of 
intracellular Ca
2+
 facilitates fusion of a ready releasable pool of insulin granules and 
the plasma membrane leading to an increased rate of exocytosis. This reaction is 
mediated by the assembly of soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) proteins (Rorsman & Renström 2003).  
 
Figure 1.1 Mechanism of glucose stimulated insulin secretion from pancreatic 
β-cells.  
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1.3.2.2 Biphasic Insulin Release and KATP Channel Independent Glucose Action 
Insulin secretion occurs in pulsatile fashion in sync with Ca
2+
 influxes during two 
major phases, and is termed “biphasic.” First-phase insulin secretion occurs within 
5–10 min following β-cell stimulation. Second-phase insulin secretion is less robust 
than the first phase, but can be sustained for several hours if elevated blood-glucose 
levels persist (Henquin, Nenquin, et al. 2006; Henquin, Dufrane, et al. 2006; Curry et 
al. 1968). These two phases of secretion are thought to use separate pools of insulin-
containing granules. First-phase secretion appears to arise from plasma membrane-
pre-docked granules, termed the “readily releasable pool” (RRP), while second-
phase secretion is believed to involve release from a granule pool deeper within the 
cell, the “storage-granule pool,” which presumably replenishes the RRP (Barg et al. 
2002). The triggering mechanism of KATP- dependant GSIS is responsible for the first 
phase of the insulin secretory response, however the second more sustained phase of 
insulin release is dependent on metabolic stimulus-secretion coupling as it was 
shown when KATP channels were prevented from closing by the addition of 
diazoxide, in the presence of glucose insulin release was still possible (Gembal et al. 
1992; Sato et al. 1992). Although molecule(s) responsible for this so termed KATP-
independent mechanism of GSIS have yet to be identified, anaplerotic metabolism of 
pyruvate by PC and subsequent efflux of the TCA cycle intermediates are considered 
key events (Newsholme et al. 2014; Komatsu et al. 2013; Brun et al. 1996) 
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1.3.2.3 The Role of Gastrointestinal Hormones in Insulin Secretion 
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide 
(GIP) are gastrointestinal hormones called incretins, which robustly enhance 
nutrient-induced insulin secretion (Drucker 2006). The effect was first observed 
when insulin secretion increased more after oral glucose administration than after 
intravenous infusion of an equivalent glucose dose, while maintaining stable plasma 
glucose levels (Holst & Gromada 2004). Incretins bind to G protein-coupled 
receptors on the β-cell membrane and increase cAMP levels. When the β-cells are 
exposed to a stimulatory concentration of glucose, cAMP further elevates GSIS 
(Holst & Gromada 2004). Incretin action is resistant to diazoxide, and therefore it is 
independent of KATP channel closure (Yajima et al. 1999). cAMP is thought to 
enhance GSIS through protein kinase A (PKA)-dependent and -independent 
mechanisms (Seino & Shibasaki 2005). cAMP leads to an increase in the size of 
RRP in a glucose concentration-dependent manner. This finding strongly indicates 
that incretins prime the β-cells in the presence of stimulatory ambient glucose 
concentration. The discovery of the insulinotropic effect of these hormones has led 
to their evaluation as therapies for improved insulin secretion in T2D with promising 
results to date (Puddu et al. 2013; Erlich et al. 2013). Along with their use as 
potential therapeutics, the action of these hormones has been shown to be improved 
following bariatric surgery, which has the ability to induce rapid resolution of T2D, 
prior to any significant weight loss further supporting a positive role for these 
hormones in insulin action (Colagiuri 2010; Sala et al. 2014). 
 
 
13 
 
1.3.3 Insulin Signalling 
Insulin signalling is mediated by a complex, highly integrated network that controls 
several processes. In the presence of insulin, the insulin receptor (IR) phosphorylates 
insulin receptor substrate proteins (IRS proteins) that are linked to the activation of 
two main signalling pathways: the phosphatidylinositol 3-kinase (PI3K)–
AKT/protein kinase B (PKB) pathway, which is responsible for most of the 
metabolic actions of insulin, and the Ras–mitogen-activated protein kinase (MAPK) 
pathway, which regulates expression of some genes and cooperates with the PI3K 
pathway to control cell growth and differentiation (Taniguchi et al. 2006). These 
pathways and the effectors involved will be discussed in further detail later. 
 
1.3.4 Insulin Function 
The biological effects of insulin on the integration of fuel metabolism are primarily 
the uptake of glucose and fatty acids into liver, adipose tissue and muscle and to 
promote the storage of these nutrients in the form of glycogen, lipids and protein 
respectively.  
 1.3.4.1 Glucose storage and uptake 
Once in the blood, insulin controls glucose homeostasis by stimulating the uptake of 
glucose into skeletal muscle, and to a lesser extent the liver and adipose tissue. In 
skeletal muscle, heart muscle and adipose tissue, this uptake is facilitated by the 
glucose transporter GLUT4 (Bryant et al. 2002). Once glucose enters the cells it is 
phosphorylated by hexokinase to glucose-6-phosphate. Glucose-6-phosphate then 
undergoes glycolysis for energy production or it is stored as glycogen. In addition to 
14 
 
promoting glucose storage, insulin inhibits the production and release of glucose by 
the liver by blocking gluconeogenesis and glycogenolysis (Saltiel & Kahn 2001). 
1.3.4.2 Protein synthesis 
Insulin can stimulate protein synthesis in many types of cells and tissues, including 
human and rat muscles, and many types of cells in culture (Garlick 2005; Proud & 
Denton 1997). This involves two major kinds of effects: the rapid activation of 
existing components of the translational apparatus and the longer term increase in the 
capacity of the cell or tissue for protein synthesis, which includes an increase in 
ribosome number.  
1.3.4.3 Lipid Metabolism 
Insulin also promotes the synthesis of lipids, and inhibits their degradation (Saltiel & 
Kahn 2001). In adipocytes, glucose is stored primarily as lipid, owing to increased 
uptake of glucose and activation of lipid synthetic enzymes, including pyruvate 
dehydrogenase, fatty acid synthase and acetyl-CoA carboxylase. Insulin also 
profoundly inhibits lipolysis in adipocytes, primarily through inhibition of the 
enzyme hormone-sensitive lipase (Anthonsen et al. 1998).  
1.3.4.4 Autocrine action on β-cell physiology and function 
Along with its actions in target tissues, insulin has also been shown to have an 
autocrine action on β-cell physiology and function (Leibiger et al. 2008). Unlike all 
other cell types the pancreatic β-cell is unique in that it continuously secretes insulin; 
basal secretion under nonstimulatory conditions and increased secretion under 
stimulatory conditions such as high glucose. Although historically insulin was 
exclusively thought to exert a negative effect on insulin signalling in the β-cell (Best 
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& Haist 1941), recent data has shown that it plays a positive role in several cellular 
processes that include regulation of gene transcription, translation, proliferation and 
β-cell survival (Leibiger et al. 2008). The presence of the IR has been documented in 
β-cell lines of different origin (HIT-T15, INS1, MIN6) as well as in primary mouse 
and human β-cells (Hribal et al. 2003; Leibiger et al. 2001; Muller et al. 2006). 
Knockout of the IR in β-cells of the βIRKO mice, and ablation of IRS2 signalling in 
β-cells  results in an age dependant decrease in β-cell mass (Kulkarni et al. 1999; 
Cantley et al. 2007). Exposure of islets from βIRKO mice to elevated glucose 
concentrations or exogenous insulin does not result in the upregulation of 
endogenous insulin gene transcription, suggesting binding of insulin to the IR is 
crucial for this process (Kulkarni et al. 1999). Furthermore gene expression profiling 
of MIN6 cells has shown that most genes that seem to be regulated by glucose were 
in fact regulated by secreted insulin (Ohsugi et al. 2004; Ohsugi et al. 2005). This 
data and others point to the pivotal role for autocrine insulin signalling in the β-cell. 
 
1.4 Type 2 Diabetes 
As mentioned previously Type 2 Diabetes is a multifactorial metabolic disorder. This 
disease is often associated with obesity and develops when chronic overnutrition 
conspires with genetic susceptibility to cause impaired insulin signalling, also 
dubbed insulin resistance, as well as a relative insulin deficiency of non-autoimmune 
aetiology. This contrasts with Type 1 diabetes, which is caused by the complete 
absence of insulin secondary to autoimmune destruction of the pancreatic β-cells. 
Due to the importance of this hormone in maintaining whole body fuel homeostasis, 
compromised insulin secretion and action therefore leads to multiple metabolic 
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abnormalities. These include hyperglycaemia due to impaired insulin stimulated 
glucose uptake and uncontrolled hepatic glucose production, and dyslipidemia, 
which includes perturbed homeostasis of fatty acids, triglycerides and lipoproteins. 
These chronic increases in circulating glucose and lipid levels can further impair 
insulin secretion and action and cause other forms of tissue damage thus termed 
glucotoxicity and lipotoxicity. A number of clinical data points support insulin 
resistance as a critically important etiological factor in Type 2 diabetes.  T2D and 
insulin resistance are highly correlated; more than 80% of individuals with T2D also 
manifest insulin resistance (Gerich 1999). Insulin resistance is also common in obese 
individuals who have not yet developed T2D (Balkau et al. 2002). Insulin resistance 
can in turn cause β-cell dysfunction via the mechanism of β-cell exhaustion such that 
increased secretory demand, due to peripheral tissue resistance to insulin signalling 
results in continual β-cell hyperstimulation and eventual failure (Kahn 2001). While 
T2D is indeed strongly correlated with insulin resistance, insulin resistance is not as 
strongly correlated with T2D. That is to say prevalence rates of insulin resistance in 
various populations are often far greater than those of T2D, large majorities of 
individuals with insulin resistance do not go on to develop the disease (Bonora et al. 
1998; Zavaroni et al. 1999). A clinical assessment of β-cell function and insulin 
resistance in 100 glucose tolerant volunteers – 50 first-degree relatives of patients 
with T2D and 50 controls noted significant reductions in insulin secretion in the 
first-degree relatives versus controls (Pimenta et al. 1995). Neither group differed in 
insulin sensitivity, but the first-degree relatives showed a clear decrement in β-cell 
response. Not only may β-cell dysfunction pathogenically precede insulin resistance, 
but there is also some evidence that the former may contribute to the latter, loss of 
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pulsatile insulin release, a β-cell secretory dysfunction associated with T2D has been 
associated with development of insulin resistance (Kahn 2001).  
 
1.4.1 β-cell dysfunction in Type 2 Diabetes 
Chronic insulin resistance will progress to T2D when the β-cells are unable to 
secrete adequate amounts of insulin to compensate for decreased insulin sensitivity 
which is largely due to insulin secretory dysfunction and loss of functional β-cells 
(Marchetti et al. 2004). Individuals with T2D always manifest increased β-cell 
apoptosis and reduced β-cell mass (Sakuraba et al. 2002; Marchetti et al. 2004). 
Although obesity is associated with T2D, most obese individuals do not develop the 
disease due to enhanced function on β-cells or expansion of β-cell mass compensates 
and thus maintains normal blood glucose levels (Flier et al. 2001). This enhanced 
functionality involves increased nutrient signals that stimulate increased growth 
factor signalling in β-cells. Increased nutrient load in the gut can enhance GLP-1 
production leading to anti-apoptotic and growth promoting effects on β-cells (van 
Citters et al. 2002; Drucker 2006). In susceptible individuals the β-cells lose their 
ability to compensate and cell dysfunction ensues. Generally, diagnosis of T2D is 
associated with approximately a 50% reduction in islet function and this is thought to 
manifest itself at least 10 years prior to disease diagnosis (Holman 1998). Obese 
non-diabetic humans show increased β-cell volume in islets while obese and non-
obese diabetic individuals with T2D show at least a 40% reduction in β-cell volume 
compared to non-diabetic controls (Butler et al. 2003). As discussed above the β-cell 
is a target for insulin action, with insulin effects on transcription, translation, cell 
proliferation, cell size, and β-cell apoptosis (Leibiger et al. 2008) As a consequence, 
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mechanisms leading to insulin resistance in the classical insulin-target tissues, 
namely liver, muscle and fat, should also affect β-cell function and survival, i.e., 
insulin resistance is also a feature of the pancreatic β-cell. An increasing body of 
data documents that mechanisms that lead to insulin resistance in the classical 
insulin-target tissues also cause β-cell insulin resistance coupled with β-cell 
dysfunction and apoptosis (D’Alessandris et al. 2004; Marchetti et al. 2004; Okada 
et al. 2007; Solinas et al. 2006). These data suggest that β-cell insulin resistance may 
add to the deterioration of β-cell function and therefore accelerate the progression of 
the disease. For these reasons the factors that lead to a change in β-cell function 
(decreased insulin expression and secretion), mass and insulin resistance are central 
to the pathology of T2D. 
 
1.5 Inflammatory mechanisms contributing to β-cell 
dysfunction 
Multiple mechanisms underlie defective insulin secretion and responses in T2D. 
These include glucotoxicity, lipotoxicity, oxidative stress, endoplasmic reticulum 
(ER) stress, alterations of the gut microbiota, and the formation of amyloid deposits 
in the islets (Bensellam et al. 2012; Lee et al. 1994; Laybutt et al. 2007; Evans et al. 
2002; Westermark et al. 2011; Carvalho & Saad 2013). The relative contribution of 
each of these mechanisms remains unclear. They likely all participate in the 
pathology of the disease, with inter-individual differences depending on genetic 
background, nutrition, physical activity, the use of antibiotics and other 
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environmental factors. Interestingly, all of these mechanisms are associated with 
inflammatory responses.  
 
1.5.1 Glucotoxicity, Oxidative Stress, ER stress and Lipotoxixity. 
Understandably, excessive glucose will lead to an increase in β-cell glucose 
metabolism and oxidative phosphorylation. Elevated electron transport chain activity 
is known to promote increased superoxide (O2
-
) anion leakage from the mitochondria 
and may cause oxidative cellular damage (Newsholme et al. 2007). Furthermore high 
glucose levels induce NOX activity via NADPH production from the metabolism of 
glucose to pentose, and through the TCA cycle, both leading to increased O2
-
 output 
(Newsholme et al. 2007). β-cells are particularly vulnerable to ROS generation as 
they express relatively low levels of antioxidant enzymes such as catalase and 
glutathione (Gehrmann et al. 2010). For this reason the detrimental combination of 
increased ROS generation coupled with low antioxidant enzyme production can 
result in oxidative damage to DNA, proteins and lipids thereby promoting 
mitochondrial mediated apoptosis. Further to this ROS also have the capability of 
activating cellular stress pathways, such as NFκB (Shimada et al. 2012) leading to 
further negative effects for the β-cell. Excessive glucose can also lead to increased 
intracellular calcium levels enhancing mitochondrial O2
- 
production, but also deplete 
ER Ca
2+ 
thereby promoting activation of the ER stress mediated cell death pathway 
(Laybutt et al. 2007) along with the unfolded protein response (UPR). Accumulation 
of unfolded proteins within the lumen causes the initiation of an acute phase 
inflammatory response (Bensellam et al. 2012)  and can ultimately promote cell 
death by the activation of caspase enzymes (Szegezdi et al. 2006).  
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Lipid accumulation often termed lipotoxicity within the ER can also mediate ER 
stress in β-cells. As mentioned previously obesity is a primary risk factor associated 
with T2D. The process by which free fatty acids accumulate within the ER is not 
entirely understood, however it has been shown that palmitic acid has the ability to 
deplete ER Ca
2+  
levels and augment ER morphology and integrity which may lead to 
activation of ER stress by the mechanisms mentioned above (Cnop 2008).  
 
1.5.2 Cytokines and Chemokines 
Cytokines and chemokines, small signalling proteins secreted primarily by immune 
cells, activate inter- and intracellular signalling during immune responses. Cytokine 
expression plays a fundamental role in the development and function of the immune 
system. Many different cell types secrete chemokines, most often to attract immune 
cells to the site of infection or injury during innate and adaptive immune responses 
(Luster 1998). The effect of a cytokine release depends on the activated cell type 
expressing the specific cytokine receptor. Cytokines and their receptors participate in 
a diverse array of functions beyond innate and adaptive immunity including 
inflammation, immune cell differentiation, angiogenesis, tumorigenesis, 
development, neurobiology, and viral pathogenesis (Cohen & Cohen 1996). 
Dysregulation of cytokine expression is a cause of immunological and inflammatory 
diseases as well as other disease states (Tracey & Cerami 1993; Finkel et al. 1992; 
Rogler & Andus 1998). 
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1.5.2.1 Cytokines in β-cell dysfunction 
Many studies have been conducted in order to investigate the relationship between 
various inflammatory mediators and T2D and have found abnormally high levels of 
various cytokines, plasminogen activator inhibitor, chemokines and acute phase 
proteins in type 2 diabetic patients (Herder et al. 2006; Spranger et al. 2003). Indeed 
high circulating levels of IL-1β, IL-6 and CRP can be the main predictive indicators 
for progression of T2D (Spranger et al. 2003; Pradhan et al. 2001). Numerous 
proinflammatory cytokines such as IL-1β, TNF-α and IL-6, that are released from 
adipose tissue macrophage during obesity have been shown to induce inflammation 
in pancreatic islets (Zhao et al. 2006). The earliest evidence for an inflammatory 
process in pancreatic islets arose from the observation that hyperglycaemia induces 
β-cell apoptosis (Donath et al. 1999). By examining the underlying mechanism, it 
was shown that high glucose concentrations induce the expression of the pro-
apoptotic receptor FAS on β-cells (Maedler et al. 2001), which is further upregulated 
by glucose induced IL-1β production in β-cells (Maedler et al. 2002). Therefore IL-
1β and FAS contribute to both the glucose-induced impairment of β-cell secretory 
function and apoptosis. Besides glucose induced stimulation of IL-1β, expression of 
IL-1β in pancreatic β-cells is also regulated by free fatty acids (FFAs) that are also 
increased in obesity. FFAs stimulate the production of IL-1β and IL-1 dependant 
proinflammatory cytokines including IL-6 (Böni-Schnetzler et al. 2008; Boni-
Schnetzler et al. 2009). Deposition of amyloid in islets, a hallmark of T2D also has 
been shown to contribute to β-cell IL-1β production (Masters et al. 2010).  
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1.5.2.2 Cytokine induced insulin resistance 
Other than IL-1β, both TNF-α and IL-6 also provide a link between inflammation, 
insulin resistance and obesity. Both of these cytokines have been shown to play a 
role in driving insulin resistance in peripheral tissues and β-cells (Hotamisligil et al. 
1994; Pradhan et al. 2001). Engagement of the TNF receptor by TNF-α induces 
inhibitory phosphorylation of serine residues of IRS1 and activates IKKβ/NK-κB 
and JNK pathways, two major intracellular regulators of insulin resistance (Tilg & 
Moschen 2008). IL-6 can induce SOCS1 and SOCS3 that link IRS proteins to 
ubiquitin-mediated degradation which also promotes insulin resistance (Ueki et al. 
2004). Il-1β has been shown to reduce IRS1 expression via ERK1/2 and can also 
activate  the IKKβ/NF-κB pathway to promote insulin resistance (Tilg & Moschen 
2008).   
 
Figure 1.2 Regulation of Insulin Resistance by Cytokines. 
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1.5.2.3 Chemokines in β-cell dysfunction 
Islet cells can also produce a wide range of chemokines in the context of T2D. In 
vitro treatment of islets with high concentrations of glucose and the saturated fatty 
acid palmitate increases the production of several biologically active chemotactic 
factors (CXC chemokine ligand 8 (CXCL8) and MCP-1 in human islets; CXCL1 in 
mouse islets) (Ehses et al. 2007; Boni-Schnetzler et al. 2009). Islets isolated from 
rodent models of T2D (Goto–Kakizaki rats, high-fat fed mice and Zucker rats) also 
show increased production of various chemokines, including CXCL1, MCP-1 and 
MIP-1α (J. A. Ehses et al. 2009). These findings for humans is supported by studies 
that have shown upregulation of various chemokines in laser captured nearly pure β-
cells from patients with T2D (Donath et al. 2010). The precise functions of the 
various chemokines remain to be clarified; however, they have a crucial role in tissue 
infiltration by immune cells in T2D. 
 
1.5.3 Toll-Like Receptors 
Toll-like receptors (TLRs) are pattern-recognition receptors that play a crucial role in 
the innate immune system, which detects the presence and the nature of pathogenic 
microbial infection, and thus provides the first line of host defence. TLRs, of which 
12 members have been identified to date in mammals, comprise a family of type I 
transmembrane receptors, which are characterized by an extracellular leucine rich 
repeat (LRR) domain and an intracellular Toll/IL1 receptor (TIR) domain, which 
shows homology with that of the IL-1 receptor (Kumar et al. 2009; Kawai & Akira 
2009). In mammals, ligand recognition by TLRs leads to the recruitment of various 
TIR domain-containing signalling adaptors such as myeloid differentiation factor 
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(MyD)88 and TIR domain-containing adaptor inducing interferons (TRIF) which 
categorize the TLR signalling pathway into MyD88-dependent and TRIF-dependent 
pathways (Kawai & Akira 2009). This recruitment of adaptors triggers a signalling 
cascade and ultimately the activation of transcription factors such as NF-κB and 
MAP kinases such as p38, JNKs and extracellular signal-regulated kinase (ERK)1/2. 
These transcription factors induce transcription of proinflammatory cytokines and 
type I interferons (Kawai & Akira 2007).  
 
1.5.3.1 Role of TLR2 and TLR4 in the β-cell 
As T2D and obesity is associated with increased circulating levels of FFA’s, it is 
unsurprising that the majority of research to date has focused on a role for TLR4 and 
TLR2 in β-cell dysfunction. TLR2 forms heterodimers with TLR1 or TLR6 for 
ligand recognition and its prototypical ligands are bacterial lipopeptides, while TLR4 
forms homodimers and is the classical receptor for bacterial lipopolysaccharides 
(LPS) (Kawai & Akira 2009). Both TLR2- and TLR4-activating pathogen associated 
molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs) 
are increased in the circulation of recently diagnosed T2D patients (Dasu et al. 2010) 
and endotoxemia is a characteristic of humans and rodents with T2D (Cani et al. 
2007) implicating these receptors in the pathophysiology of T2D. Expression of 
these TLRs in islets has been investigated at the mRNA and protein levels in various 
studies. TLRs 2 and 4 were readily detectable in mouse, rat and human islets (Wen et 
al. 2004; Amyot et al. 2012) and studies have reported TLR2 and TLR4 mRNA 
expression in rat INS-1 and BRIN-BD11 and mouse MIN6 β-cell lines (Eguchi et al. 
2011; Lee 2011; Kiely et al. 2009). TLR4 and CD14 (which acts as a co-receptor for 
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bacterial LPS) mRNA and protein expression levels have also been found in rat and 
human β-cells (Vives-Pi et al. 2003; Garay-malpartida et al. 2011). There is little 
reported about the effects of TLR2 signalling in β-cells on islet inflammation and β-
cell function. In contrast TLR4 activation has consistently been reported to inhibit 
chronic insulin secretion from the rat islets, (Osterbye et al. 2010) the rat BRIN-
BD11 b-cell line, (Kiely et al. 2009) and purified human β-cells (Garay-malpartida et 
al. 2011). Some studies have also reported that LPS can reduce acute glucose-
stimulated insulin secretion in the rat and mouse islets (Vives-Pi et al. 2003; Amyot 
et al. 2012) likely via reductions in insulin content due to inhibition of insulin gene 
transcription (Amyot et al. 2012). However, effects of TLR4 signalling on β-cell 
apoptosis are less consistent with the variable results, possibly owing to the use of 
different cell lines, mouse models and islets versus purified β-cells (Lee 2011; Kiely 
et al. 2009; Garay-malpartida et al. 2011; Amyot et al. 2012). Amyot et al however 
have shown that LPS impairs insulin gene expression through activation of NF-κB as 
LPS inhibition of gene expression in rat islets was prevented by inhibition of this 
pathway (Amyot et al. 2012). In addition to gastrointestinal (GI)-derived bacterial 
TLR2 and TLR4 PAMPs and systemic TLR2 and TLR4 DAMPs, studies have 
suggested the presence of islet tissue-derived TLR2 and TLR4 ligands. Necrotic β-
cell debris has been shown to activate macrophages and dendritic cells via TLR2 (H. 
S. Kim et al. 2007) Although not investigated as of yet, β-cells undergoing 
secondary necrosis may also be present in T2D. Recent work on islet amyloid 
polypeptide also indicates a role for TLR2 in IAPP-induced islet inflammation 
(Westwell-Roper et al. 2012).   
 
 
26 
 
1.5.3.2 Insights from knockout studies 
Along with studies showing the direct effects of TLR2 and TLR4 on β-cell function, 
selective knockout studies have also pointed to a role for these receptors in β-cell 
physiology and T2D. Both TLR2 and TLR4 deficient mice are protected from 
insulin resistance and β-cell dysfunction induced by a high-fat diet (Ehses et al. 
2010; Himes & Smith 2010; Li et al. 2013). And in human studies polymorphisms in 
the TLR4 gene have been found to be protective against the development of T2D 
(Jiang et al. 2013). This is interesting as it seems to be in direct contrast to observed 
effects in mice deficient in TLR5 the receptor for bacterial flagellin. Mice deficient 
in this receptor actually display increased hallmark signs of the metabolic syndrome 
including hyperlipidemia, hypertension, insulin resistance, and increased adiposity 
(Vijay-Kumar et al. 2010). Furthermore a nonsense polymorphism in the TLR5 gene 
in humans actually pre-disposed individuals to the development of T2D (Al-Daghri 
et al. 2013).  This shows that along with their role in β-cell inflammation, some 
TLRs may also play a homeostatic role in the β-cell. This is further supported by 
studies investigating TLR adaptor molecules. Mice deficient in the adaptor MyD88, 
show increased susceptibility to β-cell apoptosis following low dose streptozotocin 
treatment (Bollyky et al. 2009) and TRIF
-/-
 mice display hyperglycaemia associated 
with β-cell dysfunction (Hutton et al. 2010).  
 
1.5.4 Islet associated Macrophage 
Macrophages are innate immune cells derived from monocytes, which in turn arise 
from myeloid precursor cells in the bone marrow. Macrophages have many 
important roles in the innate and adaptive immune response, as well as in tissue 
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homeostasis. In T1D, immune cells such as T cells and macrophages accumulate 
within islets, where they produce various cytokines, reactive oxygen species (ROS) 
and Fas ligand, thereby contributing to β-cell damage (Bending et al. 2012).Within 
this setting, numerous macrophages are recruited to islets, where their actions have 
pathogenic effects. However, even under normal physiological conditions 
macrophages are also constitutively present within islets, where they play important 
roles during islet development and contribute to the maintenance of islet 
homeostasis. The presence of macrophages within islets was first reported thirty 
years ago (Hume et al. 1984). Macrophages are present in mouse islets during 
embryonic development and op/op mice which lack macrophages in many tissues, 
due to a mutation in colony stimulating factor-1 (CSF-1) including islets, show 
diminished β-cell mass (Banaei-Bouchareb et al. 2004). The precise mechanism by 
which macrophages support islet development is not clear, but cytokines produced 
by macrophages may be involved, as low concentrations of IL-1β are known to 
stimulate β-cell proliferation (Maedler et al. 2006).  
1.5.4.1 Macrophage polarity in T2D islets 
These findings suggest that macrophage may play an important homeostatic role in 
islets and β-cell physiology however recent studies have shown that they also make a 
crucial contribution to islet pathology in T2D. Immunohistochemical analysis of 
pancreas sections from patients with T2D, C57BL/6 mice fed a high-fat diet, db/db 
mice and Goto-Kakizaki (GK) rats all showed elevated numbers of macrophages 
within islets (Ehses et al. 2007).  In addition, high glucose or palmitate has been 
shown to induce secretion of chemokines from islets, which promoted monocyte and 
neutrophil migration (Ehses et al. 2009; Donath et al. 2010; Boni-Schnetzler et al. 
2009). This suggests that the type 2 diabetic milieu may induce chemokine 
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production and promote macrophage infiltration into pancreatic islets. In vitro 
studies have shown that Th1 cytokines, alone or in concert with microbial products, 
elicit classical M1 activation of macrophages, while Th2 cytokines (IL-4 and IL-13) 
elicit an alternative form of activation designated M2 (Gordon & Taylor 2005; 
Mosser & Edwards 2008). While classically activated M1-type macrophages play a 
central role in host defence by secreting proinflammatory cytokines and ROS, 
activated M2-type macrophages promote wound healing and may also modulate 
immune responses. Eguchi et al have reported two sub-populations of macrophage 
within islets: CD11b
+
Ly-6C
+ 
and CD11b
+
Ly-6C
−
 macrophages (Eguchi et al. 2011). 
They found that under basal conditions, islet-resident macrophages were largely 
CD11b
+
Ly-6C
−
 cells which exhibit an M2-type phenotype. Fractions of these M2-
type cells were not altered in db/db mice, as compared with control db/+ mice 
however the number of CD11b
+
Ly-6C
+
 macrophages was specifically increased in 
the T2D models. These cells express inflammatory cytokines, including IL-1β and 
TNF-α, and exhibit an M1-type phenotype. Thus macrophage polarity appears to be 
shifted towards M1 in T2D islets. 
1.5.4.2 Macrophage contribution to β-cell dysfunction 
TLR activation in macrophages induces NF-κB and IFR (interferon regulatory 
factor) driven cytokine induction and ligands activating these receptors may induce 
pro-inflammatory M1 macrophage in the islets in T2D. Added to this the T2D milieu 
may induce production of chemokines that promote macrophage infiltration into 
pancreatic islets (Donath et al. 2010). Inflammasomes are multi-protein complexes 
important for the maturation and secretion of IL-1β. To induce IL-1β secretion, two 
stimuli are required: the first induces the expression of pro-IL-1β protein, while the 
second activates inflammasomes, which in turn activate caspase I to cleave pro-IL-
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1β, yielding mature IL-1β (Latz 2010). It was recently reported that one of the first 
stimuli in islets of T2D is minimally modified low density lipoprotein (LDL), which 
activates TLR4 signalling in macrophages, priming them to process IL-1β. The 
second stimulus was identified as IAPP, which is secreted from β-cells in response to 
high glucose (Masters et al. 2010). A soluble oligomer, IAPP, triggers activation of 
the NLRP3 inflammasome and induces IL-1β secretion from the islet macrophages. 
Thus the interaction between β-cells and macrophages is important for 
inflammasome activation within islets (Masters et al. 2010). As IL-1β and other pro-
inflammatory cytokines that are secreted by M1 type macrophage have been shown 
to be detrimental to β-cell function and insulin resistance this provides a mechanistic 
link between islet macrophage and β-cell dysfunction in the context of T2D (see 
Figure 1.3). Indeed in a mouse model using infusion of palmitate to induce β-cell 
dysfunction, increased chemokines and M1 type macrophage were found in the islets 
and blocking this recruitment of macrophage using clodronate liposomes suppressed 
β-cell dysfunction (Eguchi et al. 2011). The relationship between macrophage and β-
cells in the context of islet inflammation certainly warrants further investigation. 
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                          Figure 1.3 Contribution of macrophage to β-cell dysfunction during Type 2 Diabetes.
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1.6 Aims and Objectives 
There is a growing body of evidence supporting a role for activation of the innate 
immune system and low grade inflammation in the development and pathogenesis of 
T2D. Dysfunction of the β-cells, when they can no longer compensate for insulin 
resistance by increasing their insulin output, is the critical step when insulin resistant 
individuals develop overt T2D. Recent work has focused on a role for the innate immune 
system in β-cell physiology and dysfunction. Toll-like receptor ligands both exogenous 
and endogenous have been shown to be increased in T2D. We wanted to investigate the 
effect of activation of these receptors on β-cell physiology and function. As is the case 
with many tissues throughout the body, islets contain resident macrophage, and increased 
numbers of islet macrophage are associated with and contribute towards type 2 diabetic 
pathology. We hypothesised that crosstalk between these two cell types must occur, and 
perhaps is dysregulated during the progression to T2D. We also hypothesised that as T2D 
and β-cell dysfunction is linked with low grade inflammation, and altered gut 
homeostasis can contribute to the pathogenesis of T2D, perhaps gut inflammation may 
provide a source of the infiltrating macrophages seen in diabetic islets. 
To test these hypotheses the aims of this thesis were to 
 Investigate the effect of TLR activation on pancreatic β-cells in vitro using 
the MIN6 insulin secreting pancreatic β-cell line. 
 To examine the crosstalk that occurs between pancreatic β-cells and 
macrophage with the use of the MIN6 β-cell line and the J774A.1 
macrophage cell line. 
 To investigate a possible link between gut inflammation and macrophage 
infiltration of the pancreas with the use of the DSS induced model of colitis. 
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Chapter 2 
Materials and Methods  
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2.1 Materials 
 
CELL CULTURE MATETIALS/REAGENTS 
Material 
 
Source 
 
Foetal Calf Serum 
 
Gibco 
 
DMEM 
 
Sigma-Aldrich 
 
DMEM-Glutamax 
 
Gibco 
 
RPMI-1640 
 
Gibco 
 
PBS 
 
Gibco 
 
Tissue culture flasks T-75cm2 
 
Nunc 
 
Tissue culture flask T-25cm2  
 
Nunc 
 
Sterile Petri dishes 
 
Nunc 
 
6, 24 & 96 well tissue culture plates 
 
Nunc 
 
96 well round bottomed plate 
 
Starstedt 
 
Glucose solution 
 
Sigma-Aldrich 
 
Trypan blue (0.4% w/v) 
 
Sigma-Aldrich 
 
Trypsin/EDTA 
 
Sigma-Aldrich 
 
Penicillin Streptomycin/Glutamine 
 
Gibco 
 
CellTiter 96™ Aqueos One Solution 
 
Promega 
 
rmIL-4 
 
R&D Systems 
 
Streptozotocin 
 
Sigma-Aldrich 
 
PAM3CSK4  
 
Invivogen 
 
LPS 
 
Invivogen 
 
Flagellin 
 
Invivogen 
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Griess Reagent 
 
 
Promega 
 
Exosome Free-FBS 
 
Stratech 
 
rmIL-27p28 
 
R&D Systems 
Transwell® Plates 
 
Analab 
 
Table 2.1 Cell Culture Materials. All cell culture materials/reagents used and 
corresponding sources. 
 
ELISA REAGENTS 
Material Source 
 
 
96-well microtiter plate 
 
Nunc 
 
TMB 
 
BD 
 
Tween 20 
 
Sigma-Aldrich 
 
Bovine Serum Albumin 
 
Sigma-Aldrich 
 
Sodium Azide (NaN3) 
 
Sigma-Aldrich 
 
ELISA Duoset kits 
 
R&D Systems 
 
Insulin ELISA kit 
 
Mercodia 
 
DPBS 
 
Gibco 
 
Table 2.2 ELISA Reagents. All ELISA reagents used and corresponding sources 
 
FLOW CYTOMETRY REAGENTS 
Material Source 
 
 
FACS Flow 
 
BD 
 
FACS RINSE 
 
BD 
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FACS Clean BD 
 
37% (v/v) paraformaldehyde 
 
Sigma-Aldrich 
 
Sodium Azide 
 
Sigma-Aldrich 
 
EDTA 
 
Sigma-Aldrich 
 
Triton X-100 
 
Sigma-Aldrich 
 
Anti-F4/80 antibody 
 
Biolegend 
 
Anti-CD86 antibody 
 
BD 
 
Anti-CD80 antibody 
 
BD 
 
Anti-TLR2 antibody 
 
eBioscience 
 
Anti-TLR4 antibody 
 
eBioscience 
 
Anti-TLR5 antibody 
 
Abcam 
 
Anti-MHCII antibody 
 
eBioscience 
 
Anti-CD40 antibody 
 
BD 
 
Anti-CCR5 antibody 
 
BD 
 
Anti-CD124 antibody 
 
BD 
 
Anti-CD14 antibody 
 
BD 
 
Anti-PDX1 antibody 
 
R&D systems 
 
Anti-Insulin Receptor antibody 
 
R&D systems 
 
DCFDA 
 
Abcam 
 
CompBeads 
 
BD 
 
Fluorescent Latex Beads 
 
Sigma-Aldrich 
 
Table 2.3 Flow Cytometry Reagents. All flow cytometry reagents used and 
corresponding sources. 
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RNA ISOLATION AND cDNA SYNTHESIS 
Material Source 
 
 
Nuceleospin RNA II Columns 
 
Macherey-Nagel 
 
DEPC treated water 
 
Invitrogen 
 
High Capacity cDNA Reverse 
Transcription Kit 
 
Applied Biosystems 
 
Molecular grade ethanol 
 
Sigma-Aldrich 
 
Table 2.4 RNA isolation and cDNA synthesis materials. All reagents used for 
RNA isolation and cDNA synthesis and corresponding sources. 
 
qPCR REAGENTS 
Material 
 
Source 
 
Taqman
®
 Universal Mastermix 
 
Applied Biosystems 
 
SYBR
®
 Green Matermix 
 
Roche 
 
Microamp
®
 Optical Adhesive film 
 
Applied Biosystems 
 
Microamp
®
 Optical 96-well plate 
 
Applied Biosystems 
 
IAPP PrimeTime qPCR Assay 
 
IDT 
 
FAM3B PrimeTime qPCR Assay 
 
IDT 
 
INS1 PrimeTime qPCR Assay 
 
IDT 
 
INS2 PrimeTime qPCR Assay 
 
IDT 
 
B2M PrimeTime qPCR Assay 
 
IDT 
 
IRS1 PrimeTime qPCR Primers 
 
IDT 
 
IRS2 PrimeTime qPCR Primers 
 
IDT 
 
NOS2 PrimeTime qPCR Primers 
 
IDT 
 
IL-1β PrimeTime qPCR Primers 
 
IDT 
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ARG1 PrimeTime qPCR Primers 
 
IDT 
 
MRC1 PrimeTime qPCR Primers 
 
IDT 
 
TLR4 PrimeTime qPCR Primers 
 
IDT 
 
TLR5 PrimeTime qPCR Primers 
 
IDT 
 
TNF-α PrimeTime qPCR Primers 
 
IDT 
 
IL-6 PrimeTime qPCR Primers 
 
IDT 
 
GUSB PrimeTime qPCR Primers 
 
IDT 
 
Actin PrimeTime qPCR Primers 
 
IDT 
 
IFN-λ PrimeTime qPCR Primers 
 
IDT 
 
IL-17 PrimeTime qPCR Primers 
 
IDT 
 
Table 2.5 Quantitative PCR Reagents. All qPCR reagents used and corresponding 
sources. 
 
GEL ELECTROPHORESIS REAGENTS 
Material 
 
Source 
 
Agarose 
 
Thermo-Fisher Scientific 
 
SYBR
®
 Safe DNA Gel Stain 
 
Applied Biosystems 
 
Gene-ruler 100 bp plus DNA ladder 
 
Thermo-Fisher Scientific 
 
DNA loading Buffer 
 
Fermentas 
 
Table 2.6 Gel Electrophoresis Reagents. All gel electrophoresis reagents used and 
corresponding sources. 
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IMMUNOHISTOCHEMISTRY & IMMUNOCYTOCHEMISTRY 
REAGENTS 
Material 
 
Source 
 
 
Acetone 
 
Sigma-Aldrich 
 
HCL 
 
Sigma-Aldrich 
 
Sodium Bicarbonate 
 
Sigma-Aldrich 
 
Ethanol 
 
Merck 
 
Harris Haematoxylin 
 
Sigma-Aldrich 
 
Eosin 
 
Sigma-Aldrich 
 
Histo-clear 
 
National Diagnostics 
 
Histobond microscope slides 
 
RA Lamb 
 
OCT solution 
 
Tissue-Tek 
 
HRP-DAB Cell & Tissue Staining Kit 
 
R&D Systems 
 
Paraffin wax 
 
VWR 
 
Formalin 
 
Sigma 
 
Xylene 
 
Sigma 
 
Anti-F4/80 antibody 
 
Abcam 
 
Glycine 
 
Sigma-Aldrich 
 
Fish-Gelatin 
 
Sigma-Aldrich 
 
DAKO fluorescent mounting medium 
 
DAKO 
 
Anti-PDX1 antibody 
 
Abcam 
 
DPX mounting medium 
 
Sigma-Aldrich 
 
Table 2.7 Immunohistochemistry & Immunocytochemistry Reagents. All 
immunohistochemistry reagents used and corresponding sources.
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2.2 Cell Culture 
 
All cell culture was carried out in a class II laminar airflow unit (Holten 2010 – 
ThermoElectron Corporation, OH, USA). Strict aseptic techniques were adhered to 
at all times. The laminar flow cabinet was swabbed with 70% industrial methylated 
spirits (IMS) before and after use, as were all the items used in the cabinet. The 
cabinet was cleaned each week with industrial detergents (Virkon, Antec. 
International; TEGO, TH. Goldschmidt Ltd). Cell cultures were maintained in a 
37°C incubator with 5% CO2 and 95% humidified air (Model 381 -Thermo Electron 
Corporation OH USA). Cells were grown in complete DMEM (Sigma-Aldrich) or 
DMEM-glutamax (Biosciences) supplemented with 10% FBS and 2% penicillin -
streptomycin/glutamine. FCS was heat-inactivated (56°C for 30 min) to inactivate 
complement and aliquoted for storage at -20 °C. Supplemented medium was stored 
at 4 °C for no longer than one month. 
 
2.2.1 Transgenic C57BL/6 mouse insulinoma cell line (MIN6). 
The MIN6 cell line (P15-30) was maintained in complete DMEM-glutamax 
substituted with 25 mM glucose (Sigma-Aldrich) in vented 75 cm
2
 flasks. Cell 
monolayers were passaged at confluency of ~80% (every 3-4 days). To subculture 
cells were washed once with warm PBS (Biosciences). Cells were detached by 
adding 2ml of warm 0.25% trypsin, 0.02% EDTA solution (Sigma-Aldrich). 
Trypsin/EDTA solution was left on the cells at 37ºC until the cells detached (~3-4 
mins). Fresh culture medium was then added to deactivate the trypsin/EDTA. Cells 
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were centrifuged at 1000 rpm for 5 min, resuspended in fresh media and subcultured 
in a ratio 1:4, in fresh 75 cm
2
 flasks 
 
2.2.2 Murine monocyte-derived macrophage cell line, J774A.1 
The J774A.1 cell line was purchased from the European Collection of Cell Cultures 
(ECACC) and maintained in complete DMEM in 75 cm
2
 flasks. Cell monolayers 
were passaged at a confluency of 80% (every 3 to 4 days). Cells were detached using 
a cell scraper and transferred into a 50 ml falcon. Cells were centrifuged at 250 g for 
5 min and resuspended in complete DMEM. For subculture, cells were plated at 
1x10
6
/25 ml DMEM in a fresh 75 cm
2
 flask. 
 
2.2.3 Cell counting 
Cell counting and viability determinations were carried out using the trypan-blue 
(Sigma-Aldrich) dye exclusion technique. This test is based on the ability of viable 
cells to actively exclude dye as a result of having an intact cell membrane. Dead cells 
are unable to exclude the dye and appear blue when viewed under a microscope. 100 
µl of cell suspension was mixed with 150 µl PBS and 250 µl of trypan blue solution. 
After 3 min incubation at room temperature, a sample of this mixture was applied to 
the chamber of a haemocytometer over which a glass cover slip had been placed. 
Cells in the 16 squares of the four outer corner grids of the chamber were counted 
microscopically. An average per corner grid was calculated. 
A viable cell count was determined using the following formula:  
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Cell/ml = N x 5 x 10
4
 
Where, N = average cell number counted, 5 = dilution factor, and 10
4 
= constant.  
 
2.2.4 Preparation of cell stocks 
Cryoprotective medium or freezing medium was prepared in complete culture 
medium containing 20% dimethylsulfoxide (DMSO; Sigma-Aldrich) and filter 
sterilised using  a 0.22 µm filter and syringe. The freezing medium was then placed 
on ice until used. Appropriate number of cryogenic vials (Nalgene®, Lennox) were 
labelled with the cell line, passage no, date, and placed on ice. At this point cells 
were collected and counted as previously described. . The supernatant from the 
centrifuged cells were removed and the pellet was re-suspended in 1 ml of fresh 
media. This solution (20% DMSO) was slowly added drop wise to the cell 
suspension to give a final concentration to 10% of DMSO, and a final cell 
concentration of 5 x 10
6 
cells/ml. Cryovials were placed in a Nalgene
®
 Mr. Frosty 
freezing container. The Mr. Frosty container was filled with isopropanol and placed 
in a –80°C freezer. Mr. Frosty freezing container provided slow preservation of cells 
at a rate of 1 °C/min. After 2 hr vials were transferred to liquid nitrogen or -80°C for 
long term storage.  
 
2.2.5 Retrieval of Frozen stocks 
Cryovials were carefully removed from liquid nitrogen or -80°C freezer and quickly 
thawed in a 37°C water bath. Thawed cells were transferred to 9 ml room-
temperature DMEM on ice and carefully resuspended. Cells were spun at 1200 rpm 
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for 5 min to remove excess DMSO. Following this, supernatant was discarded and 
cells resuspended in 10 ml warm DMEM, and left overnight to adhere in a 25 cm
2
 
vented flask. The next day cells were collected as previously described and 
resuspended in fresh media to remove any excess DMSO and transferred to a 75 cm
2 
flask in 25 ml media. 
 
2.2.6 Glucose-Stimulated Insulin secretion from MIN6 cells 
MIN6 cells were plated at a density of 1 x10
6
 cells/ml and left to reach confluency. 
Media was then removed and cells were washed with PBS and left to equilibrate for 
30 mins in Krebs-Ringer Buffer (KRB) containing 25 mM HEPES, 0.1% BSA and 2 
mM glucose at 37°C and 5% CO2. Following Equilibration cells were incubated for 
1hr in KRB-BSA containing various concentrations of glucose (0 – 20 mM) at 37°C 
and 5% CO2. The assay was terminated by placing the plate on ice, the media was 
removed, centrifuged at 1000 rpm for 5 mins to remove any debris and supernatant 
was analysed for insulin content by ELISA. 
 
2.2.7 Measurement of total MIN6 insulin content 
MIN6 cells were plated at a density of 1 x10
6
 cells/ml and left to reach confluency. 
Cells were washed in PBS and were lysed in ice-cold acid/ethanol solution (HCl 
1.5% [vol./vol.], ethanol 75% [vol./vol.] and H2O 23.5% [vol./vol.]) cells were then 
disrupted by sonication. Protein was quantified and normalised using the BCA assay 
(Thermo Fisher Scientific, Rockford, IL, USA) and insulin content was measured 
using a mouse insulin ELISA (Mercodia, AB, Uppsala, Sweeden). 
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2.2.8 Conditioning experiments 
MIN6 cells were grown until they were confluent after which fresh media was added 
to cells and left for a further 24hr. This media was then removed and centrifuged at 
1000 rpm for 5 mins to remove any cell debris. This media is here on referred to as 
“conditioned media”. In order to assess the effect of the conditioned media on 
macrophage function J774A.1 macrophage were plated at a concentration of 1 x 10
6
 
cells/ml in either normal DMEM or MIN6 conditioned media. Cells were then left to 
rest for 24hr prior to activation with TLR ligands and assessment of various 
parameters. 
 
2.3 Flow Cytometry 
2.3.1 Basic principles of flow cytometry 
Flow cytometry is a technology that simultaneously measures and then analyses 
multiple physical characteristics of single cells, as they ﬂow in a ﬂuid stream through 
a beam of light. The properties measured can include a particles relative size, relative 
granularity or internal complexity, and relative ﬂuorescence intensity. These 
characteristics are determined using an optical-to-electronic coupling system that 
records how the cell or particle scatters incident laser light and emits ﬂuorescence. A 
ﬂow cytometer is made up of three main systems: ﬂuidics, optics, and electronics.  
 The ﬂuidics system transports particles in a stream to the laser beam for 
interrogation. The optics system consists of lasers to illuminate the particles in the 
sample stream and optical ﬁlters to direct the resulting light signals to the appropriate 
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detectors. The electronics system converts the detected light signals into electronic 
signals that can be processed by the computer. 
When a particle or a cell passes through a laser beam, laser light is scattered in all 
directions. Light that scatters axial to the laser beam is known as forward scatter 
(FSC); light that scatters perpendicular to the laser beam is known as side scatter 
(SSC). FSC and SSC are related to certain physical properties of cells. FSC is 
proportional to the cell-surface area or size, while SSC is proportional to cell 
granularity or internal complexity. 
Fluorescent probes can also be added to the cell for detecting specific molecules in 
or on the cell. These probes are typically antibodies to cellular antigens with a 
covalently attached fluorochrome. A ﬂuorescent compound absorbs light energy over 
a range of wavelengths that is characteristic for that compound. This absorption of 
light causes an electron in the ﬂuorescent compound to be raised to a higher energy 
level. The excited electron quickly decays to its ground state, emitting the excess 
energy as a photon of light. This transition of energy is called ﬂuorescence. The 
amount of ﬂuorescent signal detected is proportional to the number of ﬂuorochrome 
molecules on the particle. 
 
2.3.2 Cell surface staining 
To carry out cell surface staining cells were washed once with PBS and then 
removed from tissue culture plates with a cell scraper. Cells were then placed in 96 
well round bottomed plates at a concentration of ~ 250,000 cells per well. Cells were 
then blocked with an equal amount of foetal bovine serum for 15 mins at room 
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temperature to prevent binding of non-specific antibodies. The plate was them 
centrifuged at 2000rpm to pellet cells and cells were washed twice with FACS buffer 
(2% FBS, 0.05% NaN3/PBS). Cells were then incubated with appropriate 
fluorochrome-conjugated antibodies for 30min at 4ºC protected from light. Cells 
were then washed twice with FACS buffer to remove the unbound antibodies and 
were analysed using a FACSAria I (BD). All the flow cytometry data was analysed 
using FlowJo software (Treestar). 
 
2.3.3 Intracellular Staining 
In order to stain intracellular antigens, the cell must be permeabilised to allow 
binding of the antibody to the intracellular antigen. Depending on the specific 
location of the intracellular antigen, different methods of permeabilisation may be 
carried out.  Cells were washed once with PBS and then removed from tissue culture 
plates with a cell scraper. Cells were then placed in 96-well round bottomed plates at 
a concentration of ~250,000 cells per well. Cells were then blocked with an equal 
amount of foetal bovine serum for 15 mins at room temperature to prevent binding of 
non-specific antibodies. The plate was them centrifuged at 2000rpm to pellet cells 
and cells were washed twice with FACS buffer (2% FBS, 0.05% NaN3/PBS). Cells 
were then fixed in 4% paraformaldehyde (PAF)/PBS for 15 mins at room 
temperature. Cells were then permeabilised in either 0.5% Tween/PBS or 0.5% 
Triton/PBS depending on antigen of interest, for 15 mins at room temperature. Cells 
were then washed twice in buffer containing detergent. Cells were incubated with 
fluorescently conjugated antibodies for 30 mins at 4°C. Antibodies were diluted in 
permeabilisation buffer to ensure cells remained permeable. Cells were then washed 
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twice with FACS buffer containing detergent to remove the unbound antibodies and 
were analysed using a FACSAria I (BD). All the flow cytometry data was analysed 
using FlowJo software (Treestar). 
 
2.3.4 Measurement of Phagocytosis 
J774A.1 macrophages were cultured in 6-well plates at a concentration of 5x10
5
 cells 
in a total volume of 2ml/well. To assess phagocytosis, macrophages were incubated 
with 1 μm fluorescent latex beads (Sigma-Aldrich), at a concentration of 20 beads 
per cell, for 2hr at 37ºC. Cells were then washed with PBS/2% FCS and the uptake 
of beads (λex ~470 nm; λem ~505 nm) was measured by flow cytometry. For the 
analysis of phagocytosis after stimulation, cells were treated with Pam3CSK4 1 
μg/ml, LPS 100 ng/ml & Flagellin 5 μg/ml for 24hr prior the addition of latex beads. 
 
2.3.5 Measurement of reactive oxygen species (ROS) production 
To measure the intracellular ROS production, 0.5x10
6
 cells/ml were incubated with 
20 μM of the cell permeant reagent 2’,7’ –dichlorofluorescein diacetate (DCFDA; 
Abcam) for 30 min at 37ºC in the dark, according to manufacturer’s instructions. 
DCFDA is a fluorogenic dye that measures hydroxyl, peroxyl and other ROS activity 
within the cell. After diffusion into the cell, DCFDA is deacetylated by cellular 
esterases to a non-fluorescent compound, which is later oxidized by ROS into 2’, 7’ 
–dichlorofluorescin (DCF). DCF is a highly fluorescent compound which can be 
detected by fluorescence spectroscopy with maximum excitation and emission 
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spectra of 495nm and 529nm respectively. The fluorescence intensity of DCF was 
measured by flow cytometry. 
 
2.4 Enzyme-linked immune-sorbent assay (ELISA) 
2.4.1 Basic principles of ELISA 
ELISA is a sensitive and reproducible method used to measure antigen concentration 
in an unknown sample. In all our studies we used a sandwich ELISA (or an 
adaptation of) to measure the amount of cytokines, chemokines and insulin in cell 
supernatants. To detect the antigen, the wells of 96-well microtiter plates are coated 
with specific (capture) antibody followed by incubation with test solutions 
containing antigen. Unbound antigen is washed out and an antigen-specific antibody 
conjugated to enzyme (i.e., developing reagent) is added, followed by incubation. 
The detection antibody is usually conjugated with biotin which then allows for the 
detection reagent (streptavidin-HRP) to bind to it. The streptavidin and biotin bind 
with high affinity and the amount of horseradish-peroxidase (HRP) is proportional to 
the amount of target antigen in the sample. Substrate solution is then added 
(tetramethylbenzidine, TMB) and the HRP enzyme catalyses the oxidation of the 
TMB into a coloured product. The reaction is allowed to progress for a defined 
period after which the reaction is stopped by altering the pH of the system. Stop 
solution is a used to terminate the enzyme substrate reaction for ELISA applications 
after attaining the desired colour intensity which is an indication of analyte level. 
The optical density (O.D.) of the colour is measured on a microplate reader. For each 
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set of samples, a standard curve is generated and the values of unknown samples are 
calculated from the standard curve. 
 
 
 
 
 
 
Figure 2.1 Schematic representation of sandwich ELISA. Schematic adapted 
from ELISA Kit Technology Principals on www.epitomics.com.  
 
2.4.2 Cytokine ELISA 
The concentration of cytokines IL-2, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, IL-17, 
IL-23, IL-27p28 and TNF-α were examined in cell using ELISA Duoset kits from 
R&D Systems in accordance with the manufacturers’ instructions. Briefly, 100 
μl/well of capture antibody (diluted to the appropriate concentration in PBS) was 
added to an ELISA plate (Nunc) and incubated overnight at room temperature. Plates 
were then washed three times by immersion  in Wash Buffer (PBS + 0.05% Tween-
20) and blocked by adding 300 μl of Blocking buffer (1% (w/v) BSA/PBS) for a 
minimum of 1hr at room temperature. The washing step was repeated and 100 μl of 
samples and standards (diluted to appropriate concentrations) were added per well, in 
triplicate. Plates were then incubated at 4ºC overnight. The plates were then washed 
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again and 100 μl of the biotinylated detection antibody was added to each well and 
incubated for 2hr at room temperature. Plates were washed and 100 μl of 
Streptavidin-HRP (R&D) was then added to each well. Plates were incubated for 20 
min at RT. Plates were washed for a final time and 100 μl of TMB (BD Biosciences) 
was added to each well and plates were left in dark for 20 min or until the blue 
colour develops. Colour development was stopped by adding 50 μl of 1M sulphuric 
acid (Sigma-Aldrich) to the wells. The optical density was determined at 450nm, 
using a VersaMax™ microplate reader (Molecular Devices). The average co-
efficient of variation obtained with this kit was lower than 0.2 using the following 
calculation Std.Dev of samples/Mean *100. 
 
2.4.3 IL-1β and IFN-λ ELISA 
The method above was followed with two deviations:   
Blocking buffer used was 1% (w/v) BSA/PBS + 0.05% NaN3. The reagent diluent 
was 0.1% (w/v) BSA/TBS + 0.05% Tween.  
 
2.4.4 Chemokine ELISA 
The concentration of chemokines MIP-1α, MIP-2, MCP-1 and RANTES in cell 
supernatants was determined using ELISA Duoset kits from R&D Systems in 
accordance with the manufacturers’ instructions. The protocol is as described in the 
last section 2.4.2. Prior to analysis, supernatants were diluted 1 in 1000. The average 
co-efficient of variation obtained with this kit was lower than 0.2 using the following 
calculation Std.Dev of samples/Mean *100. 
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2.4.5 Insulin ELISA 
The concentration of insulin in cell supernatants was determined using a mouse 
insulin ELISA kit from Mercodia in accordance with the manufacturers’ instructions. 
This kit is also based on the “sandwich” ELISA method; however the plates come 
pre-coated with capture and detection antibodies. Briefly 10 μl of sample was added 
to each well in along with 100 μl of an enzyme-conjugate solution (Mercodia). The 
plate was sealed and left on a plate shaker for 2hr after which the plate was washed 5 
times with wash buffer (Mercodia). 200 μl of substrate TMB (Mercodia) was then 
added to each well and left for 15 mins or until blue colour develops. 50 μl of stop 
solution (Mercodia) was then added to each well, the plate was briefly shaken and 
the optical density was determined at 450 nm, using a VersaMax™ microplate 
reader (Molecular Devices). Depending on the number of cells used in the original 
experiment, supernatants were subjected to a dilution of 1 in 30 or 1 in 60 prior to 
analysis. The average co-efficient of variation obtained with this kit was lower than 
0.2 using the following calculation Std.Dev of samples/Mean *100. 
 
2.5 MTS Viability Assay 
Cell viability was determined by the MTS assay (Promega). The CellTiter 96
®
 
AQueous Assay is composed of solutions of a novel tetrazolium compound [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H 
tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine 
methosulfate) PMS. MTS is bioreduced by cells into a formazan product that is 
soluble in tissue culture medium. The absorbance of  the formazan product at 490 
nm can be measured directly from 96-well assay plates without additional 
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processing. Briefly, 100 μl cell suspension (containing 1 x 106 cells/ml) was plated in 
a 96-well plate. At the end of each experiment the cell proliferation reagent MTS (20 
μl) was added to each well, and the cells were incubated at 37°C for 1hr. A490nm was 
measured using a VERSA Amax microplate reader (Molecular Devices, CA, USA). 
Results are expressed as a percentage of control cells. 
 
2.6 Measurement of Nitric Oxide (NO) Formation 
NO levels were detected in the cell supernatants by measuring the production of 
nitrite (NO
2-)
 which is a stable breakdown product of NO. The production of nitrite 
was measured using the Griess Reagent System (Promega). The Griess Reagent 
system uses sulfanilamide and N-1-napthylethylenediamine dihydrochloride (NED), 
under acidic (phosphoric acid) conditions, which form the coloured azo-compound 
in the presence of nitrite. The intensity of the colour is proportional to the 
concentration of nitrite in the sample. The nitrite concentration is then determined 
using sodium nitrite as a standard. Briefly, 50 μl of samples and standards were 
added to the 96-well plate in triplicate. 50 μl of the Sulfanilamide Solution 
(Promega) was then added to each well and plate was incubated for 10 min at RT, 
protected from light. 50 μl of the NED solution (Promega) was added to all wells and 
incubated for another 10 min at RT, protected from light. A purple/magenta colour 
develops and the absorbance was measured at 543nm using a VersaMax™ 
microplate reader (Molecular Devices). 
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2.7 Macrophage chemotaxis assay 
The transwell migration assay also known as the Boyden or modified Boyden 
chamber assay [Figure 2.2] is a method of measuring cell chemotaxis towards a 
stimulus/or invasion through a substrate. Supernatants were taken from MIN6 cells 
after 24hr incubation in the presence or absence of TLR ligands Pam (1 ug/ml), LPS 
(100 ng/ml) and Flagellin (5 ug/ml), centrifuged at 1000rpm for 5 min to remove any 
cell debris and placed in the bottom wells of a transwell
®
 plate (Analab Ltd, 
Rathfarnham, Dublin, Ireland). 250 μl of a suspension of J774 Macrophage 
containing 0.5 x 10
6 
cells was then placed in each insert after which the plate was left 
at 37°C and 5% CO2 for 6hr. The inserts were then carefully removed and the 
supernatants collected from the bottom wells. The numbers of migrated cells were 
then counted on a BD FACS Aria. 
 
 
Figure 2.2 Diagrammatic representation of Chemotaxis Transwell
®
 Assay.  
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2.8 Confocal Microscopy 
In order to assess the effect that glucose has on PDX-1 localisation in MIN6 cells, 
cells were plated at a density if 1x10
6
 cells/ml on coverslips contained in 6-well 
quiescence of insulin signalling. The cells were left overnight to attach. Following 
this the media was replaced with fresh low glucose (0.5 mM) or high glucose (20 
mM) media for 20 mins. Cells were washed with PBS and immediately fixed by 
immersion in ice-cold acetone for 1 min. Cells were then allowed to air-dry, 
coverslip edges were sealed with a hydrophobic pen. Cells were the washed for 5 
mins in PBS. To prevent non-specific binding cells were then blocked for 1hr at RT 
using blocking buffer (100mM Glycine and 1.2% fish gelatine in PBS). Cells were 
then incubated with PDX1 antibody in blocking buffer overnight at 4°C. Cells were 
then washed for 3 x 5 min in PBS and incubated with an appropriate secondary 
antibody for 1hr in the dark. Cells were washed once more with PBS, stained for 10 
mins with DAPI for nuclear visualisation and washed again. Coverslips were then 
mounted on slides using DAKO fluorescent mounting medium and sealed using 
clear nail varnish. 
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2.9 RNA Analysis 
2.9.1 Total RNA isolation 
2.9.1.1 RNA isolation from MIN6 and J774A.1 cell lines 
Cells (both MIN6 and J774) were plated at a density of 1 x 10
6
 cells/ml. Cells were 
then treated under various conditions. At the completion of the experiment cells were 
washed once with PBS, RA1 + β-ME was added to wells and cells were scraped 
using the insert of a 1ml syringe. The cells were then disrupted by passing up and 
down through a 19.5 g needle and syringe. Total RNA was then isolated using a 
Nucleospin RNA II kit (Macherey-Nagel) according to manufacturer’s instructions. 
Briefly, tissue was once again disrupted by passing up and down through a 19.5 g 
needle. The viscosity of the lysate was cleared by filtration through a NucleoSpin
®
 
filter and centrifuging for 1min at 11,000 x g. 70% ethanol was added to the 
homogenised lysate to adjust RNA binding conditions. The NucleoSpin
®
 RNA II 
column was then used to bind RNA, with the addition of Membrane Desalting 
Buffer to remove salt and improve the efficiency of rDNase digestion. DNA was 
digested using a DNase reaction mixture at room temperature for 15 min. After 15 
min Buffer RA2 and RA3 were added to inactivate rDNase and wash the column. 
The NucleoSpin® RNA II column was then placed into a nuclease free collection 
tube and RNA was eluted in RNase-free H2O. The concentration of RNA was then 
measured using the Nanodrop
®
 ND-1000 (Thermo-Fisher Scientific). The purity of 
the RNA was determined using 260nm and 280nm absorption wavelengths. All the 
RNA used in this study had an A280/A260 ratio between 1.8 and 2.1. 
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2.9.1.2 Colonic RNA isolation 
Colonic tissue (20-30 mg) was homogenised in Lysis buffer RA1 (Macherey-Nagel) 
containing β-mercaptoethanol (β-ME) using the Qiagen TissueLyser LT for 5 min at 
50 Hz. Total RNA was then isolated using a Nucleospin RNA II kit (Macherey-
Nagel) according to manufacturer’s instructions (see section 2.9.1.1) 
 
2.9.2 cDNA synthesis 
Complementary DNA (cDNA) is generated from RNA using the High Capacity 
cDNA Reverse Transcriptase Kit (Applied Biosystems, USA). This kit contains a 
master mix of dNTP, random primers and the enzyme reverse transcriptase. Reverse 
transcriptase synthesises single strain cDNA using the RNA strands as a template. 
This is then used as the template for the subsequent qPCR experiments. 1 μg (colon) 
and 2 μg (cell lines) of RNA was used in each cDNA synthesis reaction. The settings 
in Table 2.1 are used in the reaction on a PTC-200 PCR thermal cycler (MJ 
Research). 
    Step 1 Step 2 Step 3 Step 4 
Temperature (°C) 25 37 85 4 
Time (min) 10 120 5 ∞ 
Table 2.8 Thermal cycling conditions 
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2.9.3 Basic principles of quantitative real time PCR (qPCR) 
The polymerase chain reaction (PCR) is one of the most powerful technologies in 
molecular biology. Using PCR, specific sequences within a DNA or cDNA template 
can be copied, or “amplified”, many thousand- to a millionfold. In traditional 
(endpoint) PCR, detection and quantitation of the amplified sequence are performed 
at the end of the reaction after the last PCR cycle, and involve post-PCR analysis 
such as gel electrophoresis and image analysis. The advantage of qPCR is that the 
amount of PCR product is measured at each cycle. This ability to monitor the 
reaction during its exponential phase enables users to determine the initial amount of 
target with great precision. In real-time PCR, the amount of DNA is measured after 
each cycle by the use of fluorescent markers that are incorporated into the PCR 
product. The increase in fluorescent signal is directly proportional to the number of 
PCR product generated in the exponential phase of the reaction. Fluorescent 
reporters used include double-stranded DNA (dsDNA)- binding dyes, or dye 
molecules attached to PCR primers or probes. These fluorescent reagents can be 
sequence specific or non-sequence specific. In this thesis both types of reagents were 
used, Taqman
®
 assay and SYBR
®
 green dye. 
 
2.9.3.1 SYBR
®
 green dye 
SYBR
®
 green is a fluorescent dye that binds to the minor groove of double-stranded 
DNA. SYBR
®
 green, an intercalating dye is a non-sequence-specific fluorescent 
dyes that exhibits a large increase in fluorescence emission when it intercalates into 
double-stranded DNA. During PCR, the primers amplify the target sequence and 
multiple molecules of the dye are inserted between bases of the double-stranded 
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product, causing fluorescence. SYBR
®
 green dye is non-sequence specific, which 
means it can bind to any double-stranded sequence such as primer-dimer artefacts or 
non-target sequence. To assess the specificity of the SYBR
®
 green assay we 
performed the dissociation analysis for each product. The dissociation step was 
added after the final PCR cycle. If there is only one product present in the tube it 
should have one specific melting temperature, Tm. The PCR software transforms the 
melt profile into a peak. If there is more than one peak present that usually signals 
the amplification of non-target products. Presence of one pure peak shows that one 
target amplified, but to further evaluate this the products were also run on a gel 
[appendix B ]. 
 
2.9.3.2  Taqman
®
 assay 
TaqMan
®
 probes require a pair of PCR primers in addition to a probe with both a 
reporter and a quencher dye attached. The probe is designed to bind to the sequence 
amplified by the primers. During qPCR, the probe is cleaved by the 5´ nuclease 
activity of the Taq DNA polymerase; this releases the reporter dye and generates a 
fluorescent signal that increases with each cycle. Because all three components (2 
primers and 1 probe) must hybridize to the target, this method allows detection of the 
PCR product with greater specificity and higher accuracy. 
 
2.9.4 qPCR protocol 
PCR was prepared in triplicate for each sample by adding cDNA, master mix and 
RNase free water (Invitrogen). In experiments with Taqman
®
 primer/probes 
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Taqman® Gene Expression Mastermix (Applied Biosystems) was used. In other 
experiments SYBR Green Mastermix (Roche) was used. All the primers and 
primer/probes were ordered from IDT and are listed in Table 2.5 and Appendix C. 
ROX dye was used as a passive reference to normalise the well to well differences 
that may occur due to artefacts such as pipetting errors or instrument limitations. 
Samples were added to a 96-well reaction plate (Applied Biosystems) and sealed 
with optically clear film (Applied Biosystems). Plates were centrifuged for 1 min at 
1000 x g and run on the ABI Prism 7500 (Applied Biosystems) or Lightcycler® 96 
system (Roche) under the conditions shown in Table 2.9 The results were analysed 
using the ABI Prism sequence detection software (Applied Biosystems), the 
Lightcycler® 96 software (Roche)  and Excel Software (Microsoft). 
 Step 1 Step 2 Step 3a Step 3b 
Temp (°C) 50 95 95 60 
Time  2min 10min 15sec* 15sec* 
   *Repeat for 40 cycles  
Table 2.9 Thermal cycling conditions. 
2.9.5 PCR data analysis 
For gene expression analysis we used a relative quantification method in which the 
gene levels are expressed as a fold difference between a sample and a calibrator 
(such as untreated/control cells). Samples were first normalised to an endogenous 
control which is a gene that maintains consistent expression levels despite treatment. 
Several endogenous controls were tested and the most suitable one was selected. For 
MIN6 cells this was B2M, for J774A.1 macrophage Actin and for murine colonic 
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tissue GUSB [see Appendix]. Normalised samples were then compared to the 
calibrator (control) using ΔΔCt method: 
                                 
Where ΔCt sample = Ct sample – Ct endogenous control and ΔCt calibrator = Ct 
calibrator – Ct endogenous control. 
 
2.9.6 DNA product analysis by gel electrophoresis 
Gel electrophoresis was used to check DNA products following qPCR [see 
appendix]. Samples were run on a 2% agarose gel. The gel was prepared by 
dissolving 2 g of agarose (Termo-Fisher Scientific) in 100 ml 1X TAE buffer and 
heating to boiling point. After cooling, 10 μl of SYBR® safe DNA gel stain (Applied 
Biosystems) was added to the gel mix before pouring into a gel mould and setting 
the well comb. DNA samples were mixed with loading buffer (Fermentas) and 
loaded straight onto the gel, together with GeneRuler 100 bp DNA ladder (Termo-
Fisher Scientific). Gels were run for 1hr in 1X TAE buffer at 100 V and visualised 
using the G-box imaging system (Syngene). 
 
2.10 Primary cell isolation  
2.10.1 Mice 
 BALB/c mice, 6-8 weeks old, were purchased from Charles River. Mice were kept 
under specific pathogen-free conditions at the Bioresource Unit, Faculty of Health 
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and Science, Dublin City University, Ireland. All mice were maintained according to 
the guidelines of the Irish Department of Children and Health. 
 
2.10.2 Isolation and differentiation of bone marrow-derived macrophages  
The bone marrow was flushed out of the femurs and tibias of adult mice. Cells were then 
centrifuged at 250 x g for 5min and resuspended in complete RPMI (Gibco) 
supplemented with 10% FBS (Gibco) and 2% penicillin streptomycin/glutamine 
(Gibco). 50 ng/ml M-CSF (eBioscience) was added to generate macrophages (Sweet & 
Hume 2003). Cells were plated on petri dishes (4 petri dishes/mouse; 10 ml/petri dish) 
and placed in a CO2 incubator at 37ºC. After 3 days, 10 ml of fresh media with 50 ng/ml 
M-CSF was added to each plate. At day 6 non-adherent cells were removed by washing 
with RPMI and the adherent cells were displaced using a cell scraper (Sarstedt) and 
collected for further experiments. The purity of harvested bone marrow-derived 
macrophages was assessed by flow cytometry and was typically >95% F4/80+. 
 
2.11 Dextran sulfate sodium (DSS) induced model of colitis 
 
Dextran sodium sulphate (DSS) model of colitis is one of the most widely used 
chemically induced models of inflammatory bowel disease. It is directly toxic to the 
colonic epithelial cells in the basal crypts and induces an acute inflammatory 
response (Kullmann et al. 2001).  
 
10 BALC/c female mice were house at the Biological Resource Unit (BRU), at 
Dublin City University. DSS was administered to mice in drinking water. DSS was 
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prepared fresh every day in normal tap water at a final concentration of 5%. Mice 
were administered DSS for 5 days followed by 2 days on water alone and were 
sacrificed for sample and tissue processing on day 7. Mice were split into two groups 
for this study. 
1. Control 
No DSS was administered to the control mice, animals were sacrificed for sample 
and tissue processing on day 7. 
2. DSS 
Mice were administered DSS for 5 days (day 0 – day 4) followed by 2 days on water 
and sacrificed for sample and tissue processing on day 7. 
 
The clinical symptoms recorded in DSS-treated and the Control mouse were body 
weight and fur texture/posture which were measured every day. These were used to 
generate a daily disease activity index (DDAI) as described below. 
 
Score 0 1 2 3 
Stool 
Consistency 
Normal, well-
formed pellets 
Changed formed 
pellets 
Loose stool Diarrhoea 
Fur texture/ 
Posture 
Smooth/ Not 
hunched 
Mildly scruffy 
Mildly hunched 
Very scruffy 
Very hunched 
 
 
Table 2.10 Daily Disease Activity Index (DDAI).  
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At the end point of each group the length & weight of each colon was also measured 
and used as an indication of colitis in the mouse model. Sections of distal colon were 
collected for tissue homogenisation and RNA purification. 
 
 
2.11.1. Tissue Sectioning - Pancreas 
The mice were euthanized and pancreas was removed within 10 mins of death. The 
pancreas was then cut in two – the tail section was infused multiple times with RA1 
buffer (Macherey-Nagel) until inflation was observed and then flash frozen in liquid 
nitrogen. The head of the pancreas (part closest to the intestine) was placed in a 
tissue cassette, flattened between two sponges and left in formalin overnight at RT to 
fix. Following overnight fixation the tissue was then put in a TP1020 processor 
(Leica Biosystems) for paraffin tissue processing. Briefly the steps included 1Hr in 
70% EtOH, 1hr in 96% EtOH, 1hr in 100% EtOH followed by 2hr in 100% EtOH. 
This ensures adequate dehydration of the tissue. The program continued with 1hr in 
xylene, 2hr in xylene to remove alcohol before paraffin embedding, and finally 3 x 
1hr in paraffin. The tissue is then fixed in small paraffin blocks and left to set. 0.5 
μm sections were cut from the blocks and put onto slides. The slides were left to dry 
and then baked at 50°C for at least 40 mins. 
 
2.11.2 Tissue Sectioning – Colon 
Tissue sections of 0.5 μm were removed from the distal part of the washed colon and 
submitted to the paraffin tissue processing program outlines in section 2.11.1. 
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2.11.3 Haemotoxylin and Eosin staining 
Prior to staining slides had to be de-parrafinised, this was done by immersion in 
Histoclear (National Diagnostics) for 2 x 10 mins. This was followed by re-hydration 
of tissue which includes 2 x 5 mins in 100% EtOH, 2 mins in 95% EtOH and 2 mins 
in 75% EtOH. This allows for gradual re-hydration of the tissue. Slides were stained 
with Harris haematoxylin (Sigma-Aldrich) for 10 mins and washed again under 
running tap water for 5 min. The slides were differentiated in 1% acid/alcohol for 30 
s 3 times and then washed under a tap for 1 min. After washing slides were placed in 
0.1% sodium bicarbonate (Sigma-Aldrich) for 1 min followed by washing under a 
tap for 5 min. The slides were then rinsed in 95% ethanol (Merck) for 10 dips before 
counterstaining with Eosin (Sigma-Aldrich) for 1 min by dipping up and down. 
Finally the slides were dehydrated again by dipping in 75% ethanol for 3 min, 95% 
ethanol for 3 min (x2), followed by 100% ethanol for 3 min and 3 min in Histoclear. 
Slides were then mounted with mounting medium (DPX) and the cover slips pushed 
firmly to remove bubbles. 
 
2.11.4 HRP-DAB-F4/80 staining Pancreas 
F4/80 was visualised in the pancreas using the HRP-DAB SYSTEM (R&D Systems) 
according to the manufacturer’s protocols. Detection is based on the formation of the 
Avidin-Biotin Complex (ABC) with primary antibodies that react with tissue 
antigens under study. Visualization is based on enzymatic conversion of a 
chromogenic substrate 3,3' Diaminobenzidine (DAB) into a colored brown 
precipitate by horseradish peroxidase (HRP) at the sites of antigen localization, 
which can then be viewed using brightfield microscopy. Briefly slides were fist de-
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parrafinised as outlined in section 2.11.3. Samples were then covered with 1-3 drops 
of the Peroxidase Blocking Reagent for 5 mins. Samples were then rinsed and 
washed in buffer (PBS) for 5 mins. Samples were then incubated with 1-3 drops of 
Serum Blocking Reagent G for 15 mins. Buffer was drained off and carefully wiped 
from slide. Sample was then incubated with Avidin blocking reagent for 15 mins and 
washed with buffer prior to 15 min incubation with Biotin Blocking Buffer. Samples 
were rinsed with buffer and incubated with anti F4/80 antibody overnight at 4°C. 
The next day samples were was for 3 x 15 mins in buffer prior to incubation with 
Biotinylated Secondary Antibody 60 mins. Samples were once again washed for 3 x 
15 mins with buffer prior to incubation for 30 mins with HSS-HRP. Samples were 
washed with buffer for 3 x 2 mins and incubated with freshly prepared DAB-
Chromogen solution for 15 mins. Samples were rinsed with distilled water and 
counterstained with Harris Haematoxylin by dipping for 30 seconds. Samples were 
rinsed with tap water for 5 mins to remove excess stain, left to air dry and were then 
mounted with mounting medium (DPX) and the cover slips pushed firmly to remove 
bubbles. 
 
2.12 Exosome Fractionation and Isolation  
 
In order to ascertain if the effects of MIN6 conditioning on macrophage function are 
due to something secreted in exosomes we aimed to isolate different fractions from 
MIN6 conditioned medium based on their size. In order to do this MIN6 cells were 
cultured in complete medium containing exosome free- FBS (Stratech). As FBS is 
known to contain a lot of exosomes this helped us ensure that exosomes isolated 
were indeed from the MIN6 cells and not FBS associated exosomes. Once cells had 
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reached confluency fresh media was added for a further 24hr. This media was then 
taken, spun down at 1000 rpm for 5 mins to remove any cell debris and stored at -
80°C for further processing. The media (a total of 75 ml) was subjected to 
hydrostatic dialysis through a homemade device made of a dialysis membrane tube 
with a molecular weight cut off (MWCO) of 1,000 kDa (Spectrum Laboratories) 
connected to a separating funnel and the other end sealed by a clip. The hydrostatic 
pressure of the media in the funnel is strong enough to push the solvent and all the 
analytes below the MWCO through the mesh of the dialysis membrane made of 
cellulose ester. After the concentration of the media (5-8 ml) the funnel was refilled 
with 200 ml of PBS to wash away what was left until the volume reached 8 ml. The 
retained  fraction was then spun at 20,000g calculated  at maximum radius 105 mm 
in an ultra JA-20 fixed angle rotor (clearing factor or k factor = 770) (Beckman 
Coulter)-centrifuge for 1hr at 4°C using a Beckman JA26 centrifuge (Beckman 
Coulter). The pellet was resuspended in 1ml PBS. The supernatant was then taken 
and centrifuged at 200,000g calculated at the maximum radius 91.9 mm of 70 Ti 
fixed angle rotor  (k factor = 44) (Beckman Coulter) using a Beckman XL-80 
ultracentrifuge (Beckman Coulter) for 2hr at 4°C. The pellet formed was 
resuspended in 1vml PBS. The supernatants and all resuspended pellets were then 
stored at -80°C. After the first step anything in the flow through below 1,000 kDa 
(HDb) would not have been collected in the column. The flow through therefore was 
taken and subjected to another hydrostatic dialysis step using a dialysis membrane of 
300 kDa in size MWCO (Spectrum Laboratories) and repeated the steps described 
above including the differential centrifugation protocol. Both the pellet and the 
supernatant were kept and all fractions were stored at -80°C until further use. Prior to 
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use the fractions were UV irradiated for 15 mins and then resuspended in 50 ml 
complete DMEM. 
 
2.13 Statistical Analysis 
Results are presented as mean ± standard error of the mean (SEM) and groups were 
compared using an unpaired Student’s t-test or for multiple groups, a one-way 
ANOVA followed by a Newman-Keuls post-hoc test. All data were analysed using 
Prism Software (GraphPad Software, Inc.). Values of less than p<0.05 were 
considered statistically significant. 
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Chapter 3 
Characterisation of the insulin 
secreting cell line MIN6 and the 
effects of TLR ligation on insulin 
signalling.  
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3.1 Introduction 
β-cells, which are located in islets of Langerhans in the pancreas are the sole 
producers of insulin and thus are critical regulators of metabolism. Insulin is 
synthesized as preproinsulin and processed to proinsulin. Proinsulin is then 
converted to insulin and C-peptide and stored in secretary granules awaiting release 
on demand. β-cells release insulin in response to a number of stimuli, glucose being 
the primary inducer however they also respond to signals from amino acids, some 
hormones and free fatty acids to name a few (Fu et al. 2013).  Thus, the β-cell is a 
metabolic hub in the body, connecting nutrient metabolism and the endocrine 
system. 
MIN6 cells originate from a transgenic C57Bl/6 mouse insulinoma expressing an 
insulin-promoter/t-antigen construct (Miyazaki et al. 1990). MIN6 cells produce 
insulin and have morphological characteristics of pancreatic beta cells. MIN6 cells 
exhibit glucose stimulated insulin secretion (GSIS) comparable with cultured normal 
mouse islet cells (Miyazaki et al. 1990) and are considered as an appropriate model 
for investigating the mechanism of GSIS. Glucose metabolism and the glucose 
concentration-dependence of insulin secretion from MIN6 cells closely resemble 
those in normal beta cells, and this cell line is thus a useful tool for studying GSIS in 
normal pancreatic beta cells (Ishihara et al. 1993). 
Toll-like receptors (TLRs) are pattern-recognition receptors and play a crucial role in 
the innate immune system, which detects the presence and the nature of pathogenic 
microbial infection, and thus provides the first line of host defence (Takeda et al. 
2003).  
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Ligand recognition by TLRs leads to the recruitment of various TIR domain-
containing signalling adaptors such as myeloid differentiation factor (MyD)88, TIR 
domain-containing adapter protein (TIRAP), TIR domain-containing adaptor 
inducing interferon (TRIF) and TRIF-related adaptor molecule (TRAM), which 
categorize the TLR signalling pathway into MyD88-dependent and TRIF-dependent 
pathways (Kumar et al. 2009). MyD88 is an essential signalling adaptor for most 
TLRs (Kawai & Akira 2009). This recruitment of adaptors triggers a signalling 
cascade and ultimately the activation of transcription factors such as NF-κB. 
Moreover, MAP kinases such as p38, JNKs and extracellular signal-regulated kinase 
(ERK)1/2, which subsequently activate the transcription factor AP-1, are also 
activated. These transcription factors induce transcription of inflammatory cytokines 
and type I interferons. This proinflammatory reaction is fundamental for the 
initiation of an innate immune response and subsequent adaptive responses but can 
also damage tissues if inflammation persists too long.  
TLRs can also interact with endogenous ligands generated at sites of injury  and 
endogenous ligands such as oxLDL (oxidized LDL), HSPs (heat shock proteins) 60 
and 70, fibrinogen, fibronectin and free-fatty acids (FFAs) (Wagner 2006; Yu et al. 
2010). It is thought that TLRs play a role not only in host defence but also in 
maintenance of homeostasis of cells and or tissue. Indeed recent evidence has 
implicated the TLR adaptor protein Myd88 as playing a homeostatic role in 
pancreatic β-cell function (Bollyky et al. 2009). Myd88 -/-  mice are normoglycemic 
however have reduced β cell volume and islet size in comparison to C57BL/6 
controls and suffer enhanced β-cell apoptosis following low-dose streptozotocin 
(STZ) treatment. This suggests that Myd88 signalling and certain TLRs may mediate 
a homeostatic effect on β-cells primarily in the setting of injury. Findings like these 
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taken together with the fact that Type 2 diabetes is now being closely associated with 
low grade levels of inflammation throughout the body and within the pancreas itself 
(Marselli et al. 2013; J. a Ehses et al. 2009; Donath et al. 2013; Yin et al. 2014; Dasu 
et al. 2012) make Toll-like receptors and their function within the β-cell an attractive 
study. 
The aim of this study was to characterise the properties of the insulin secreting cell 
β-cell line MIN6 and assess the effects that activation with TLR ligands had on their 
properties. This was carried out by assessing a number of parameters including cell 
viability, insulin secretion and content, insulin gene expression and cell surface 
marker expression. 
 
3.2 Results 
 
3.2.1 Characterization of a Murine Insulinoma cell line, MIN6 
The insulin secreting Min6 cell line is described in the literature as a good model for 
insulin producing pancreatic beta cells (Ishihara et al. 1993) . We first needed to 
establish the optimal glucose stimulated insulin secretion conditions for this cell line. 
 
3.2.1.1 Glucose stimulation of Min6 cells results in a dose dependant insulin 
secretion response 
MIN6 cells were grown in 24 well plates and left to reach confluency. Prior to 
stimulation cells were left in low glucose (2mM) Krebs-Ringer Buffer for 1hr for 
quiescence of insulin secretion. Cells were then stimulated with various 
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concentrations of glucose for 1hr (0, 2, 5, 10, 20 and 40mM). This conditioned 
medium was then analysed for insulin content by ELISA (Mercodia AB).  
Glucose stimulation resulted in a dose dependant increase in insulin secretion 
[Figure 3.1]. Insulin secretion peaked at 20mM glucose stimulation and decreased 
with 40mM glucose stimulation. This was most likely due to the harmful effect high 
concentrations of glucose have on MIN6 cells. 
 
 
3.2.1.2 Min6 cells display greatest glucose dose response when cultured in 25mM 
glucose 
There was variation in the literature regarding methods of culturing MIN6 cells 
therefore we tested their glucose responsiveness after long term culture in DMEM-
glutamax containing various concentrations of glucose. 
To examine whether the amount of glucose in the MIN6 culture medium affected 
cell viability the cells were plated on 96 well plates in media containing different 
amounts of glucose (5.6, 11 and 25mM). After 24 and 48hr the cell viability was 
assessed using Cell Titer 96 Aqueous One Solution (Promega, WI, USA) according 
to the manufacturer’s instructions. Figure 3.2 shows that the amount of glucose in 
the culture medium does not affect cell viability. 
To assess the glucose-stimulated insulin response following culture in media 
containing different glucose concentrations (5.6, 11 and 25mM) cells were grown in 
24 well plates and left to reach confluency. Prior to stimulation cells were left in low 
glucose (2mM) Krebs-Ringer Buffer for 1hr for quiescence of insulin secretion. 
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Cells were then stimulated with various concentrations (2, 10 20 and 40mM) of 
glucose for 1hr. Conditioned medium was then analysed for insulin content by 
ELISA (Mercodia AB). Cells grown in culture medium containing 25mM glucose 
showed the greatest glucose stimulated insulin secretion response [Figure 3.3]. This 
amount of glucose was added to culture medium for MIN6 cells in all subsequent 
experiments unless stated otherwise. 
 
3.2.1.3 Glucose stimulation induces PDX-1 translocation to the nucleus in MIN6 
cells 
One of the mechanisms whereby glucose stimulates insulin gene transcription in 
pancreatic β-cells involves activation of the homeodomain transcription factor PDX1 
(pancreatic/duodenal homeobox-1) via a stress-activated pathway involving stress-
activated protein kinase 2 (SAPK2) (Elrick & Docherty 2001).  Glucose stimulates 
translocation of PDX1 from the cytoplasm to the nucleus in pancreatic β –cells 
(Wendy M Macfarlane et al. 1999). To investigate if this occurs in the MIN6 cell 
line, cells were grown overnight on coverslips in low glucose media (0.5mM). Cells 
were then stimulated with low (0.5mM) or high (20mM) glucose for 20 minutes, and 
subsequently fixed and stained with antibodies for PDX-1 and DAPI (for nuclear 
localisation). Stimulation of MIN6 cells with 20mM glucose induces translocation of 
PDX-1 from the cytoplasm to the nucleus [Figure 3.4]. This does not occur when 
cells are in low glucose [Figure 3.4].  
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3.2.2 TLR ligation of MIN6 cells does not significantly affect cell viability 
Given that we wanted to examine the effects of TLR ligands on MIN6 cells, we first 
assessed their effect on MIN6 cell viability. MIN6 cells were plated on a 96 well 
plate and left to reach confluency. Following this cells were stimulated with a panel 
of TLR ligands (Pam3CSK4 0.25-1μg/ml, LPS 25-100ng/ml & Flagellin 1-5μg/ml) 
for 24hr after which the cell viability was assessed using Cell Titer 96 Aqueous One 
Solution (Promega, WI, USA) according to the manufacturer’s instructions. These 
TLR ligand concentrations have previously been shown to elicit an inflammatory 
response from immune cells.  As the conversion of MTS into the aqueous soluble 
formazan is accomplished by dehydrogenase enzymes found in metabolically active 
cells the quantity of formazan product as measured by the amount of 490nm 
absorbance is directly proportional to the number of living cells in culture. No 
significant decrease in cell viability was seen comparing control to TLR treated cells 
[Figure 3.5].  
 
3.2.3 The effects of TLR ligation on MIN6 insulin secretion 
3.2.3.1 TLR stimulation alters the normal glucose stimulated insulin secretion 
profile of MIN6 cells 
MIN6 cells were plated on 6 well plates and left to grow to confluency. Cells were 
then activated with TLR ligands (Pam3CSK4 1μg/ml, LPS 100ng/ml & Flagellin 
5μg/ml). Following 24hr stimulation, the media was removed and the cells were left 
in low glucose (2mM) Krebs-Ringer Buffer for 1hr for quiescence of insulin 
secretion and were then stimulated with various concentrations of glucose (0 – 
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40mM) for 1hr. Conditioned medium was then analysed for insulin content by 
ELISA (Mercodia AB). Under normal circumstances MIN6 cells show a typical dose 
dependant secretion of insulin following glucose stimulation [Figure 3.6A]. 
Following 24hr stimulation with all TLR ligands, Pam (1μg/ml), LPS (100 ng/ml) 
and Flagellin (5μg/ml), MIN6 cells basal levels of insulin secretion were 
significantly increased versus control cells [Figure 3.6B] (p<0.05). This was in stark 
contrast to the significant decrease in stimulated insulin secretion observed at 20mM 
following TLR ligation [Figure 3.6D], with Flagellin (p<0.01) causing a more 
profound effect than LPS (p<0.05). Both Pam (p<0.001) and LPS (p<0.001) 
stimulation resulted in a very significant decrease in total insulin content [Figure 
3.6E] whereas Flagellin (p<0.05) caused a slight increase in total insulin content 
[Figure 3.6E]. 
 
3.2.3.2 Expression levels of INS1 and INS2 genes following 24h TLR ligation 
Cells were seeded at 1 x 10
6  
 cells/ml on a 6 well plate and left to grow to 
confluency after which fresh media was added and the cells were stimulated with 
TLR ligands (Pam 1μg/ml, , LPS- 100ng/ml & Flagellin- 5μg/ml) for 24 hr. 
Following homogenisation, RNA was extracted using Nucleospin RNA II kit  
(Macherey-Nagel) and quantified on the nanodrop. Equalised amounts of RNA were 
converted into cDNA using a High Capacity cDNA Mastermix (Roche). The levels 
of INS1 and INS2 mRNA were quantified using qPCR. The expression levels were 
normalised to B2M levels and the gene expression is shown as a fold change relative 
to the control. The only significant change found in gene expression was a decrease 
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in INS2 [Figure 3.7] following stimulation with flagellin (p<0.001). No other results 
achieved significance. 
 
3.2.3.3 Expression levels of IRS1 and IRS2 following 24h TLR ligation 
Cells were seeded at 1 x 10
6  
 cells/ml on a 6 well plate and left to grow to 
confluency after which fresh media was added and the cells were stimulated with 
TLR ligands (Pam 1μg/ml, LPS 100ng/ml & Flagellin 5μg/ml) for 24 hr. Following 
homogenisation, RNA was extracted using Nucleospin RNA II kit (Macherey-Nagel) 
and quantified on the nanodrop. Equalised amounts of RNA were converted into 
cDNA using a High Capacity cDNA Mastermix (Roche). The levels of IRS1 and 
IRS2 mRNA were quantified using qPCR. The expression levels were normalised to 
B2M levels and the gene expression is shown as a fold change relative to the control. 
As a general trend stimulation with all TLR ligands seemed to decrease IRS1 
expression (all be it insignificantly) and increase IRS2 expression Pam (p<0.01) 
Flagellin (p<0.05) and LPS (n/s) [Figure 3.8]. 
 
3.2.3.4 TLR ligation alters Insulin Receptor expression on MIN6 cells 
As insulin itself can act in an autocrine manner on the β-cell through the insulin 
receptor (IR) and knockout of the insulin receptor in pancreatic β cells creates an 
insulin secretory defect similar to that in Type 2 Diabetes (Kulkarni et al. 1999) we 
examined the expression of the β-subunit of the IR following 24 h stimulation with 
TLR ligands. Cells were plated at a concentration of 1 x 10
6 
cells per ml and allowed 
to grow to confluency prior to 24hr stimulation with ligands (Pam 1μg/ml, LPS 
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100ng/ml & Flagellin 5μg/ml). Cells were then analysed for cell surface expression 
of the β subunit of the IR. Cell-surface expression of the IR-β subunit, as examined 
by flow cytometry was decreased following stimulation with both LPS and Flagellin 
[Figure 3.9], however in contrast to this stimulation with Pam resulted in an 
increased surface expression of the IR-β. 
 
3.2.4 Optimisation of permeabilisation technique for MIN6 cells 
Detection of intracellular antigens requires a cell permeabilisation step prior to 
staining. Depending on the location of the specific antigen of interest the optimum 
method used for permeabilisation can differ greatly. As we intended to look at a 
number of intracellular antigens it was important to figure out the best method of 
permeabilisation for each antigen. In order to do this MIN6 cells were fixed by a 
number of methods and subsequently stained with antibodies for intracellular 
antigens Insulin (APC), TLR5 (FITC) and PDX-1 (PE).  Cells were fixed prior to 
permeabilisation with triton (A), tween (B) or Saponin (C) [Figure 3.10]. Figure 
3.10 shows that the FSC of cells can vary greatly following different methods of 
permeabilisation. As our data showed greatest expression levels when cells were 
permeabilised with tween when looking at PDX-1 and saponin for TLR5 these were 
used for all future experiments unless stated otherwise.  
 
3.2.4 TLR ligation alters PDX-1 expression on MIN6 cells 
PDX-1 (Pancreatic and duodenal homeobox 1), also known as insulin promoter 
factor 1, is a transcription factor necessary for pancreatic development, β-cell 
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maturation and the maintenance of β-cell function. Islet β cell-specific transcription 
of the insulin gene is mediated through the binding of the islet-enriched PDX-1, 
BETA2, and MafA transcription factors to conserved 5’-flanking region regulatory 
elements (Le Lay & Stein 2006). Cells were plated at a concentration of 1 x 10
6 
cells 
per ml and allowed to grow to confluency prior to 24hr stimulation with ligands 
(Pam 1μg/ml, LPS 100ng/ml & Flagellin 5μg/ml). Cells were then analysed for 
intracellular expression of PDX-1 by flow cytometry. Stimulation with Pam, LPS 
and Flagellin all resulted in a minor but consistent decrease in the expression levels 
of PDX-1 [Figure 3.11]. 
 
3.2.5 TLR stimulation does not affect Reactive Oxygen Species production from     
MIN6 cells  
Pancreatic β-cells exposed to conditions such as hyperglycaemia produce reactive 
oxygen species (ROS) which in turn can suppress glucose-induced insulin secretion 
(Sakai et al. 2003). Toll-like receptor activation has long been known to induce ROS 
generation (Gill et al. 2010) therefore we sought to investigate the effect of TLR 
activation of MIN6 cells on ROS production. ROS levels were measured using the 
cell permeant reagent 2’,7’ – dichlorofluorescein diacetate (DCFDA), a fluorogenic 
dye that measures hydroxyl, peroxyl and other ROS activity within the cell. MIN6 
cells were plated and stimulated with TLR ligands as previously described. The 
fluorescent signal relative to intracellular ROS generation was then measured by 
flow cytometry and compared between control and treated cells. TLR stimulation of 
MIN6 cells did not result in any significant change in ROS production [Figure 3.12 
A & B]. In Figure 3.12A histograms representative of ROS fluorescence are off-set 
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to easily allow visualisation. In Figure3.12B the mean fluorescence intensity (MFI) 
from n=3 samples/treatment was graphed and assessed for significance by unpaired 
t-test. 
 
3.2.6 Effect of TLR stimulation on MIN6 surface marker expression 
Pancreatic β-cells have been shown to express certain toll-like receptors and co-
stimulatory molecules (Lee et al. 2012; Yin et al. 2014). We used flow cytometry to 
confirm expression of the molecules on MIN6 cells in control conditions and 
following TLR stimulation. For all markers investigated cell surface staining was 
used apart from for TLR5 in which case the antibody used recognizes an intracellular 
epitope in the cytoplasmic domain of TLR5. Cells were plated at a concentration of 1 
x 10
6 
cells per ml and allowed to grow to confluency prior to 24hr stimulation with 
ligands (Pam 1μg/ml, LPS 100ng/ml & Flagellin 5μg/ml). Following this cells were 
stained with fluorescently labelled antibodies against TLR2, TLR4, TLR5, CD14, 
MHCII, CD40, CD80 & CD86. Histograms show surface marker expression of 
unstimulated control cells (black line) compared to TLR-ligand stimulated cells 
(dashed line). Filled histograms represent fluorescence of unstained cells.  MIN6 
cells were found to express surface markers TLR2, TLR4, TLR5, CD14 MHCII and 
CD40 however no or minimal expression of both CD80 and CD86 was observed 
[Figure 3.13]. TLR stimulation of MIN6 cells with Pam, LPS and flagellin failed to 
illicit a significant change in expression of these surface markers [Figures 3.13, 3.14 
& 3.15] except in the case of flagellin which caused a slight increase in expression of 
MHCII, TLR2 and CD40 [Figure 3.15]. 
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Expression on TLR4 and TLR5 on MIN6 cells was also confirmed by qPCR. Again 
cells were plated at a concentration of 1 x 10
6 
cells per ml and allowed to grow to 
confluency prior to 24hr stimulation with ligands as previously described. RNA was 
extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the 
nanodrop. Equalised amounts of RNA were converted into cDNA using a High 
Capacity cDNA Mastermix (Roche). The levels of TLR4 and TLR5 mRNA were 
quantified using qPCR. The expression levels were normalised to B2M levels and 
the gene expression is shown as a fold change relative to the control. The only 
significant change found in gene expression was a decrease TLR4 (p<0.01) and 
TLR5 (P<0.01) [Figure 3.16] following stimulation with flagellin. No other results 
achieved significance. 
 
3.2.7 Effect of TLR stimulation on expression levels of IAPP and FAM3B 
Two molecules closely associated with islet inflammation and β cell failure in the 
context of diabetes are islet amyloid polypeptide (IAPP) and pancreatic-derived 
factor (PANDER or FAM3B). Both have been linked with islet dysfunction and or 
death (Cao et al. 2003; Wang et al. 2011; Montane et al. 2012).  Expression levels of 
these molecules were measured by qPCR. Again cells were plated at a concentration 
of 1 x 10
6 
cells per ml and allowed to grow to confluency prior to 24hr stimulation 
with ligands as previously described. RNA was extracted as previously described 
and equalised amounts of RNA were converted into cDNA using a High Capacity 
cDNA Mastermix (Roche). The levels of IAPP and FAM3B mRNA were quantified 
using qPCR. The expression levels were normalised to B2M levels and the gene 
expression is shown as a fold change relative to the control. IAPP expression levels 
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remain unchanged apart from following Pam stimulation [Figure 3.17A] where a 
significant decrease in expression was detected (P<0.05). FAM3B expression levels 
also remain unchanged apart from after Flagellin stimulation [Figure 3.17B) where a 
significant decrease in expression was detected (P<0.05). 
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3.3 Figures 
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Figure 3.1 Glucose Stimulated Insulin Secretion from MIN6 cells. Cells were 
seeded at 1 x 10
6 
cells/ ml in a 24 well plate and left to grow until confluent. Cells 
were then washed twice in warm KRB-BSA and left in KRB-BSA containing 2mM 
Glucose for 1hr. Following this cells were stimulated with varying concentrations of 
Glucose in KRB-BSA (0-40mM). Supernatants were then analysed for insulin 
content using a mouse insulin ELISA (Mercodia AB, Upsalla, Sweeden). Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. *** p< 0.001 as determined by one way ANOVA 
followed by post-hoc Newman-Keuls analysis. 
 
 
 
 
 
 
 
 
82 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Culture of MIN6 cells in different concentrations of Glucose does not 
affect cell viability. Cells were plated at a concentration of 1 x 10
6
 cells/ml on a 96 
well plate in DMEM-Glutamax containing either 5.6, 11 or 25mM glucose and left 
for 24 and 48hr. Following this 20μl of the CellTiter 96® AQueous Non-Radioactive 
Cell Proliferation Assay solution (Promega, WI, USA) was added to each well and 
left at 37°C 5% CO2 for 1hr. The plate was then read at a wavelength of 450nm. 
Results are expressed as a percentage of the control (100%). Data are presented as 
mean ± SEM of three replicates and are representative of three independent 
experiments. 
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Figure 3.3 MIN6 Cells Cultured in 25mM Glucose show Greatest Dose 
Response to Glucose Stimulation. Cells were seeded at 1 x 10
6 
cells per ml in a 24 
well plate and left to grow until confluent in media containing either 5.6, 11 or 
25mM glucose. Fresh media was added for 24hr. Cells were then washed twice in 
warm KRB-BSA and left in KRB-BSA containing 2mM Glucose for 1hr. Following 
this cells were stimulated with varying concentrations of Glucose in KRB-BSA (2 – 
40mM). Supernatants were then analysed for insulin content using a mouse insulin 
ELISA (Mercodia AB, Upsalla, Sweeden). 
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Figure 3.4 Glucose induces PDX-1 translocation to the nucleus in MIN6 cells. 
Cells (1 x 10
6 
/ ml) were left overnight to attach to coverslips in low glucose 
(0.5mM) media. Cells were then stimulated for 20 mins with 0.5 & 20 mM glucose 
prior to acetone fixation and subsequent staining with PDX-1 (green) and DAPI 
(blue) antibodies. 
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Figure 3.5 TLR Ligation of MIN6 cells do not significantly affect cell viability. 
Cells were seeded at 1 x 10
6
cells per ml in a 96 well plate and left to grow overnight 
prior to 24hr stimulation with various TLR Ligands (PAM 0.25 - 1μg/ml, LPS 25 - 
100ng/ml & Flagellin 1 - 5μg/ml). Following this 20μl of the CellTiter 96® 
AQueous Non-Radioactive Cell Proliferation Assay solution (Promega, WI, USA)   
was added to each well and left at 37°C 5% CO2 for 1hr. The plate was then read at a 
wavelength of 450nm. Results are expressed as a percentage of the control viability 
(100%).Data are presented as mean ± SEM of three replicates and are representative 
of three independent experiments. 
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Figure 3.6 TLR stimulation alters the normal glucose stimulated insulin 
secretion profile of MIN6 cells. Cells were seeded at 1 x 10
6  
 cells/ml on a 24 well 
plate and left to grow to confluency after which fresh media was added and the cells 
were stimulated with TLR ligands (Pam 1μg/ml, LPS 100ng/ml, Flagellin 5μg/ml) 
for 24hr. Cells were then washed twice in warm KRB-BSA and left in KRB-BSA 
containing 2mM Glucose for 1hr. Following this cells were stimulated with varying 
concentrations of Glucose in KRB-BSA (0-40mM) for 1hr. Supernatants were then 
analysed for insulin content using a mouse insulin ELISA (Mercodia AB, Upsalla, 
Sweden). Total insulin was extracted from cells using ice cold acid/ethanol. 
Supernatants were then analysed for insulin content using a mouse insulin ELISA 
(Mercodia AB, Upsalla, Sweden). Data are presented as mean ± SEM of three 
replicates and are representative of three independent experiments. *p<0.05, 
**p<0.01, ***p<0.001 as determined by unpaired t-test. 
  
(A) 
(B) (C) (D) 
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Figure 3.7 Expression levels of INS1 & INS2 following 24hr TLR ligation. The 
expression of INS1 and INS2 was measured by qPCR. Cells were seeded at 1 x 10
6  
 
cells/ml on a 6 well plate and left to grow to confluency after which fresh media was 
added and the cells were stimulated with TLR ligands (Pam 1μg/ml, LPS 100ng/ml, 
Flagellin 5μg/ml) for 24hr. Following homogenisation, RNA was extracted using 
Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised 
amounts of RNA were converted into cDNA using a High Capacity cDNA 
Mastermix (Roche). The cDNA was mixed with primers for INS1 & INS2 (IDT) and 
analysed on the ABI Prism 7500. cDNA samples were assayed in triplicate and gene 
expression levels were normalised to endogenous control, B2M. The mean relative 
gene expression was calculated using the 2-ΔΔCt method. Results are mean ± SEM. 
***P<0.001 vs. control, determined by unpaired t-test 
88 
 
                   
 
 
Figure 3.8 Expression levels of IRS1 & IRS2 following 24hr TLR ligation. The 
expression of IRS1 and IRS2 was measured by qPCR. Cells were seeded at 1 x 10
6  
 
cells/ml on a 6 well plate and left to grow to confluency after which fresh media was 
added and the cells were stimulated with TLR ligands (Pam 1μg/ml, LPS 100ng/ml, 
Flagellin 5μg/ml) for 24hr. Following homogenisation, RNA was extracted using 
Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised 
amounts of RNA were converted into cDNA using a High Capacity cDNA 
Mastermix (Roche). The cDNA was mixed with primers for IRS1 & IRS2 (IDT) and 
analysed on the ABI Prism 7500. cDNA samples were assayed in triplicate and gene 
expression levels were normalised to endogenous control, B2M. The mean relative 
gene expression was calculated using the 2-ΔΔCt method. Results are mean ± SEM. 
*P<0.05, **P<0.01 vs. control, determined by unpaired t-test 
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Figure 3.9 TLR ligation alters Insulin Receptor expression on MIN6 cells. Cells 
were plated at a concentration of 1 x 10
6 
cells per ml and allowed to grow to 
confluency prior to 24hr stimulation with ligands (Pam 1μg/ml, LPS 100ng/ml, 
Flagellin 5μg/ml. Cells were then analysed for cell surface expression of the β 
subunit of the IR by flow cytometry. Histograms show IR-β expression on control 
(black line) and TLR stimulated (dashed line) cells. Filled histograms represent 
fluorescence of unstained cells. Data are representative of three independent 
experiments.   
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Figure 3.10 Optimisation of permeabilisation technique for MIN6 
cells. . Cells were plated at a concentration of 1 x 10
6 
cells per ml and 
allowed to grow to confluency. Cells were then collected and 
permeabilised with a number of different methods (A) Triton, (B) Tween 
& (C) Saponin. Following this cells were stained with antibodies to 
Insulin (APC), TLR5 (FITC) & PDX-1 (PE) and analysed by flow 
cytometry on the BD FACS Aria. 
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Figure 3.11 TLR ligation alters PDX-1 expression on MIN6 cells. Cells were 
plated at a concentration of 1 x 10
6 
cells per ml and allowed to grow to confluency 
prior to 24hr stimulation with ligands Pam (1μg/ml), LPS (100ng/ml) & Flagellin 
(5μg/ml). Cells were then analysed for expression of PDX-1 by flow cytometry. 
Histograms show PDX-1 expression on control (black line) and stimulated (dashed 
line) cells. Data are representative of three independent experiments    
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Figure 3.12 TLR stimulation does not affect Reactive Oxygen Species 
production from MIN6 cells. . Cells were plated at a concentration of 1 x 10
6 
cells 
per ml and allowed to grow to confluency prior to 24hr stimulation with ligands Pam 
(1μg/ml), LPS (100ng/ml) & Flagellin (5μg/ml).  To measure the production of 
reactive oxygen species, cell were labelled with DCFDA (Abcam), according to 
manufacturer’s instructions, and the fluorescent signal relative to intracellular ROS 
generation was then measured by flow cytometry. In figure (A) Histograms represent 
fluorescence of DCFDA, histograms are offset to allow for easy comparison of 
multiple parameters. In Figure (B) MFI from 3 independent experiments is collated 
to analyse significance. Data are representative of three independent experiments.  
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Figure 3.13 Expression of cell surface markers on MIN6 cells in response to stimulation with Pam. MIN6 cells were 
stimulated with PAM3CSK4 (1μg/ml) or medium alone as a control. After 24hr cells were stained with fluorescently 
labelled antibodies and the expression of surface markers was measured by flow cytometry. Histograms show surface 
marker expression of unstimulated control cells (black line) compared to TLR-ligand stimulated cells (dashed line). Filled 
histograms represent fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 3.14 Expression of cell surface markers on MIN6 cells in response to stimulation with LPS. MIN6 cells were 
stimulated with LPS (100ng/ml) or medium alone as a control. After 24hr cells were stained with fluorescently labelled 
antibodies and the expression of surface markers was measured by flow cytometry. Histograms show surface marker 
expression of unstimulated control cells (black line) compared to TLR-ligand stimulated cells (dashed line). Filled 
histograms represent fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 3.15 Expression of cell surface markers on MIN6 cells in response to stimulation with Flagellin. MIN6 cells 
were stimulated with Flagellin (5μg/ml) or medium alone as a control. After 24hr cells were stained with fluorescently 
labelled antibodies and the expression of surface markers was measured by flow cytometry. Histograms show surface 
marker expression of unstimulated control cells (black line) compared to TLR-ligand stimulated cells (dashed line). Filled 
histograms represent fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 3.16 Expression levels of TLR4 & TLR5 following 24h TLR ligation. 
The expression of TLR4 and TLR5 was measured by qPCR. Cells were seeded at 1 
x 10
6  
 cells/ml on a 6 well plate and left to grow to confluency after which fresh 
media was added and the cells were stimulated with TLR ligands (Pam 1μg/ml, 
LPS 100ng/ml, Flagellin 5μg/ml) for 24hr. Following homogenisation, RNA was 
extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the 
nanodrop. Equalised amounts of RNA were converted into cDNA using a High 
Capacity cDNA Mastermix (Roche). The cDNA was mixed with primers for TLR4 
& TLR5 (IDT) and analysed on the ABI Prism 7500. cDNA samples were assayed 
in triplicate and gene expression levels were normalised to endogenous control, 
B2M. The mean relative gene expression was calculated using the 2-ΔΔCt method. 
Results are mean ± SEM. *P<0.05, **P<0.01, vs. control, determined by unpaired 
t-test 
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Figure 3.17 Expression levels of IAPP & FAM3B following 24h TLR ligation. 
The expression of IAPP and FAM3B was measured by qPCR. Cells were seeded at 1 
x 10
6  
 cells/ml on a 6 well plate and left to grow to confluency after which fresh 
media was added and the cells were stimulated with TLR ligands (Pam 1μg/ml, LPS 
100ng/ml, Flagellin 5μg/ml) for 24hr. Following homogenisation, RNA was 
extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the 
nanodrop. Equalised amounts of RNA were converted into cDNA using a High 
Capacity cDNA Mastermix (Roche). The cDNA was mixed with primers for TLR4 
(A) & TLR5 (B) (IDT) and analysed on the ABI Prism 7500. cDNA samples were 
assayed in triplicate and gene expression levels were normalised to endogenous 
control, B2M. The mean relative gene expression was calculated using the 2-ΔΔCt 
method. Results are mean ± SEM. *P<0.05, **P<0.01, vs. control, determined by 
unpaired t-test 
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3.4 Discussion 
MIN6 cells originate from a transgenic C57Bl/6 mouse insulinoma expressing an 
insulin-promoter/t-antigen construct (Miyazaki et al. 1990). They produce insulin 
and have morphological characteristics of pancreatic beta cells. MIN6 cells exhibit 
GSIS comparable with cultured normal mouse islet cells (Miyazaki et al. 1990) and 
are considered as an appropriate model for investigating the mechanism of glucose 
stimulated insulin secretion (GSIS). Glucose metabolism and the glucose 
concentration-dependence of insulin secretion from MIN6 cells closely resemble 
those in normal beta cells, and this cell line is thus a useful tool for studying GSIS in 
normal pancreatic beta cells (Ishihara et al. 1993). We have shown that MIN6 cells 
secrete insulin in a dose dependant manner following glucose stimulation. Although 
the increase seen in insulin secretion following glucose stimulation is not as great as 
that seen using either isolated islets or indeed in vivo the fact that glucose stimulation 
induced a reproducible insulin response still provided us with the possibility to study 
GSIS in an in vitro system. Glucose activation also induced PDX-1 translocation to 
the nucleus.  Taken together these findings suggest that we were working with 
optimal culturing conditions for this cell line to promote insulin sensitivity.  
 
In this chapter we set out to characterise MIN6 cells and assess the effects of TLRs 
on these cells, given the reports that pancreatic bets cells express TLRs. In our study 
we have confirmed that the MIN6 cells express receptors TLR2 and TLR4 and also 
provide novel data that they express TLR5. Activation of these receptors on MIN6 
cells did not results in a significant decrease in cell viability. This is similar to 
findings from (Kiely et al. 2008) who describe no effect on cell viability following 
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24 hour stimulation with LPS (0-1000ng/ml) of the BRIN-BD11 β-cell line. Others 
(Garay-malpartida et al. 2011) have described a reduction in cell viability of isolated 
human islets following exposure to LPS (50ng/ml) however this was after 48 hour 
incubation in comparison to our 24 hour incubation so this may account for the 
differences observed. Another study (Weile et al. 2011a) also found no visible or 
measurable signs of death in cultured rat islets following 24h exposure to flagellin 
(50ng/ml).  
 
A primary factor in the pathogenesis of type 2 diabetes is the inability of the β-cell to 
sustain the increased demand for insulin secretion in response to decreased insulin 
sensitivity seen in organs such as the liver, skeletal muscle and adipose tissue. The 
regulation of insulin secretion from the β-cell is complex and the molecular defects 
underlying the relative failure of the β-cell in type 2 diabetes are still unclear. One of 
the characteristic features of this defect is a failure of the β-cell to respond to a 
glucose stimulus while retaining its response to other secretagogues such as amino 
acids (Muoio & Newgard 2008).  Here we have shown that MIN6 cells in resting 
state actually increase their insulin output following stimulation with Pam, LPS and 
Flagellin however their ability to respond to glucose (20mM) is altered with a 
decrease seen in GSIS following TLR stimulation particularly with LPS and 
Flagellin. This is similar to findings from Vives-Pi et al who report that LPS 
enhanced insulin secretion from rat islets at low glucose concentrations (5.5mM) 
while reducing secretion at higher glucose concentrations (16.7mM) (Vives-Pi et al. 
2003). The same can be said for Flagellin, with Weile et al  finding that basal insulin 
secretion was increased, however glucose stimulated insulin secretion was decreased 
in rat islets following TLR5 activation (Weile et al. 2011a).  This suggests that 
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activation of these TLRs on the β-cell is in some way inhibiting glucose stimulated 
insulin secretion from the cell. Although all three TLR ligands similarly effect 
glucose stimulated insulin secretion, they differentially alter intracellular insulin 
content with Pam and LPS significantly reducing and Flagellin significantly 
increasing total insulin. In the case of LPS similar findings have been reported 
elsewhere (Garay-malpartida et al. 2011; Amyot et al. 2012) in the case of both 
isolated islets and MIN6 β-cells, however Kiely et al reported no change in insulin 
content in the clonal rat BRIN-BD11 cell line. Slight variations in the MIN6 and 
BRIN-BD11 cell lines may account for the differences observed.  The fact Pam and 
LPS decreased and Flagellin increased insulin content suggests that the observed 
effect of ligation on glucose stimulated insulin secretion occurs independent of an 
effect on intracellular insulin stores. Furthermore the novel observation that Flagellin 
activation actually resulted in an increased intracellular insulin concentration shows 
that it is most likely activating a different downstream signalling pathway than that 
of LPS. Whereas secretion of insulin is similarly affected by all three ligands, Pam 
and LPS appear to be having a negative impact on insulin translation and synthesis. 
Flagellin on the other hand appears to be having a positive effect on insulin 
translation with an increase in intracellular insulin stores observed. 
 
Most animals have only a single copy of the insulin gene, but rodents have two non-
allelic insulin genes (INS1 & INS2). They differ in their number of introns and 
chromosomal locations (Soares et al. 1985). Although no great effect of TLR ligand 
activation was seen on insulin gene expression with only Flagellin (p<0.05) causing 
a decrease in INS2 expression, a more profound effect of TLR ligation can be seen 
101 
 
on the expression of the IRS proteins with Pam and Flagellin increasing IRS2 
expression levels. Insulin receptor substrate (IRS) proteins mediate a variety of the 
metabolic and growth-promoting actions of insulin and IGF-1. After phosphorylation 
by activated receptors, these intracellular signalling molecules recruit various 
downstream effector pathways including phosphatidylinositol 3-kinase and Grb2 
(Burks & White 2001). Ablation of the IRS-2 gene in mice results in a phenotype 
with characteristics of type 2 diabetes; IRS-2–deficient animals present defects in 
both insulin action and insulin production and reduced β-cell mass (Withers et al. 
1998). In direct contrast to the reduced β-cell mass caused by deletion of IRS-2, 
disruption of the gene for IRS-1 enhances β-cell mass in mice; IRS1–/– mice have a 
twofold increase in pancreatic β cells (Brüning et al. 1997). The absence of IRS1 in 
islets appears to also convey functional abnormalities in β-cell physiology. IRS1–/– β-
cells display a reduced response to both glucose and arginine (Kulkarni et al. 1999). 
With this in mind it is interesting to note that TLR ligation seemed to cause 
somewhat of a decrease in expression, particularly with Flagellin (although not 
significantly) in IRS1 expression. If this is the case, it ties in nicely with the 
observed reduction in GSIS from MIN6 cells following TLR ligation. The increase 
seen in IRS2 expression following TLR2 and TLR5 ligation could perhaps serve as a 
protective mechanism in the β-cell. IRS2 is also known to play an anti-apoptotic role 
in the β-cell (Withers et al. 1998) where increased numbers of apoptotic cells were 
found to be present within the β-cells of IRS2–/– mice compared with wild-type 
animals. In the setting of activation of innate immunity and perhaps inflammation, 
shifting of the balance from IRS1 to IRS2 may therefore provide the β-cell with 
some level of protection. This “shift” is most apparent when cells are activated with 
Flagellin as a decrease is seen in IRS1 mRNA expression with a concurrent increase 
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in IRS2 expression levels. Once again this suggests a potential protective role for 
TLR5 in β-cells. 
 
There are other ways in which the ligands may be affecting GSIS. Insulin is known 
to act on the β-cell in an autocrine and paracrine fashion through the transmembrane 
insulin receptor (IR) (Okada et al. 2007). Mice lacking the β-cell insulin receptor 
show a loss of insulin secretion in response to glucose, but not to arginine (Kulkarni 
et al. 1999), and depletion of the IR with siRNA in murine insulinoma cells leads to 
inhibition of glucose stimulated insulin secretion (Da Silva Xavier et al. 2004). 
These studies and others (Okada et al. 2007; Lee et al. 2012; Ohsugi et al. 2005) 
highlight a role for the β-cell IR in glucose stimulated insulin secretion, however its 
role remains undefined. Here we have shown that stimulation of MIN6 cells with 
TLR ligands (LPS and Flagellin) leads to a significant reduction in the cell surface 
expression of the β-subunit of the insulin receptor. This may account for the 
reduction observed in glucose stimulated insulin secretion following TLR 
stimulation. Both the insulin receptor and Toll-like receptors share common 
downstream signalling pathways (Fresno et al. 2011).  It is possible that engagement 
of TLRs on β-cells results in the activation of MAP-kinases that interfere with 
insulin receptor substrate downstream of the insulin receptor leading to a 
compromised insulin secretion. One possible scenario in which TLR activation of β-
cells could be relevant is in the case of sepsis in which there are increased levels of 
circulating TLR ligands. GSIS suppression may be relevant in this scenario to ensure 
a sufficient supply of glucose to important tissues such as the brain, and to 
phagocytic and reparative cells (Mizock 1995). This correlates with a general switch 
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from primarily insulin-dependent glucose uptake to primarily non-insulin dependent 
uptake during sepsis (Lang & Dobrescu 1991).  
 
Pancreatic β-cells have the ability to produce reactive oxygen species (ROS) in 
response to certain stimuli such as high glucose levels and palmitate (Ježek et al. 
2012) which in turn can affect insulin secretion (Sakai et al. 2003). TLR activation 
has been shown to induce ROS production in a number of cell types (Gill et al. 2010) 
however we did not find any increase in production of ROS from MIN6 cells 
following TLR activation. Pancreatic β-cells are also known to produce islet amyloid 
polypeptide (IAPP) and pancreatic derived factor (PANDER or FAM3B) in times of 
stress (Cao et al. 2003; Wang et al. 2011; Cai et al. 2011).  Amyloid forms within 
pancreatic islets in type 2 diabetes from aggregates of the β-cell peptide IAPP. These 
aggregates are toxic to β-cells, inducing β-cell death and dysfunction, as well as 
inciting islet inflammation (Westermark et al. 2011). PANDER is a cytokine-like 
protein that is highly expressed in pancreatic islets. In vitro, recombinant PANDER 
pre-treatment or PANDER overexpression significantly promotes apoptosis of  α and 
β cells of mouse, rat, and human islets in a dose- and time-dependent manner (Cao et 
al. 2003; Cao et al. 2005). Overexpression of PANDER in mouse islets or the β-cell 
line βTC6 also represses glucose-stimulated insulin secretion (Yang et al. 2005). 
Treatment of MIN6 cells with TLR ligands did not increase expression levels of 
IAPP or FAM3B. In fact treatment with Pam significantly reduced expression of 
IAPP and treatment with Flagellin significantly reduced mRNA expression of 
FAM3B. Although we did not look at the protein levels, therefore post-translational 
modifications cannot be taken into account; Xiang et al while using the fatty acid 
palmitate to induce FAM3B expression in the β-cell line βTC6 reported findings 
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whereby treatment of βTC6 cells with palmitate significantly increased FAM3B 
mRNA and protein levels, and that the mRNA expression pattern was consistent 
with the protein expression pattern (Xiang et al. 2012). They also report that 
treatment of the cells with a JNK-specific inhibitor reduced the palmitate induced 
PANDER protein expression. This is a novel finding that TLR activation actually 
works in a way to reduce mRNA expression of proteins that can be harmful to the β-
cell, once again highlighting a potential protective role for TLR5 in the β-cell. Also 
as there is no increase in mRNA expression levels of FAM3B, it is unlikely that it is 
contributing to the observed decrease in GSIS seen following TLR activation in 
MIN6 cells. 
We also assessed the cell surface expression of a variety of immune surface markers 
on MIN6 cells in both control and TLR stimulated conditions and demonstrated that 
Min6 cells express TLR2, TLR4, TLR5, CD14, CD40, MHCII Our findings are 
similar to those of Garay-Malpartida et al who showed TLR4 and CD14 expression 
in murine islets and MIN6 cells, and observed a 4.5 and 7.6 fold increase in both 
TLR4 and CD14 mRNA levels respectively in response to LPS (50ng/ml) 
stimulation (Garay-malpartida et al. 2011). Contrary to their findings we did not see 
a significant increase in expression levels of these surface markers following 
stimulation, however this may be accounted for by the fact that they used a 48 hour 
time point as opposed to a 24 hour time point, and they looked at the expression at a 
transcriptional level where as we used flow cytometry. TLR2 (Vives-Pi et al. 2003) 
and TLR5 (Weile et al. 2011a) expression has been described in mouse islet cells, 
but to our knowledge had not been published in MIN6 cells as of yet. The only 
increase seen in surface expression was that of TLR2, MHCII and CD40 following 
exposure to Flagellin. As β-cells are not immune-cells per-se, changes in surface 
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marker expression may be minimal and therefore hard to detect flow cytometrically. 
Interestingly when examined at the level of mRNA, flagellin stimulation resulted in 
a significant decrease in expression levels of both TLR4 and TLR5. This once again 
may be a protective mechanism within the cell whereby upon initial activation of this 
TLR leads to down regulation of other TLRs on the cell to limit propagation of an 
inflammatory response.  
 
To summarise we have shown that activation of TLR ligands on MIN6 cells has the 
ability to alter their insulin secretion in response to glucose, their insulin content, and 
insulin receptor expression as well as a number of other parameters without 
significantly affecting cell viability. Of note is that although all TLR ligands 
similarly affected MIN6 GSIS, they differentially affected MIN6 insulin content and 
INS and IRS expression levels among other things. This suggests that the TLR 
ligands are working in different pathways within the cell. Also worthy of mention is 
the fact that of all ligands used TLR5 seemed to have the most profound effect on 
MIN6 cells. It was the only ligand to increase MIN6 insulin content, decrease INS2 
expression and it induced a “shift” from IRS1 to IRS2 expression. It also caused a 
decrease in FAM3B, TLR4 and TLR5 mRNA expression levels. To date the 
majority of research has focused on the role of TLR4 (and to a lesser extent TLR2) 
in the β-cell, however our work provides novel data on the important role of TLR5 in 
the β-cell. This is further emphasised by the fact that recent work has shown that 
mice lacking TLR5 develop hallmark features of metabolic syndrome, including 
hyperlipidemia, hypertension, insulin resistance, and increased adiposity (Vijay-
kumar et al. 2010). Other reports have shown that glucose activation of mouse islet 
cells induced an increase in TLR5 mRNA expression levels (Weile et al. 2011a).  
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Taken together this highlights TLR5 as a novel player in β-cell physiology and it 
certainly warrants further investigation. In the next chapter we will further 
investigate the effect of TLR activation of MIN6 cells on secretion of inflammatory 
mediators. We will also address the crosstalk that exists between these cells and 
macrophage, which have been shown to infiltrate the islet in the setting of type 2 
diabetes (Ehses et al. 2007). 
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Chapter 4 
Inflammatory properties of MIN6 
cells and investigation of their 
crosstalk with J774A.1 macrophage  
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4.1 Introduction 
Cytokines and chemokines, small signalling proteins secreted primarily by immune 
cells, activate inter- and intracellular signalling during immune responses. Cytokine 
expression plays a fundamental role in the development and function of the immune 
system. Many different cell types secrete chemokines, most often to attract immune 
cells to the site of infection or injury during innate and adaptive immune responses. 
The effect of a cytokine release depends on the activated cell type expressing the 
specific cytokine receptor. Cytokines and their receptors participate in a diverse 
array of functions beyond innate and adaptive immunity including inflammation, 
immune cell differentiation, angiogenesis, tumorigenesis, development, 
neurobiology, and viral pathogenesis. Dysregulation of cytokine expression is a 
cause of immunological and inflammatory diseases as well as other disease states. 
 
Typical cytokines thus far associated with diabetes and β-cell death are IL-1β, IFN-γ 
and TNF-α. IL-1β and/or TNF-α plus IFN-γ have been shown to induce β-cell 
apoptosis via the activation of β-cell gene networks under the control of the 
transcription factors NF-κB and STAT-1 (Cnop et al. 2005; Wachlin et al. 2003). 
Additionally it has been shown that oligomers of islet amyloid polypeptide (IAPP) 
triggered the NLRP3 inflammasome and generated mature IL-1β in pancreatic islets 
(Hull et al. 2009). Other mediators such as high glucose and FFA’s have also been 
shown to induce islet cytokine secretion (Boni-Schnetzler et al. 2009; Yin et al. 
2014; Böni-Schnetzler et al. 2008; Donath et al. 2010) 
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Cytokines and chemokines both have the ability to activate macrophages. 
Macrophages are key innate immune effector cells best known for their role as 
professional phagocytes. Macrophages play a crucial role in innate and adaptive 
immunity in response to microorganisms and are major mediators of the 
inflammatory response. During infection, macrophage effector functions are critical 
for the elimination of pathogens; however uncontrolled inflammatory responses can 
induce injury of the tissue environment and must be repressed to allow the process of 
repair. Two major macrophage populations have been characterised in vitro. 
Classically activated or type I macrophages, induced in particular by IFNγ (Dalton et 
al 1993), display a proinflammatory profile whereas alternatively activated or type II 
macrophages, induced by Th-2 cytokines, express anti-inflammatory and tissue 
repair properties (Gordon 2003). Tissue macrophages respond to changes in the local 
environment by changing their polarization status, and, thus, the M1 and M2 
classifications are oversimplifications of the more dynamic and varied polarization 
states of macrophages that can be observed in vivo. 
 
To date the majority of research has focused on the role of the adipose tissue 
macrophages (ATM) in the pathogenesis of obesity, insulin resistance and type 2 
diabetes. The discovery that adipose tissue from obese mice and humans is infiltrated 
with increased numbers of macrophages provided a major mechanistic advancement 
into understanding how obesity propagates inflammation (Weisberg et al. 2003). 
These ATMs are a major source of proinflammatory cytokines, which can function 
in a paracrine and autocrine fashion to cause decreased insulin sensitivity. Activation 
of these tissue macrophages leads to a release of various chemokines, which in turn 
recruit additional macrophages, setting up a feed-forward process that further 
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increases ATM content and propagates the chronic inflammatory state (Kanda et al. 
2006). It was relatively recently that the first study demonstrating increased islet 
macrophage infiltration in patients with type 2 diabetes (Ehses et al. 2007) was 
published. Increased islet-associated immune cells were also observed in a variety of 
animal models of this disease including the GK (Goto-Kakizaki) rat (Homo-Delarche 
et al. 2006) the high-fat-diet fed and db/db mouse (Ehses et al. 2007) and the Cohen 
diabetic rat (Weksler-zangen et al. 2008). Whether or not the presence of 
macrophage is causative or a symptom of type 2 diabetes islet pathology remains 
unclear. 
 
In the last chapter we characterised the MIN6 β-cell line. Our aim now is to 
investigate the effect of TLR ligation on MIN6 cytokine and chemokine secretion 
and explore what role they may play in the function of the β-cell. Secondly given 
that we found that activation of MIN6 cells with TLRs increased chemokine 
production, and these supernatants were capable of inducing macrophage migration 
our objective was to investigate the crosstalk that exists between the pancreatic β-
cell line MIN6 and the macrophage cell line J774A.1 This was examined by 
culturing J774A.1 macrophages in MIN6 conditioned media and assessing their 
viability, surface marker expression, cytokine and chemokine secretion and 
subsequent response to activation by a panel of TLR ligands. 
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4.2 Results 
 
4.2.1 Effect of TLR stimulation on MIN6 cytokine and chemokine secretion 
TLR stimulation has long been understood to be an inducer of both cytokine and 
chemokine secretion in numerous cell types. To investigate the effect of TLR 
stimulation of MIN6 cytokine and chemokine production cells were plated at a 
concentration of 1 x 10
6 
cells per ml and allowed to grow to confluency prior to 24hr 
stimulation with ligands (Pam 1μg/ml, LPS 100ng/ml & Flagellin 5μg/ml). 
Following this supernatant was removed, spun down in a centrifuge to remove any 
cell debris and analysed for cytokine and chemokine content by ELISA (R&D 
systems, Minneapolis, MN, USA). There was no detectable levels of the cytokines 
IL-1β, IL-2, IL-6, IL-10, IL-12p40, IL-12p70, IL-17, IL-23, TNF-α and IFN-γ. 
Under control conditions MIN6 cells secrete the cytokines IL-4 & IL-27p28 and 
chemokines Mip-1, Mip-2, MCP-1 & RANTES [Figure 4.1].   
Stimulation with Pam did not alter IL-4 secretion but did cause a significant increase 
in levels of IL-27p28 (P<0.05), Mip-1 (P<0.001), Mip-2 (P<0.001), MCP-1 (P<0.05) 
and RANTES (P<0.05) [Figure 4.1].  Stimulation with LPS resulted in a significant 
decrease in IL-4 secretion (p<0.001) and a significant increase in secretion of Il-
27p28 (p<0.01), Mip-1 (p<0.05), Mip-2 (p<0.001), MCP-1 (p<0.01) and RANTES 
(p<0.001) [Figure 4.1]. Stimulation with flagellin also resulted in a significant 
decrease in IL-4 secretion (p<0.001) and a significant increase in secretion of Il-
27p28 (p<0.001), Mip-1 (p<0.001), Mip-2 (p<0.001), MCP-1 (p<0.05) and 
RANTES (p<0.01) [Figure 4.1]. 
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Although no detectable levels of IL-1β, TNF-α and IFN-γ secretion were found, as 
these cytokines are known to induce β-cell death (Wachlin et al. 2003) we assessed 
their expression at mRNA level. Stimulation with Flagellin did cause a significant 
increase in both IL-1β (p<0.01) and TNF-α (p<0.001) mRNA expression levels 
[Figure 4.4]. With IL-1β only a half a fold increase is seen however with TNF-α 30 
fold increase. No significant change in IFN-γ expression was observed. 
 
4.2.2 Min6 cells express the IL-4 receptor and stimulation with IL-4 results in 
increased PDX-1 expression 
As we found that TLR stimulation resulted in the decreased secretion of interleukin 4 
from MIN6 cells, along with altered glucose stimulated insulin secretion and 
intracellular content, we thought it pertinent to investigate the effects of IL-4 on 
Min6 cells. We first checked for expression of the IL-4 receptor (also known as 
CD124) by flow cytometry. To do this, cells were plated as previously described and 
stained with a fluorescently labelled antibody to the IL-4 receptor. Figure 4.5A 
shows expression of the IL-4 receptor on MIN6 cells when compared to unstained 
cells.  In order to assess the effects of IL-4 on PDX-1 expression, MIN6 cells were 
stimulated with 10ng/ml of recombinant IL-4 for 24 hr. Cells were then fixed, 
permeabilised and stained with a fluorescently labelled PDX-1 antibody. Cells 
treated with recombinant IL-4 showed higher expression levels of PDX-1 [Figure 
4.5B]. Histograms show surface marker expression of unstimulated control cells 
(black line) compared to IL-4 stimulated cells (dashed line). Filled histograms 
represent fluorescence of unstained cells.   
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4.2.3 Pre-incubation with Flagellin and IL-27 provides partial protection 
against Streptozotocin induced cell death in MIN6 cells 
As we found that MIN6 cells secrete IL-27p28 in response to TLR ligation [Figures 
4.1 - 4.3] we wanted to see if perhaps IL-27p28 played a protective role in MIN6 
cells. Streptozotocin (STZ) is a known inducer of cell death in pancreatic β-cells. As 
LPS and Flagellin were shown to be the strongest inducers of IL-27 secretion cells 
were pre-incubated (for 24hr) with either IL-27p28 (10ng/ml), LPS (100ng/ml) or 
Flagellin (5μg/ml) prior to 24hr stimulation with STZ (2.5mM). 20μl of the CellTiter 
96® AQueous Non-Radioactive Cell Proliferation Assay solution (Promega, WI, 
USA) was added to each well and left at 37°C 5% CO2 for 1 Hour. The plate was 
then read at a wavelength of 490nm. Results are expressed as a percentage of control 
cell viability. Both IL-27p28 (p<0.05) and Flagellin (p<0.01) significantly reduced 
cell death when compared to cells treated with STZ alone [Figure 3.21]. Pre-
incubation with LPS did not significantly alter cell viability. 
 
4.2.4 TLR stimulated MIN6 secretions induce J774A.1 macrophage migration 
Type 2 diabetes is associated with an increased number of islet associated 
macrophages (Richardson et al. 2009; Ehses et al. 2007). As we saw that stimulation 
of MIN6 cells with TLR ligands had the ability to elicit secretion of chemokines 
[Figures 4.1 – 4.3] we wanted to investigate whether these secretions could elicit a 
chemotactic response. MIN6 cells were plated and stimulated as previously 
described.  Following stimulation supernatants were removed and spun down to 
remove any cell debris. Supernatants were then transferred to the bottom of a trans-
well plate. Microporous inserts containing 5 x 10
5
 J774A.1 macrophage were then 
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placed in each well and left for 6hr after which time the inserts were removed and 
the number of migrated cells were counted using the BD FACS ARIA. Figure 4.7 
shows that supernatants from all treatments increased J774A.1 migration, with LPS 
(p<0.05) and Flagellin (P<0.01) reaching significance. 
 
4.2.5 Effect of MIN6 conditioning on J774A.1 macrophage in control conditions 
4.2.5.1 Culture of J774A.1 Macrophage in MIN6 conditioned medium does not 
affect cell viability 
Given that we wanted to examine the effect that MIN6 conditioned media had on the 
inflammatory profile of J774 macrophages it was first essential to investigate 
whether culture in this conditioned media affected the viability of J774 macrophages.  
MIN6 cells were cultured in DMEM-glutamax for 24hr, after which the conditioned 
media was removed and spun down to remove any cell debris. J774 macrophages 
were then plated in 96 well plates in either MIN6 conditioned media or 
unconditioned DMEM as a control. The viability of the cells was then assessed using 
the MTS assay, 24 and 48hr later. 
Culture of J774 macrophage in MIN6 conditioned media for either 24 or 48hr did 
not significantly alter cell viability [Figure 4.8]. 
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4.2.5.2 MIN6 conditioned media does not have a strong effect of J774A.1 surface 
marker expression 
J774A.1 macrophage were plated at a concentration of 1 x 10
6 
cells/ml in 6 well 
plates in either MIN6 conditioned media or unconditioned DMEM-glutamax 
(control). The cells were left for 24hr prior to analysis of surface marker expression 
by flow cytometry. Cells were stained with fluorescently labelled antibodies for 
TLR2, TLR4, MHCII, CCR5, CD80, CD86 and CD40. Histograms show surface 
marker expression of control cells (black line) compared to MIN6 conditioned cells 
(dashed line). Filled histograms represent fluorescence of unstained cells. As would 
be expected of a macrophage cell line J774A.1 show clear expression levels of all 
surface markers tested for [Figure 4.9]. Conditioning with MIN6 secretions resulted 
in a slight decrease in expression levels of surface markers TLR2, MHCII, CCR5 
and CD40.  
 
4.2.5.3 Cytokine and chemokine secretion from MIN6 conditioned J774A.1 
J774A.1 macrophage were plated at a concentration of 1 x 10
6 
cells/ml in 6 well 
plates in either MIN6 conditioned media or unconditioned DMEM-glutamax 
(control). The cells were left for 24hr, the media was then removed and spun down 
to remove any cell debris and analysed for cytokine and chemokine content by 
ELISA (R&D). Conditioning of macrophage did not result in any significant changes 
in cytokine secretion [Figure 4.10]. Conditioned macrophage show no difference in 
chemokines MIP-1 and MIP-2 secretion, however display a significant increase in 
MCP-1 (p<0.01) and a significant decrease in RANTES (p<0.01) secretion when 
compared to control macrophage [Figure 4.11]. 
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4.2.6 Effect of MIN6 conditioning on macrophage response to TLR ligation 
To better assess the effect of MIN6 conditioning on macrophage phenotype we next 
investigated how conditioned macrophage respond to TLR ligation compared to 
control macrophage. 
 
4.2.6.1 Conditioned macrophage show altered surface marker expression 
following TLR ligation 
J774 macrophage were then plated at a concentration of 1 x 10
6 
cells/ml in 6 well 
plates in either MIN6 conditioned media or unconditioned DMEM-glutamax 
(control). The cells were then left to rest for 24hr prior to 24hr stimulation with 
either PGN (5μg/ml), LPS (100ng/ml) or Flagellin (5μg/ml). Cells were stained with 
fluorescently labelled antibodies for TLR2, TLR4, MHCII, CCR5, CD80, CD86 and 
CD40. Histograms show surface marker expression of stimulated cells (black line) 
compared to stimulated MIN6 conditioned cells (dashed line). Grey line represents 
unstimulated control cells and filled histograms represent fluorescence of unstained 
cells. Note for CCR5 and CD40 histograms are off-set as there are two populations 
and it allows for easier visualisation. J774.A1 macrophages respond to TLR ligation 
(TLR2, TLR4 & TLR5) with an increase in cell surface marker expression [Figure 
4.12, 4.15 and 4.18].  In almost all cases conditioning of macrophages prior to TLR 
stimulation results in a decreased surface marker expression response [Figure 4.12, 
4.15 and 4.18].  Exceptions to this rule are in the case of Flagellin stimulated 
macrophage where conditioning fails to decrease surface marker expression of 
TLR4, MHCII, CD80 and CD86 and CD40 expression is actually increased [Figure 
4.18]. 
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4.2.6.2 Conditioned macrophage show altered cytokine response following TLR 
ligation 
J774 macrophage were plated at a concentration of 1 x 10
6 
cells/ml in 6 well plates in 
either MIN6 conditioned media or unconditioned DMEM-glutamax (control). The 
cells were then left to rest for 24hr prior to 24hr stimulation with either PGN 
(5μg/ml), LPS (100ng/ml) or Flagellin (5μg/ml). The media was then removed and 
spun down to remove any cell debris and analysed for cytokine content by ELISA 
(R&D). TLR activation of J774A.1 macrophage resulted in increased secretion of 
cytokines [Figures 4.13, 4.16 and 4.19]. Exceptions to this are once again only in 
the case of activation with flagellin which did not elicit an IL-6 or IL-27 response 
[Figure 4.19]. As a general rule preconditioning of macrophages with MIN6 media 
prior to activation with TLR ligands resulted in significant decreases in cytokine 
secretion. Upon activation with PGN, preconditioned macrophage show decreased 
secretion of IL-6 (p<0.001), IL-12p40 (p<0.001), IL-23 (p<0.001), TNF-α (p<0.001) 
and IL-27 levels remain unchanged in stimulated versus preconditioned stimulated 
cells [Figure 4.13]. Upon activation with LPS preconditioned macrophage show 
decreased secretion of IL-6 (p<0.001), IL-12p40 (p<0.001), IL-27p28 (p<0.05), IL-
23 and TNF-α levels remain unchanged in stimulated versus preconditioned 
stimulated cells [Figure 4.16]. Upon activation with flagellin preconditioned 
macrophage show decreased secretion of IL-12p40 (p<0.001), IL-23 (p<0.05), there 
is no change to TNF-α levels in stimulated versus preconditioned stimulated cells 
and there is a slight increase in IL-27 levels although it did not reach significance 
[Figure 4.19]. Data is summarised in Table 4.1. 
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 + PGN + LPS + Flagellin 
IL-6 ↓ *** ↓*** ↔ 
IL-12p40 ↓*** ↓*** ↓*** 
IL-23 ↓*** ↔ ↓** 
IL-27 ↔ ↓** ↔ 
TNF-α ↓*** ↔ ↔ 
↓ = decrease in secretion ↔ = no change in secretion **p<0.01, ***p<0.001 as determined by one way 
ANOVA 
Table 4.1 Summary of conditioning effect on macrophage cytokine secretion 
following TLR activation. 
 
4.2.6.3 Conditioned macrophage show altered chemokine response following TLR 
ligation 
J774 macrophage were plated at a concentration of 1 x 10
6 
cells/ml in 6 well plates in 
either MIN6 conditioned media or unconditioned DMEM-glutamax (control). The 
cells were then left to rest for 24hr prior to 24hr stimulation with either PGN 
(5μg/ml), LPS (100ng/ml) or Flagellin (5μg/ml). The media was then removed and 
spun down to remove any cell debris and analysed for chemokine content by ELISA 
(R&D). TLR activation of J774A.1 macrophage resulted in increased secretion of all 
chemokines tested for [Figures 4.14, 4.17 and 4.20].  Upon activation with PGN, 
preconditioned macrophage show decreased secretion of MIP-1 (p<0.001), MIP-2 
(p<0.001), MCP-1 (p<0.01) and RANTES (p<0.01) [Figure 4.14]. Upon activation 
with LPS, preconditioned macrophage show decreased secretion of RANTES 
(P<0.001), no change in secretion of MIP-1 or MIP-2 and enhanced secretion of 
MCP-1 (p<0.001) [Figure 4.17]. Upon activation with flagellin, preconditioned 
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macrophage show decreased secretion of MIP-1 (p<0.001) and RANTES (P<0.001) 
and no significant change in secretion of MIP-2 or MCP-1, however the trend 
appears to be increased [Figure 4.20]. Data is summarised in Table 4.2.  
 
 + PGN + LPS + Flagellin 
MIP-1 ↓*** ↔ ↓*** 
MIP-2 ↓*** ↔ ↔ 
MCP-1 ↓** ↑*** ↔ 
RANTES ↓** ↓*** ↓*** 
↓ = decrease in secretion ↔ = no change in secretion ↑ = increase in secretion **p<0.01, ***p<0.001 as 
determined by one way ANOVA 
Table 4.2 Summary of conditioning effect on macrophage chemokine secretion 
following TLR activation.     
 
4.2.7 Conditioned macrophage display phagocytotic ability comparable to 
control cells 
Macrophages are often referred to as “professional phagocytes” in so far as one of 
their key roles in the body is to phagocytose pathogens and cell debris which 
initiates the innate immune response, which in turn orchestrates the adaptive 
response (Aderem & Underhill 1999). It has been reported that macrophage from 
patients with T2D have impaired phagocytic capability (Lecube et al. 2011). For this 
reason we though it pertinent to assess phagocytotic ability of conditioned 
macrophage compared to control. To do this J774A.1 macrophages were cultured in 
the presence of conditioned or control media for 24hr before we assessed their ability 
to phagocytose. When the phagocytosis was measured in response to stimuli, TLR 
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ligands were added for 24hr following 24hr pre-conditioning. To measure 
phagocytosis, fluorescent latex beads were added to the culture and macrophages 
were left to phagocytose for 3hr. Cells were then washed and the uptake of beads 
was measured flow cytometrically. Cells that ingested the beads display green 
fluorescence which can be measured in the FITC channel of the flow cytometer and 
expressed as a percentage of phagocytosing (FITC
+
) cells. Macrophages do increase 
their phagocytosis following activation with TLR ligands, however only minimally 
[Figure 4.21]. Pre-conditioning macrophage prior to activation does not appear to 
affect phagocytosis [Figure 4.21]. 
 
4.2.8 Conditioned macrophages produce lower levels of reactive oxygen species 
(ROS) in a steady state and in response to stimulation 
Classically activated macrophages produce large quantities of inflammatory 
mediators such as reactive oxygen species (ROS) in response to bacterial endotoxins 
(Gill et al. 2010). ROS levels were measured using the cell permeant reagent 2’,7’ – 
dichlorofluorescein diacetate (DCFDA), a fluorogenic dye that measures hydroxyl, 
peroxyl and other ROS activity within the cell. J774A.1 macrophages were 
conditioned as previously described and the fluorescent signal relative to 
intracellular ROS generation was then measured by flow cytometry and compared 
between unconditioned (black histograms) and conditioned cells (dashed 
histograms). Conditioned cells showed decreased production of ROS in both a 
steady state and following stimulation with both PGN and LPS [Figure 4.22]. 
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4.2.9 Conditioned macrophage show increased “M2” genes and decreased “M1” 
genes 
As mentioned previously two major macrophage populations have been 
characterised in vitro. Classically activated or type I macrophages, induced in 
particular by IFNγ, display a proinflammatory profile whereas alternatively activated 
or type II macrophages, induced by Th-2 cytokines, express anti-inflammatory and 
tissue repair properties (Gordon 2003). One method to identify activation status of 
macrophage is to look at expression levels of certain genes. To do this J774A.1 
macrophage were plated and conditioned as previously described. Following 24hr 
conditioning, cells were either stimulated with PBS (control) or LPS (100ng/ml) for 
a further 24 Hr. Following homogenisation, RNA was extracted using Nucleospin 
RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised amounts of 
RNA were converted into cDNA using a High Capacity cDNA Mastermix (Roche). 
The levels of IL-1β, NOS2, ARG1 and MRC1 were quantified using qPCR. The 
expression levels were normalised to actin levels and the gene expression is shown 
as a fold change relative to the control. MIN6 conditioned macrophage show 
decreased expression of the “M1” genes IL-1β and NOS2 in both steady state (IL-1β 
p<0.05, NOS2 p<0.001) and following stimulation with LPS (IL-1β p<0.01, NOS2 
p<0.001) [Figure 4.23]. Concurrently conditioned macrophage show an increase in 
typical “M2” genes ARG1 and MRC1 both in steady state (ARG1 p<0.001, MRC1 
p<0.05) and also following stimulation with LPS (ARG1 p<0.001, MRC1 p<0.05) 
[Figure 4.24]. 
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4.2.10 Conditioning macrophage alters IRS2 expression but not IRS1 
expression 
As T2D has been shown to impair IRS2 mediated PI3K activity in primary 
macrophage (Connor et al. 2007a) we thought to investigate the effect of stimulation 
with LPS had on IRS expression levels in both control and conditioned macrophage. 
J774A.1 macrophage were plated and conditioned as previously described. 
Following 24hr conditioning cells were either stimulated with PBS (control) or LPS 
(100ng/ml) for a further 24hr. Following homogenisation, RNA was extracted using 
Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised 
amounts of RNA were converted into cDNA using a High Capacity cDNA 
Mastermix (Roche). The levels of IRS1 and IRS2 were quantified using qPCR. The 
expression levels were normalised to actin levels and the gene expression is shown 
as a fold change relative to the control. Stimulation of J774 macrophage with LPS 
caused an increase in IRS1 expression in both conditioned (p<0.01) and control cells 
(p<0.01) [Figure 4.25A]. Stimulation with LPS also caused an increase in IRS2 
expression (p<0.05) however this increase is blocked in conditioned macrophage 
(p<0.05) [Figure 4.25B]. This decrease in IRS2 expression is seen in both steady 
state and LPS treated macrophage.  
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4.3 Figures                
 
 
 
Figure 4.1 Stimulation with Pam alters the Cytokine and Chemokine Profile of 
MIN6 Cells. Cells were seeded at 1 x 10
6
 cells per ml in a 6 well plate and were 
allowed to grow to confluency prior to stimulation for 24hr with Pam (1μg/ml) in 
fresh media. Following stimulation supernatants were removed and were analysed by 
ELISA (R&D systems, Minneapolis, MN, USA). Data are presented as mean ± SEM 
of three replicates and are representative of three independent experiments. *p<0.05, 
**p<0.01, ***p<0.001 as determined by unpaired t-test. 
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Figure 4.2 Stimulation with LPS alters the Cytokine and Chemokine Profile of 
MIN6 Cells. Cells were seeded at 1 x 10
6
 cells per ml in a 6 well plate and were 
allowed to grow to confluency prior to stimulation for 24hr with LPS (100ng/ml) in 
fresh media. Following stimulation supernatants were removed and analysed by 
ELISA (R&D systems, Minneapolis, MN, USA. Data are presented as mean ± SEM 
of three replicates and are representative of three independent experiments. *p<0.05, 
**p<0.01, ***p<0.001 as determined by unpaired t-test. 
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Figure 4.3 Stimulation with Flagellin alters the Cytokine and Chemokine 
Profile of MIN6 Cells. Cells were seeded at 1 x 10
6
 cells per ml in a 6 well plate and 
were allowed to grow to confluency prior to stimulation for 24hr with Flagellin 
(5μg/ml) in fresh media. Following stimulation supernatants were removed and were 
analysed by ELISA (R&D systems, Minneapolis, MN, USA). Data are presented as 
mean ± SEM of three replicates and are representative of three independent 
experiments. *p<0.05, **p<0.01, ***p<0.001 as determined by unpaired t-test. 
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Figure 4.4 Expression levels of IL-1β, IL-6 and TNF-α following 24h TLR 
ligation. The expression of the above genes was measured by qPCR. . Cells were 
seeded at 1 x 10
6  
 cells/ml on a 6 well plate and left to grow to confluency after 
which fresh media was added and the cells were stimulated with TLR ligands (Pam 
1μg/ml,  LPS 100ng/ml, Flagellin 5μg/ml) for 24hr. Following homogenisation, 
RNA was extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified 
on the nanodrop. Equalised amounts of RNA were converted into cDNA using a 
High Capacity cDNA Mastermix (Roche). The cDNA was mixed with primers for 
IL-1β, IL-6 and TNF-α (IDT) and analysed on the ABI Prism 7500. cDNA samples 
were assayed in triplicate and gene expression levels were normalised to endogenous 
control, B2M. The mean relative gene expression was calculated using the 2-ΔΔCt 
method. Results are mean ± SEM. **P<0.01, ***P<0.001 vs. control, determined by 
unpaired t-test 
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Figure 4.5 MIN6 cells express the IL-4 receptor and increase PDX-1 expression 
in response to IL-4 stimulation. Cells were seeded at a concentration of 1 x 10
6  
 
cells per ml and left to grow to confluency. In (A) cells were stained with a 
fluorescently labelled antibody to the IL-4R (CD124) (BD) and its expression was 
measured by flow cytometry. Histograms show surface marker expression of control 
cells (black line) compared unstained cells (grey histogram). In (B) cells were 
stimulated for 24 Hr with 10ng/ml of recombinant IL-4 (R&D). Following this cells 
were permeabilised and stained with a fluorescently labelled antibody to PDX-1. 
Histograms show surface marker expression of unstimulated control cells (black 
line) compared to IL-4 stimulated cells (dashed line). Filled histograms represent 
fluorescence of unstained cells.   
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Figure 4.6 Pre-incubation with Flagellin and IL-27, but not LPS provide partial 
protection again Streptozotocin induced MIN6 cell death. Cells were seeded at a 
concentration of 1 x 10
6  
 cells per ml and left to grow to confluency after which 
fresh media was added and the cells were stimulated with TLR ligands (LPS 
100ng/ml & Flagellin 5μg/ml) and IL-27 (10ng/ml) for 24hr. Following this cells 
were stimulated with 2.5mM STZ for a further 24 hours. 20ul of the CellTiter 96® 
AQueous Non-Radioactive Cell Proliferation Assay solution (Promega, WI, USA) 
was added to each well and left at 37°C 5% CO2 for 1 Hour. The plate was then read 
at a wavelength of 490nm. Results are expressed as a percentage of control cell 
viability. Data are represented as mean ± SEM of three replicates and are 
representative of three independent experiments. *P<0.05, ***p<0.01 as determined 
by one way ANOVA with Newman Keuls post-hoc test.  
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Figure 4.7 TLR stimulated secretions induce J7741.A macrophage migration. 
MIN6 cells were seeded at 1 x 10
6
 cells per ml and were allowed to grow to 
confluency prior to stimulation for 24hr with TLR ligands  (Pam 1μg/ml, , LPS- 
100ng/ml, Flagellin- 5μg/ml) in fresh media. Following stimulation supernatants 
were removed and spun down to remove any cell debris. Supernatants were then 
transferred to the bottom of a trans-well plate. Microporous inserts containing 5 x 
10
5
 J774A.1 MØ were then placed in each well and left for 6 hours after which time 
the inserts were removed and the number of migrated cells were counted. Data are 
represented as mean ± SEM of three replicates and are representative of three 
independent experiments. *P<0.05 as determined by unpaired t-test. 
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Figure 4.8 Culturing J774 Macrophage in MIN6 conditioned medium does not 
affect cell viability. MIN6 cells were cultured in DMEM-glutamax for 24hr. The 
conditioned media was then removed and transferred to J774A.1 macrophages for 24 
and 48hr. Following this 20μl of the CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay solution (Promega, WI, USA) was added to each well and left at 
37°C 5% CO2  for 1 Hour. The plate was then read at a wavelength of 450nm. 
Results are expressed as a percentage of the control viability (100%). Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. 
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Figure 4.9 Expression of surface markers on MIN6 conditioned macrophages. J774A.1 macrophages were 
incubated with normal medium or MIN6 conditioned medium for 24hr. Following this cells were stained with 
fluorescently labelled antibodies for TLR2, TLR4, MHCII, CCR5, CD80, CD86 & CD40 and expression was 
measured by flow cytometry. Histograms show surface marker expression of conditioned cells (dashed line) 
compared to unconditioned control cells (black line). Filled histograms represent fluorescence of unstained 
cells. Data are representative of three independent experiments. 
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Figure 4.10 Cytokine secretion from MIN6 conditioned macrophages. 
J774A.1 macrophages were incubated with normal medium or MIN6 
conditioned medium for 24hr. Following this supernatants were collected and 
cytokine secretion was measured by ELISA (R&D) according to 
manufacturer’s instruction. Data are presented as mean ± SEM of three 
replicates and are representative of three independent experiments. 
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Figure 4.11 Chemokine secretion from MIN6 conditioned 
macrophages. J774A.1 macrophages were incubated with normal 
medium or MIN6 conditioned medium for 24hr. Following this 
supernatants were collected and chemokine secretion was 
measured by ELISA (R&D) according to manufacturer’s 
instruction. Data are presented as mean ± SEM of three replicates 
and are representative of three independent experiments. **P<0.01 
by unpaired t-test. 
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Figure 4.12 Expression of surface markers on MIN6 conditioned macrophages following TLR2 ligation. J774A.1 
macrophages were incubated with normal medium or MIN6 conditioned medium for 24hr. Cells were then stimulated 
with PGN (5μg/ml) for a further 24hr. Cells were then stained with fluorescently labelled antibodies for TLR2, TLR4, 
MHCII, CCR5, CD80, CD86 & CD40 and expression was measured by flow cytometry. Histograms show surface 
marker expression of conditioned cells (dotted line) compared to unconditioned control cells (black line) following TLR2 
stimulation. Grey line represents the expression on unstimulated controls. Filled histograms represent fluorescence of 
unstained cells. Data are representative of three independent experiments. 
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Figure 4.13 Cytokine secretion from MIN6 conditioned macrophages 
following TLR2 ligation. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Fresh media was 
added to cells followed by 24hr stimulation with PGN (5μg/ml). Following 
this supernatants were collected and cytokine secretion was measured by 
ELISA (R&D) according to manufacturer’s instruction. Data are presented 
as mean ± SEM of three replicates and are representative of three 
independent experiments. Statistical significance for multiple comparisons 
was determined by one-way ANOVA followed by Newman-Keuls analysis. 
***P<0.01, ***P<0.001 vs. unconditioned PGN-stimulated cells. 
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Figure 4.14 Chemokine secretion from MIN6 conditioned macrophages 
following TLR2 ligation. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Fresh media was 
added to cells followed by 24hr stimulation with PGN (5μg/ml). Following 
this supernatants were collected and chemokine secretion was measured by 
ELISA (R&D) according to manufacturer’s instruction. Data are presented 
as mean ± SEM of three replicates and are representative of three 
independent experiments. Statistical significance for multiple comparisons 
was determined by one-way ANOVA followed by Newman-Keuls analysis. 
**P<0.01, ***P<0.01 vs. unconditioned PGN-stimulated cells. 
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Figure 4.15 Expression of surface markers on MIN6 conditioned macrophages following TLR4 ligation. J774A.1 
macrophages were incubated with normal medium or MIN6 conditioned medium for 24hr. Cells were then stimulated 
with LPS (100ng/ml) for a further 24hr. Cells were then stained with fluorescently labelled antibodies for TLR2, TLR4, 
MHCII, CCR5, CD80, CD86 & CD40 and expression was measured by flow cytometry. Histograms show surface 
marker expression of conditioned cells (dotted line) compared to unconditioned control cells (black line) following TLR4 
stimulation. Grey line represents the expression on unstimulated controls. Filled histograms represent fluorescence of 
unstained cells. Data are representative of three independent experiments. 
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Figure 4.16 Cytokine secretion from MIN6 conditioned macrophages 
following TLR4 ligation. J774A.1 macrophages were incubated with normal 
medium or MIN6 conditioned medium for 24hr. Fresh media was added to cells 
followed by 24hr stimulation with LPS (100ng/ml). Following this supernatants 
were collected and cytokine secretion was measured by ELISA (R&D) according 
to manufacturer’s instruction. Data are presented as mean ± SEM of three 
replicates and are representative of three independent experiments Statistical 
significance for multiple comparisons was determined by one-way ANOVA 
followed by Newman-Keuls analysis. **P<0.01, ***P<0.001 vs. unconditioned 
LPS-stimulated cells. 
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Figure 4.17 Chemokine secretion from MIN6 conditioned macrophages 
following TLR4 ligation. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Fresh media was 
added to cells followed by 24hr stimulation with LPS (100ng/ml). 
Following this supernatants were collected and chemokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data 
are presented as mean ± SEM of three replicates and are representative of 
three independent experiments. Statistical significance for multiple 
comparisons was determined by one-way ANOVA followed by Newman-
Keuls analysis. ***P<0.001 vs. unconditioned LPS-stimulated cells. 
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Figure 4.18 Expression of surface markers on MIN6 conditioned macrophages following TLR5 ligation. J774A.1 macrophages 
were incubated with normal medium or MIN6 conditioned medium for 24hr. Cells were then stimulated with Flagellin (5μg/ml) for a 
further 24hr. Cells were then stained with fluorescently labelled antibodies for TLR2, TLR4, MHCII, CCR5, CD80, CD86 & CD40 
and expression was measured by flow cytometry. Histograms show surface marker expression of conditioned cells (dotted line) 
compared to unconditioned control cells (black line) following TLR5 stimulation. Grey line represents the expression on 
unstimulated controls. Filled histograms represent fluorescence of unstained cells. Data are representative of three independent 
experiments. 
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Figure 4.19 Cytokine secretion from MIN6 conditioned macrophages 
following TLR5 ligation. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Fresh media was 
added to cells followed by 24hr stimulation with Flagellin (5μg/ml). 
Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data 
are presented as mean ± SEM of three replicates and are representative of 
three independent experiments Statistical significance for multiple 
comparisons was determined by one-way ANOVA followed by Newman-
Keuls analysis. **P<0.01, ***P<0.001 vs. unconditioned Flagellin-
stimulated cells. 
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Figure 4.20 Chemokine secretion from MIN6 conditioned macrophages 
following TLR5 ligation. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Fresh media was 
added to cells followed by 24hr stimulation with Flagellin (5μg/ml). 
Following this supernatants were collected and chemokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data 
are presented as mean ± SEM of three replicates and are representative of 
three independent experiments. Statistical significance for multiple 
comparisons was determined by one-way ANOVA followed by Newman-
Keuls analysis. ***P<0.001 vs. unconditioned Flagellin-stimulated cells
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Figure 4.21 Conditioned and control macrophage display 
comparable phacocytotic activity. J774A.1 macrophages were 
incubated with normal media or MIN6 conditioned media 24hr. Pre-
conditioned cells were stimulated with PGN (5μg/ml) LPS (100ng/ml) 
& Flagellin (5μg/ml) for 24hr. To assess phagocytic ability of cells, 
1μm of fluorescent latex beads (Sigma) were added to the culture and 
macrophages were left to phagocytose for 2hr. Cells were then washed 
and analysed by flow cytometry for the uptake of beads. Histograms 
show the percentages of cells that contain beads (FITC+) or do not 
contain beads (FITC-).0 
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Figure 4.22 Conditioned macrophages produce lower levels of reactive oxygen 
species (ROS) in a steady state and in response to PGN & LPS stimulation. 
J774A.1 macrophages were incubated with control media or MIN6 supernatants for 
24hr. Cells were stimulated with PGN (5μg/ml) & LPS (100ng/ml) for 24hr. To 
measure the production of reactive oxygen species, cell were labelled with DCFDA 
(Abcam), according to manufacturer’s instructions, and the fluorescent signal 
relative to intracellular ROS generation was then measured by flow cytometry and 
compared between unconditioned cells (black line) and conditioned cells (dashed 
line). Data are representative of three independent experiments. 
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Figure 4.23 Conditioned macrophage display decreased IL1β & NOS2 activity 
in steady state and following stimulation with LPS. The expression of IL1β and 
NOS2 was measured by qPCR. J774A.1 macrophages were cultured in MIN6 
conditioned or control media for 24hr prior to 24hr stimulation with LPS 100ng/ml. 
Following homogenisation, RNA was extracted using Nucleospin RNA II kit 
(Macherey-Nagel) and quantified on the nanodrop. Equalised amounts of RNA were 
converted into cDNA using a High Capacity cDNA Mastermix (Roche). The cDNA 
was mixed with primers for IL1β & NOS2 (IDT) and analysed on the ABI Prism 
7500. cDNA samples were assayed in triplicate and gene expression levels were 
normalised to endogenous control, actin. The mean relative gene expression was 
calculated using the 2-ΔΔCt method. Results are mean ± SEM. **P<0.01, 
***P<0.001, vs. control, determined by unpaired t-test 
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Figure 4.24 Conditioned macrophage display increased ARG1 & MRC1 activity 
in steady state and following stimulation with LPS. The expression of ARG1 and 
MRC1 was measured by qPCR. J774A.1 macrophages were cultured in MIN6 
conditioned or control media for 24hr prior to 24hr stimulation with LPS 100ng/ml. 
Following homogenisation, RNA was extracted using Nucleospin RNA II kit 
(Macherey-Nagel) and quantified on the nanodrop. Equalised amounts of RNA were 
converted into cDNA using a High Capacity cDNA Mastermix (Roche). The cDNA 
was mixed with primers for ARG1 & MRC1 (IDT) and analysed on the ABI Prism 
7500. cDNA samples were assayed in triplicate and gene expression levels were 
normalised to endogenous control, actin. The mean relative gene expression was 
calculated using the 2-ΔΔCt method. Results are mean ± SEM. *P<0.05, 
***P<0.001, vs. control, determined by unpaired t-test. 
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Figure 4.25 LPS stimulated macrophage show increased IRS1 and IRS2 
expression and IRS2 expression in decreased by conditioning. The expression of 
IRS1 and IRS2 was measured by qPCR. J774A.1 macrophages were cultured in 
MIN6 conditioned or control media for 24hr prior to 24hr stimulation with LPS 
100ng/ml. Following homogenisation, RNA was extracted using Nucleospin RNA II 
kit (Macherey-Nagel) and quantified on the nanodrop. Equalised amounts of RNA 
were converted into cDNA using a High Capacity cDNA Mastermix (Roche). The 
cDNA was mixed with primers for IRS1 and IRS2 (IDT) and analysed on the ABI 
Prism 7500. cDNA samples were assayed in triplicate and gene expression levels 
were normalised to endogenous control, actin. The mean relative gene expression 
was calculated using the 2-ΔΔCt method. Results are mean ± SEM. *P<0.05, 
**P<0.01, vs. control, determined by unpaired t-test. 
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4.4 Discussion 
 
Of all cytokines we assessed in MIN6 cells we only detected that they secreted IL-4 
and IL-27p28 in a resting state. Under control conditions MIN6 cells are seen to 
secrete high levels of the cytokine IL-4. IL-4 is a pleiotropic cytokine that exerts its 
effects via activation of the transcription factor Signal Transducer and Activator of 
Transcription (STAT) 6 (Takeda et al. 1996). The majority of research has focused 
on its functions in the immune system which include Th2 differentiation of helper T 
cells, activation of B cells to release IgE, and stimulation of alternative macrophage 
activation (Gordon 2003). In the context of the pancreatic β-cells and diabetes, 
genetic studies have revealed a significant association between IL-4 promoter 
polymorphisms and T2D  (Ho et al. 2010). In recent times IL-4 has been associated 
with regulation of glucose metabolism and insulin sensitivity in major metabolic 
organs including liver, fat and muscle (Ricardo-gonzalez et al. 2010). Disruption of 
STAT6 decreases insulin action and enhances a peroxisome proliferator-activated 
receptor α (PPARα) driven program of oxidative metabolism (Ricardo-gonzalez et 
al. 2010). Conversely, activation of STAT6 by IL-4 improves insulin action by 
inhibiting the PPARα-regulated program of nutrient catabolism and attenuating 
adipose tissue inflammation. These findings have identified an unexpected molecular 
link between the immune system and nutrient metabolism. Taking this in 
consideration we have shown that TLR stimulation results in a significant decrease 
in production of IL-4 from MIN6 β-cells in the case of TLR4, and TLR5. This 
suggests perhaps a role for IL-4 in the islet as an insulin sensitizing agent and TLR 
stimulation may decrease this affect. Indeed Gaddy et al reported that a single 
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treatment with double-stranded adeno-associated virus serotype 8 (dsAAV8) vectors 
expressing IL-4 under regulation of the insulin promoter enhanced β-cell 
proliferation and survival in vivo, significantly delaying diabetes progression in 
NOD mice (Gaddy et al. 2012). This is in line with our own findings which show 
that treatment of MIN6 β-cells with recombinant IL-4 causes an increase in the 
transcription factor PDX-1 which is essential for pancreatic development and for the 
maintenance of β-cell function. Another role for IL-4 is the alternative activation of 
macrophages (Gordon 2003). This decrease in IL-4 production seen upon TLR 
stimulation may result in an alteration in the phenotype of and resident islet or 
infiltrating macrophages which in turn could affect the function of the β-cell. 
 
Under control conditions there is a low level of secretion of the cytokine IL-27p28 
from Min6 cells. IL-27 is a hetero-dimeric cytokine of the IL-6 and IL-12 family 
composed of the IL-27p28 and EBI3 subunits. IL- 27p28 and EBI3 are produced 
primarily by antigen-presenting cells after stimulation by microbial products or 
inﬂammatory mediators (Hunter & Kastelein 2012). IL-27 was initially described as 
a proinflammatory cytokine that promoted T helper (Th)1 responses (Pflanz et al. 
2002). Subsequent studies in multiple models of infectious and autoimmune disease 
have confirmed an anti-inflammatory role for IL-27 in Th1, Th2 and Th17 responses 
(Stumhofer & Hunter 2008) and recent work has shown that IL-27 can induce T cells 
to produce the anti-inflammatory cytokine IL-10 (Awasthi et al. 2007), thus IL-27 
can exert both inflammatory and anti-inflammatory effects. As low amounts of IL-27 
are secreted from MIN6 β-cells under control conditions we postulate that it may 
play an anti-inflammatory regulatory role in the islet. Upon activation of TLR2, 
TLR4 and TLR5 in MIN6 cells we observed an increase in the production of IL-27. 
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Recently Fujimoto et al have shown that the administration of recombinant IL-27 
decreased blood glucose levels, immune cell infiltration into islets, and IL-1β mRNA 
expression in the pancreas and increased islet proinsulin levels in mice treated with 
streptozotocin (Fujimoto et al. 2011). Our findings that MIN6 cells secrete IL-27p28 
and TLR5 stimulation in particular increases this secretion may help explain their 
findings and may point to a protective role for IL-27 in islets. This may represent a 
novel therapeutic approach for β-cell protection in diabetes. Indeed we found that 
when MIN6 cells were preconditioned with IL-27 and Flagellin (strongest inducer of 
IL-27 in these cells) STZ induced cell death was decreased when compared with 
control STZ treated and LPS preconditioned STZ treated cells. 
 
As mentioned previously IL-1β, TNF-α and IFN-γ are cytokines that are known to 
induce β-cell death and dysfunction (Wachlin et al. 2003). Although no detectable 
secretion levels of these cytokines were found in control or stimulated conditions 
from MIN6 cells. Flagellin stimulation of MIN6 cells resulted in a significant 
increase in mRNA expression levels of IL-1β and TNF-α. The mechanisms by which 
IL-1β may contribute to the pathogenesis of diabetes are controversial. Islet cells 
demonstrate autocrine increases in IL-1β when exposed to IL-1β or glucose (Zeender 
et al. 2004; Maedler et al. 2002). It is possible that IL-1β acts in concert with other 
cytokines to cause islet cell death. For example, whereas no apoptosis was observed 
in nondiabetic human islet cells incubated with either IL1β or IFN-γ alone, exposure 
to both cytokines simultaneously resulted in increased apoptosis as a result of death 
protein 5/harikari activation (Gurzov et al. 2009), which in turn is associated with an 
NFκB-regulated increase in expression of the p53 upregulated modulator of 
apoptosis (Makeeva et al. 2006).  Although in vitro experiments suggest that IL-1β is 
151 
 
detrimental to insulin secretion, mouse studies from the 1980s suggest that IL-1β is 
protective against chemically induced diabetes development. IL-1β injected into 
alloxan-treated mice decreased glucose levels within 30 min. In streptozotocin-
treated mice the decrease in glucose levels was more modest and required multiple 
IL-1β injections, whereas there was improvement in diabetic db/db mice with one 
injection of IL-1β (del Rey & Besedovsky 1989). As flagellin is the only ligand that 
results in an increase in IL-1β mRNA expression, and we have shown that activation 
of MIN6 cells with flagellin prior to STZ treatment provides partial protection we 
postulate that IL-1β could be acting in a protective mechanism in this case. The same 
could be said for the increase seen in TNF-α expression levels following flagellin 
stimulation. TNF-α has an extremely complex role in the immune system. It is a 
regulatory cytokine that co-ordinates communication between immune cells and 
controls many of their functions, such as activation, apoptosis, survival, proliferation 
and differentiation (Parameswaran & Patial 2010). Exposure of cells to TNF-α can 
result in activation of a caspase cascade leading to apoptosis. However, binding of 
TNF-α can also lead to activation of major transcription factors, AP-1 and NF-κB, 
that in turn induce the genes to suppress apoptosis (Bradley 2008). TNF-α has been 
shown to cause β-cell death in MIN6 cells, however only when used in conjunction 
with IFN-γ (Suk et al. 2001) and we did not find increased expression of IFN-γ 
following stimulation of MIN6 cells. Once again as Flagellin is the only activator of 
TNF-α in MIN6 cells, and as flagellin seems to act in a protective role in that setting 
activation of TNF-α could be playing an anti-apoptotic role. In line with the previous 
chapter this data once again highlights a potential protective role for TLR5 in the β-
cell. 
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TLR2, TLR4 and TLR5 activation of MIN6 cells also resulted in a significant 
increase in the production of the chemokines MIP-1α (CCL3), MIP-2α (CXCL2), 
MCP-1 (CCL2) and RANTES (CCL5). This suggests that TLR activation results in 
increased chemotactic properties of MIN6 cells. This is supported by the fact that we 
have shown that supernatants from TLR stimulated MIN6 cells have the ability to 
induce macrophage migration. Increased levels of chemokines have also been 
associated with type 2 diabetes (Ehses et al. 2007; Herder et al. 2006). 
Immunohistochemical analysis of pancreas sections from patients with T2D, 
C57BL/6 mice fed a high-fat diet, db/db mice and Goto-Kakizaki (GK) rats all 
showed elevated numbers of macrophages within islets (Ehses et al. 2007).  Of note 
is the observation that increased numbers of macrophages were detectable very early 
in high-fat-fed mouse islets, before the onset of diabetes and possible early 
infiltration of macrophages may be beneficial to islet function (Ehses et al. 2007). 
Increased circulating levels of MCP-1 are increased in obesity, associated with 
insulin resistance and predict development of T2D (Herder et al. 2006). Recent 
findings by Cai et al  also have shown that MCP-1 up-regulates amylin expression in 
murine pancreatic β-cells and Min6 cells (Cai et al. 2011). Islet amyloid deposition is 
a characteristic pathological feature of the pancreas in type 2 diabetes patients. 
Therefore the ability of TLR activation of β-cells to induce macrophage migration 
may be protective in the short term, however throughout disease progression 
macrophages may become constitutively activated and play a role accelerating 
pancreatic islet dysfunction and death. Further work needs to be carried out to 
investigate the polarity of migrating macrophages induced following TLR 
stimulation.  
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As MIN6 media (both control and stimulated) had the ability to induce J774A.1 
macrophage migration we next sought to investigate the effect that this media had on 
macrophage function. In a steady state, conditioning of J774A.1 macrophage with 
MIN6 media results in a slight decrease in some surface markers with no change to 
cytokine secretion. Conditioning of J774 macrophage with MIN6 media seems to 
confer a certain level of anti-inflammatory protection against TLR ligand 
stimulation. As a general trend we saw a reduction in the secretion of pro-
inflammatory cytokines and chemokines from conditioned cells in comparison to 
control cells with a few exceptions. As it is known that pro-inflammatory cytokines 
can cause β-cell dysfunction and death, and interfere with insulin signalling (Donath 
et al. 2010) it is likely that there are measures in place in the islet to tightly regulate 
these processes, and crosstalk between the β-cell and macrophages may be key in 
this. We know that Min6 β-cells secrete IL-4 and IL-27p28 therefore it is probable 
that these cytokines play a role in the crosstalk between these two cell types.  
IL-4 is a known inducer of alternative macrophage activation (Gordon 2003). From 
an immunological stand-point these macrophages play prominent roles in host 
responses to parasitic infections that stimulate the production of Th2 cytokines IL-4 
and IL-13, however there is an increasing body of evidence that alternatively 
activated macrophages play important roles in the maintenance of tissue homeostasis 
and wound repair (Gordon 2003). For this reason, the driving of an alternative 
activation phenotype may be beneficial for resident or infiltrating macrophages in 
the islet, and perhaps is not maintained during T2D leading to classically activated 
macrophages secreting pro-inflammatory cytokines in the environment of the islet 
causing damage to the β-cells. Consistent with our data IL-4 (Fiorentino et al. 1991) 
and IL-27 (Hölscher et al. 2005) have been shown to inhibit production of pro-
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inflammatory cytokines in macrophages such as TNF-α, IL-6 and IL-12 and 
alternatively activated macrophages have been shown to have increased 
responsiveness to the suppressive effects of IL-27 (Rückerl et al. 2006). A further 
link to the importance of IL-4 for macrophages in the context of T2D comes from a 
study which shown macrophages isolated from obese/diabetic db/db mice have 
impaired IRS-2-mediated PI3K activity and constitutively overexpress suppressor of 
cytokine signaling (SOCS)-3, which impairs IL-4-dependent production of IL-1RA, 
an important anti-inflammatory function (Connor et al. 2007b). In terms of 
macrophage activation status our own studies have shown that conditioning of 
macrophage results in a decrease in “M1” type genes IL-1β and NOS2 and an 
increase in “M2” type genes ARG1 and MRC1 in both control and LPS stimulated 
cells. Once again, as this was studied at an mRNA level and not at the protein level 
we cannot say for certain that processes such as post-translational modification and 
activation of caspases are not influencing our results to be certain of this protein 
work would have to be carried out. However, in similar studies reporting a shift from 
an M1 to M2 phenotype in mouse bone-marrow derived macrophage Cho et al 
reported a similar decrease in NOS2 expression with a concurrent increase in ARG1 
expression. The authors found that both protein levels and mRNA levels correlated 
with each other (Cho et al. 2014) leading us to believe that if investigated we would 
see similar results in our cells. 
 
The effect of MIN6 conditioned media on chemokine secretion from J774 
macrophage does not seem as straight-forward however, a dampened down effect 
can be seen in some cases. In the case of un-stimulated cells, the levels of MIP-1 and 
MIP-2 secretion are similar, RANTES secretion is decreased whereas MCP-1 
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secretion is increased in conditioned versus control cells. RANTES is the only 
chemokine that we found to be consistently down-regulated in both control and 
stimulated states. RANTES is involved in direct antimicrobial activity by inducing 
NO in macrophages, however RANTES can have detrimental effects via the 
recruitment of immune cells such as T cells, dendritic cells, eosinophils, NK cells, 
mast cells, and basophils to sites of inflammation and infection that enhance 
inflammatory processes such as arthritis, atopic dermatitis and colitis (Villalta et al. 
1998). For this reason the dampening down of the response in both control and 
stimulated cells may be beneficial for the β-cells to exert a measure of control over 
the inflammatory environment in the islet. In the case of MCP-1, in un-stimulated 
conditions, levels are increased in conditioned cells versus control cells and this is 
also the case in the majority of TLR stimulated conditioned cells vs control cells. As 
MIN6 media alone had the ability to induce MCP-1 secretion from J774 macrophage 
we postulate that this effect is potentiated in conditioned cells upon TLR stimulation. 
MCP-1 has been shown to induces amylin expression in mouse islets and MIN6 β-
cells (Cai et al. 2011) and is associated with insulin resistance therefore secretion of 
MCP-1 by macrophage may pose a detrimental effect to the β-cell. However in our 
own studies we did not find an increase in IAPP mRNA levels following TLR 
stimulation. Although dampening of the immune response is beneficial in some 
environments, some level of response needs to be mounted to fight off infection; 
therefore the preservation of MCP-1, MIP-1 and MIP-2 secretion in conditioned 
macrophages may be important for a normal immune response. MIP-1 and MIP-2 
have also been implicated in playing homeostatic roles in some cell types and 
environments (Rollins 1997), and this may be another reason that their expression is 
not dramatically altered in response to MIN6 conditioning. 
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Molecules expressed on the cell surface of macrophage are a functional interest 
because they determine the ability the cell to interact with pathogens, and with other 
cell types, to generate an appropriate innate and acquired immune response. In 
general activation of macrophage with TLR ligands results in an increase in many 
cell surface markers required to mount an immune response. In resting conditions, 
J774 macrophage cultured in MIN6 media show a slight decrease in cell surface 
expression of TLR2, TLR4, MHCII, CCR5 and CD40 when compared with control 
cells. This once again lends itself to the idea of the MIN6 media exerting an overall 
anti-inflammatory action on the macrophages. This idea is carried through by the 
fact that although MIN6 conditioned J774 macrophage respond to TLR stimulation 
by up-regulation of their cell surface markers, the response is severely blunted in 
comparison to control cells. In many cases the response to TLR stimulation from 
MIN6 conditioned J774 macrophage is 50% of that of control cells. As before this is 
most likely a protective mechanism as hyper-responsive macrophages in the 
environment of the islet could lead to uncontrolled inflammation which would be 
detrimental to β-cell function and survival. Another key finding pointing to MIN6 
conditioning of macrophage resulting in a hypo-responsive phenotype is the decrease 
seen in ROS production in conditioned macrophage in both a steady state and 
following stimulation. Although ROS production is decreased, their phagocytotic 
ability – the hallmark of macrophage function is not affected. This is of note as in 
type 2 diabetes and metabolic syndrome macrophages have been shown to display 
some altered immune and inflammatory activities. For example, these macrophages 
have decreased phagocytosis of microbes (Plotkin et al. 1996).   
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In this chapter we have demonstrated that activation of MIN6 cells with TLR ligands 
has the ability to alter their immune response by altering both cytokine and 
chemokine secretion and cell surface marker expression. Some of the mediators 
involved, most notably IL-27p28 whose secretion is induced most strongly upon 
flagellin stimulation, appear to play a protective role in the β-cell. For this reason we 
postulate that TLRs may exist on β-cells not only for immune mediated defence but 
they may also play a homeostatic role. This is further supported by that fact that mice 
deficient in the TLR adaptor protein MyD88 were more susceptible to HFD- induced 
diabetes (Hosoi et al. 2010). We have also shown that MIN6 cells are capable of 
interacting with J774 macrophage. MIN6 secretions have the ability to induce 
macrophage migration, and induce an overall anti-inflammatory phenotype in the 
macrophage. In the next chapter we will further confirm the influence of MIN6 cells 
on macrophage phenotype and then explore whether the factors that mediate this 
effect are present in MIN6 β-cell exosomes.   
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Chapter 5 
Investigation of mediators 
involved in β-cell – MØ crosstalk 
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5.1 Introduction 
 
In the previous chapter we have shown the development of an anti-inflammatory 
phenotype in macrophages, induced by MIN6 β-cell secretions. These macrophage 
display low production of pro-inflammatory cytokines and other pro-inflammatory 
mediators, a reduced response to stimuli and a decrease in proinflammatory “M1” 
genes and increased “M2” genes.  With this in mind we sought to investigate what 
may be mediating this response. 
 
The 2013 Nobel Prize in Physiology or Medicine was jointly awarded to three 
scientists for their discovery of vesicle transport in cells, a clear indication of the 
importance of vesicles in physiology and their applied potential in diagnostics and 
therapy. Almost all cells release different types of membrane microvesicle and 
nanovesicle, which have a variety of important physiological effects. Exosomes, 
classed as nanovesicles, are between 30–100 nm in diameter. The protein content of 
different types of extracellular vesicle mostly reflects that of the parent cells and 
vesicles are enriched in certain molecules, including adhesion molecules, membrane 
trafficking molecules, cytoskeleton molecules, heat shock proteins, cytoplasmic 
enzymes, signal transduction proteins, cytokines, chemokines, proteinases and cell-
specific antigens (Robbins & Morelli 2014; Raposo & Stoorvogel 2013).  It is 
thought that extracellular vesicles have important roles in intercellular 
communication, both locally and systemically, as they have the ability to transfer 
their contents, including proteins, lipids and RNAs, between cells (Ratajczak et al. 
2006; Valadi et al. 2007). Recent evidence has pointed to a role for exosomes from 
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both immune and non-immune cells in numerous immunological processes (Robbins 
& Morelli 2014). Of particular interest to us is the observation that cell derived 
exosomes have been shown to have immunosuppressive effects in a number of 
different models (Wieckowski et al. 2009; S. H. Kim et al. 2007; van Koppen et al. 
2012). With this in mind we sought to investigate whether the extracellular vesicles 
isolated from MIN6 culture medium, were mediating the effect on macrophage 
function. 
 
We have shown that there is crosstalk between beta cells and macrophage and there 
is evidence in the literature to demonstrate that infiltration of macrophage into the 
pancreas may play a role in the development of type 2 diabetes (Westwell-Roper et 
al. 2014; Richardson et al. 2009; Eguchi & Manabe 2013; Ehses et al. 2008; Ehses et 
al. 2007). Furthermore, studies have shown that inflammation in the gut may have 
the ability to influence insulin signalling and T2D. This has been particularly evident 
from two lines of investigation. Firstly, studies have demonstrated that after bariatric 
surgery, used to correct obesity which is linked to low grade inflammation (Donath 
et al. 2013) , there is an almost immediate recovery from type 2 diabetes following 
the anatomical change which impacts on the connection between the gut and the 
pancreas (Rubino et al. 2006; Buchwald et al. 2009; Schauer et al. 2003; Dixon et al. 
2008). Furthermore numerous studies have linked altered gut microbiota and 
inflammation with T2D and metabolic syndrome (Chassaing & Gewirtz 2014; 
Carvalho & Saad 2013; Ding et al. 2010). These studies clearly outline important 
signalling mechanisms between the gut in the context of inflammation, obesity and 
T2D. Therefore, we decided to explore whether inflammation in the gut has the 
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ability to influence infiltration of macrophage into the pancreas. To do this we used 
the mouse model of DSS-induced colitis. 
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5.2 Results 
 
5.2.1 Conditioned macrophage return to normal phenotype once removed from 
MIN6 media 
To be sure that the effect on macrophage phenotype was arising from conditioning 
with MIN6 media, we looked at how they responded when they were returned to 
normal media and re-stimulated. To do this J774 macrophage were  plated at a 
concentration of 1 x 10
6 
cells/ml in 6 well plates in either MIN6 conditioned media 
or unconditioned DMEM-glutamax (control). The cells were then left to rest for 24hr 
prior to 24hr stimulation with LPS (100ng/ml).  Media was then removed and cells 
were washed and normal (unconditioned) DMEM was added to all cells. Cells were 
then left to rest for 6hr prior to reactivation with LPS (100ng/ml) for 24 hours. Cells 
were stained with fluorescently labelled antibodies for CD40, CD80, CD86, MHCII, 
TLR2 and TLR4. Histograms show surface marker expression of stimulated cells 
(black line) compared to stimulated (previously conditioned) cells (dashed line). 
Filled histograms represent fluorescence of unstained cells. Figure 5.1 clearly shows 
that surface marker expression on previously conditioned cells returns to expression 
levels similar to that of non-conditioned cells once the MIN6 media has been 
removed.   
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5.2.1 Pre-conditioning macrophage with recombinant IL-4 does not mimic 
effects of MIN6 conditioning 
As we had previously shown that MIN6 cells constitutively secrete IL-4 [Figure 
3.17] and as this is a known inducer of alternative macrophage activation (Gordon 
2003), we sought to investigate whether preconditioning with recombinant IL-4 
would have similar effects to that of MIN6 conditioning of macrophage surface 
marker expression. In order to do this, J774A.1 macrophage were plated at a 
concentration of 1 x 10
6 
cells per ml in 6 well plates. 2000pg/ml of recombinant IL-4 
(R&D) was added to the cells to mimic the amount of IL-4 secreted from MIN6 cells 
(~1500 pg/ml). Cells were then left for 24hr prior to surface expression analysis by 
flow cytometry. Cells were stained with fluorescently labelled antibodies for CD40, 
CD80, CD86, MHCII, TLR2 and TLR4. Histograms show surface marker 
expression of stimulated cells (black line) compared to IL-4 conditioned, stimulated 
cells (dashed line). Filled histograms represent fluorescence of control cells. Pre-
conditioning cells with 2000 pg/ml of IL-4 for 24hr does not mimic the effect of 
conditioning with MIN6 supernatants [Figure 5.2]. Conditioning cells with IL-4 
prior to activation with LPS did result in lower surface marker expression of CD40 
and CD80. However CD86 and TLR2 remain the same and MHCII and TLR4 
expression is actually higher in IL-4 treated cells than in control cells [Figure 5.2].  
 
5.2.3 Expression of surface markers on MIN6 conditioned bone marrow derived 
macrophage 
In order to assess the effect of MIN6 conditioning in an “ex vivo” situation, bone 
marrow cells were isolated from the femurs and tibias of BALB/c mice and 
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differentiated into BMMØ in vitro in the presence of the macrophage colony-
stimulating factor (eBioscience) for 6 days. The macrophage colony-stimulating 
factor (M-CSF) is a lineage-specific growth factor responsible for differentiation and 
proliferation of myeloid progenitors into cells of macrophage lineage (Sweet & 
Hume 2003). Cells were then plated at a concentration of 1 x 10
6 
cells per ml in 6 
well plates in either control media or MIN6 conditioned media. Cells were then left 
to rest for 24hr prior to 24hr stimulation with or without LPS (100ng/ml). Cells were 
then stained with fluorescently labelled antibodies for CD40, CD80, CD86, MHCII, 
TLR2 and TLR4. Histograms show surface marker expression of stimulated cells 
(black line) compared to MIN6 conditioned, stimulated cells (dashed line). Grey line 
represents unstimulated control cells and filled histograms represent fluorescence of 
unstained cells.  Conditioning of BMMØ in MIN6 supernatants for 24hr prior to 
activation with LPS results in decreased expression of cell surface markers when 
compared to control LPS treated cells [Figure 5.3]. This decrease can be seen in the 
case of all surface markers examined with the exception of CD40 in which 
conditioned cells show slightly higher expression compared to control LPS treated 
cells [Figure 5.3].  
 
5.2.4 MIN6 exosome isolation and fractionation 
Extracellular vesicles, including exosomes, are small membrane vesicles derived 
from multivesicular bodies or from the plasma membrane. Most, if not all, cell types 
release extracellular vesicles, which then enter the bodily fluids. These vesicles 
contain a subset of proteins, lipids and nucleic acids that are derived from the parent 
cell. It is thought that extracellular vesicles have important roles in intercellular 
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communication, both locally and systemically, as they transfer their contents, 
including proteins, lipids and RNAs, between cells. As cell culture medium is known 
to be rich in vesicles, we thought to investigate whether or not these fractions had the 
capability to alter macrophage function. In order to do this, vesicles were isolated 
from MIN6 conditioned medium and fractioned according to their size.  
 
Name Size ug Protein 
FR1 ↑ 1000 kDa P20,000g 290.5ug 
FR2 ↑ 1000 kDa P200,000g 1135.8ug 
FR3 ↑ 1000kDa SN 200,000g 745.7ug 
FR4 ↑ 300 kDa SN 200,000g 3929.2ug 
FR4 ↑ 300 kDa P200,000g 407.5 ug 
P = Pellet, FR = Fraction, SN = Supernatant ↑=above size 
Table 5.1 MIN6 exosome isolation. 
 
5.2.4.1 Culturing MIN6 cells in exosome-free FBS does not affect cell viability 
As FBS is known to contain a lot of vesicles, it was necessary to culture the MIN6 
cells in exosome-free FBS to make sure that anything isolated was indeed from the 
cells themselves.  Cells were grown to confluency in DMEM supplemented with 
either normal FBS or exosome free FBS. Cells were then plated in 96 well plates at a 
concentration of 1 x 10
6
 cells/ml and left for 24hr. The viability of the cells was then 
assessed using the MTS assay. Culturing MIN6 cells in exosome-free FBS did not 
significantly alter cell viability when compared to normal media [Figure 5.4 A]. 
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5.2.4.2 Culturing J774 cells in media containing resuspended exosome fractions 
does not alter cell viability 
Once MIN6 vesicle fractions were isolated they were stored at -80°C until further 
use. The fractions were isolated from a total of 75mls of conditioned media. Each 
fraction was then resuspended in 50ml of complete DMEM. To assess the effect of 
fractions on viability, J774 macrophage were plated at a concentration of 1 x 10
6
 
cells/ml in 96 well plates in normal media and media containing 1 of 5 fractions 
isolated (from here on in referred to as FR1- FR5). Cells were left for 24hr and 
viability was assessed using the MTS assay. None of the 5 fractions tested had a 
significant effect on cell viability when compared to control cells [Figure 5.4 B]. 
 
5.2.3 Effect of vesicle fractions on J774 macrophage response to TLR ligation 
 
5.2.3.1 J774 cell surface markers 
In chapter 4 we showed that conditioning J774 macrophage with MIN6 conditioned 
medium prior to activation with LPS resulted in an over-all dampening down of the 
immune response to this stimulus. In order to ascertain whether or not this effect 
may be caused by mediators released in exosomes, J774 macrophage were cultured 
in DMEM containing resuspended vesicle fractions from MIN6 conditioned medium 
for 24hr prior to activation with LPS (100ng/ml) for a further 24hr. Cells were 
stained with fluorescently labelled antibodies for TLR2, TLR4, CD40, CD80 and 
CD86. Histograms show surface marker expression of stimulated cells (black line) 
compared to stimulated MIN6 conditioned cells (dashed line). Grey line represents 
unstimulated control cells. TLR2 expression is decreased following stimulation with 
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LPS in cells cultured with FR2, FR4 & FR5 [Figures 5.5 B, D & E] in comparison 
to non-conditioned LPS treated cells. Cells cultured with FR1 and FR 3 did not show 
decreased TLR2 expression when compared to non-conditioned LPS treated cells 
[Figures 5.5 A & C]. TLR4 expression is decreased following LPS activation in 
cells cultured with all fractions [Figures 5.6 A – E] in comparison to control LPS 
treated cells. CD40 expression remains unchanged in fraction treated vs control cells 
[Figure 5.7 A – D] following stimulation with the exception of FR5 treated cells 
where a decrease in expression is seen [Figure 5.7 E]. Treatment with all fractions 
resulted in a decrease in CD80 expression following LPS stimulation [Figure 5.8 A-
C & D] with the exception of FR4 [Figure 5.8 D] where no change is observed in 
control vs fraction treated LPS stimulated cells. Finally no change to CD86 
expression was observed for any fraction [Figure 5.9 A – D].  All data is 
summarised in Table 5.2. 
 TLR2 TLR4 CD40 CD80 CD86 
FR1 ↔ ↓ ↔ ↓ ↔ 
FR2 ↓ ↓ ↔ ↓ ↔ 
FR3 ↔ ↓ ↔ ↓ ↔ 
FR4 ↓ ↓ ↔ ↔ ↔ 
FR5 ↓ ↓ ↓ ↓ ↔ 
↔ = no change in expression ↓=decrease in expression vs control LPS treated J774 
Table 5.2 Summary of surface marker expression of J774 cultured with MIN6 
vesicle fractions following LPS stimulation 
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5.2.3.2 J774 cytokine secretion 
We next assessed the effects of the exosome fractions on MIN^ induced macrophage 
cytokine and chemokine secretion. J774 macrophage were cultured in DMEM 
containing resuspended vesicle fractions from MIN6 conditioned medium for 24hr 
prior to activation with LPS (100ng/ml) for a further 24hr. Supernatants were then 
analysed for cytokines IL-6, IL-12p40, IL-23, IL-27p28 and TNF-α secretion by 
ELISA (R&D). IL-6 secretion is decreased in J774 macrophage conditioned with 
FR1 (p<0.001), FR2 (p<0.05), FR4 (p<0.001) and FR5 (p<0.01) [Figures 5.10 A, B, 
D & E] following LPS stimulation in comparison to unconditioned LPS stimulated 
cells. However conditioning with FR3 actually resulted in increased IL-6 secretion 
compared to control LPS stimulated cells [Figure 5.10 C]. IL-12p40 secretion is 
decreased following LPS stimulation in macrophage conditioned with FR1 (p<0.01), 
FR3 (p<0.05), FR4 (p<0.001) and FR5 (p<0.01) and remains unchanged with FR2 
[Figures 5.11 A-E]. IL-23 secretion is decreased in macrophage conditioned with 
FR2 (p<0.001), FR3 (p<0.05) and FR4 (p<0.001) and remains unchanged with FR1 
and FR5 [Figures 5.12 A-E]. IL-27p28 secretion is increased following LPS 
stimulation in macrophage conditioned with all fractions [Figures 5.13 B-E] 
(p<0.01, p<0.01, & p<0.01 respectively) apart from FR1 (p<0.01) [Figure 5.13 A] 
where a decrease is observed in comparison to control LPS treated macrophage. 
Finally TNF-α secretion is decreased following conditioning with FR1 (p<0.05), 
FR2 (p<0.001) and FR3 (p<0.05) whereas no change in secretion levels is observed 
with FR4 and FR5 [Figure 5.14 A-E]. Data is summarised in Table 2.3. 
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 IL-6 IL-12 IL-23 IL-27p28 TNF-α 
FR1 ↓ ↓ ↔ ↓ ↓ 
FR2 ↓ ↔ ↓ ↑ ↓ 
FR3 ↑ ↓ ↓ ↑ ↓ 
FR4 ↓ ↓ ↓ ↑ ↔ 
FR5 ↓ ↓ ↔ ↑ ↔ 
↓decrease in secretion ↑=increase in secretion ↔+ no change in secretion vs control LPS treated J774 
Table 2.3 Summary of cytokine secretion from J774 cultured with MIN6 vesicle 
fractions following LPS stimulation 
 
5.2.4 DSS-induced model of Colitis 
As recent evidence had linked changes in gut homeostasis as playing a possible role 
in type 2 diabetes we decided to investigate whether or not the DSS-model of colitis, 
which causes inflammation in the intestine, had any effect on the pancreas. 
 
5.2.4.1 Clinical assessment of DSS-induced colitis 
The DSS model was carried out Biological Resource Unit (BRU), at Dublin City 
University as described in materials and methods (2.11). To assess the development 
of the disease, mice were weighed and scored (every day) for daily disease activity 
index (DDAI) based on stool composition, fur texture and posture. No significant 
difference in weight was observed in control vs DSS mice throughout the 7 day 
period [Figure 5.15 A]. The DDAI however showed disease progression. No disease 
activity was observed in the control mice, while there was an increase in the disease 
activity scores in DSS treated mice as soon as day 1 which peaked on day 6 [Figure 
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5.15B]. At each end point, colons were removed, measured and weighed. The weight 
and length of the colon are useful indicators of disease progression as the cell 
infiltration and inflammation increase the weight of the colon and also shrink the 
colon length (Okayasu et al. 1990). As we can see in Figure 5.15 C colons from the 
DSS treated mice were significantly (p<0.05) shorter than control. Also, there was 
what appears to be an increase in colon weight in DSS treated mice [Figure 15.D] 
however it did not achieve significance.  
Small sections of distal colon (0.5cm) were removed for histology and stained with 
haematoxylin and eosin (H&E), as described in Materials and methods section 2.11.3 
The H&E staining of control shows a healthy colon with crypts and goblet cells 
present [Figure 5.16] In the DSS treated colon we can see a visible reduction in 
goblet cells, together with loss of crypts and infiltration of inflammatory cells to the 
mucosa [Figure 5.16].  
 
5.2.4.2 Cytokine expression in Colon in DSS-induced colitis 
RNA was isolated from colonic tissue from healthy control and DSS treated mice as 
described in materials and methods section 2.9.1.2. Complementary DNA (cDNA) 
was then generated from RNA using the High Capacity cDNA Reverse Transcriptase 
Kit (Applied Biosystems, USA) as described in materials and methods section 2.9.2. 
The levels of IL-1β, IFN-γ, TNF-α, IL-6 and IL-17 mRNA were quantified using 
qPCR. The expression levels were normalised to GusB levels and the gene 
expression is shown as a fold change relative to the control. It appears as if IL-1β 
and IFN-γ expression is increased in DSS colon however this fails to achieve 
significance [Figure 5.17 A&B]. Both TNF-α and IL-6 expression are increased in 
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DSS colon compared to control healthy colon with a 5 fold increase seen in TNF-α 
levels (p<0.05) and a 10 fold increase in IL-6 levels (p<0.05) [Figure 5.17 C&D].  
No expression of IL-17 was found in either control or DSS colon [Figure 5.17 E]. 
 
5.2.4.3 TLR expression in Colon in DSS- induced colitis 
The role that TLRs play in the DSS colitis model is unclear, however it has been 
shown that mice deficient in the TLR adaptor molecule MyD88 develop severe 
intestinal inflammation during DSS-induced colitis (Araki et al. 2005). With this in 
mind the levels of TLR4 and TLR5 mRNA in both healthy and DSS treated colon 
were quantified using qPCR. The expression levels were normalised to GusB levels 
and the gene expression is shown as a fold change relative to the control. No 
significant difference in TLR4 expression between control and diseased colon was 
found, although a slight increase is observed [Figure 5.18A]. On the other hand 
TLR5 expression is significantly decreased (p<0.01) in diseased colon compared to 
healthy controls [Figure 5.18B]. 
 
5.2.5 Pancreas histology in DSS-induced Colitis 
5.2.5.1 Haematoxylin & Eosin 
Sections from the head of the pancreas from both healthy and DSS treated mice were 
removed, paraffin embedded and stained with Haematoxylin and Eosin. Figure 5.19 
shows sections from both control and DSS treated pancreas. Staining clearly shows 
pancreatic lobules made up mainly of acinar cells (dark pink). Islets (light pink 
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circles) can be seen in both sections. No visible morphological difference between 
control and DSS-treated mice was observed. 
 
5.2.5.2 Macrophage infiltration to pancreas in DSS-induced colitis 
During the course of DSS-induced colitis an inflammatory response is occurring 
throughout the intestine. As the pancreas is a part of the gastro-intestinal system we 
sought to investigate whether or not inflammation occurring in the intestine could 
affect the pancreas. In order to do this we stained sections of pancreas from both 
healthy control and DSS-treated mice with an antibody to the macrophage marker 
F4/80 using the HRP-DAB system (R&D Systems). Figure 5.20 shows sections 
from control (left) and DSS-treated (right) mice. Acinar cells are counter stained a 
light blue colour. F4/80 positive cells stain a light brown colour. Figure 5.20 clearly 
shows a higher number of F4/80 positive cells in the DSS-treated pancreas. This is 
indicative of macrophage infiltration. 
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                       5.3 Figures 
                                            
Figure 5.1 Conditioned macrophage returned to control media return to normal phenotype. J774A.1 macrophages were incubated with 
normal medium or MIN6 conditioned medium for 24hr. Cells were then stimulated with LPS (100ng/ml) for a 24hr. Cells were then washed 
twice and returned to normal media, left to rest for 6hr and stimulated once more with LPS (100ng/ml) for 24hr. Cells were then stained with 
fluorescently labelled antibodies for TLR2, TLR4, MHCII, CD80, CD86 & CD40 and expression was measured by flow cytometry. Histograms 
show surface marker expression of conditioned cells (dotted line) compared to unconditioned control cells (black line) following TLR4 
stimulation. Filled histograms represent fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 5.2 Pre-conditioning macrophage with IL-4 does not mimic effects of MIN6 conditioning. J774A.1 macrophages were incubated 
with normal medium containing 2μg/ml of recombinant IL-4 for 24hr. Cells were then stimulated with LPS (100ng/ml) for a further 24hr. Cells 
were then stained with fluorescently labelled antibodies for TLR2, TLR4, MHCII, CD80, CD86 & CD40 and expression was measured by flow 
cytometry. Histograms show surface marker expression of LPS stimulated IL-4 treated cells (dotted line) compared to control cells (black line) 
following TLR4 stimulation. Filled histograms represent control cells (unstimulated). Data are representative of three independent experiments. 
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Figure 5.3 Expression of surface markers on MIN6 conditioned bone marrow derived macrophage. Bone marrow-derived macrophages 
were incubated with normal medium or MIN6 conditioned medium for 24hr. Cells were then stimulated with LPS (100ng/ml) for a further 24hr. 
Cells were then stained with fluorescently labelled antibodies for TLR2, TLR4, MHCII, CD80, CD86 & CD40 and expression was measured by 
flow cytometry. Histograms show surface marker expression of conditioned cells (dotted line) compared to unconditioned control cells (black 
line) following TLR4 stimulation. Grey line represents the expression on unstimulated controls. Filled histograms represent fluorescence of 
unstained cells.  
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Figure 5.4 Exosome free FBS does not affect MIN6 viability & Conditioning 
J774 macrophage with media containing MIN6 fractions does not affect 
viability. (A) MIN6 cells were cultured in normal DMEM and DMEM containing 
exosome free FBS for 24hr. Following this 20μl of the CellTiter 96® AQueous Non-
Radioactive Cell Proliferation Assay solution (Promega, WI, USA) was added to 
each well and left at 37°C 5% CO2  for 1hr. The plate was then read at a wavelength 
of 450nm. Results are expressed as a percentage of the control viability (100%). (B) 
J774 macrophage were cultured in normal DMEM and DMEM containing 1 of 5 
fractions (FR1-FR5) from MIN6 conditioned medium for 24hr. Following this 20μl 
of the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay solution 
(Promega, WI, USA) was added to each well and left at 37°C 5% CO2  for 1hr. The 
plate was then read at a wavelength of 450nm. 
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Figure 5.5 TLR2 expression on LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Cells were then stained with a fluorescently labelled antibody for TLR2 and 
expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dotted line) compared to unconditioned control cells 
(black line) following TLR4 stimulation. Grey line represents the expression on 
unstimulated controls.  
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Figure 5.6 TLR4 expression on LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Cells were then stained with a fluorescently labelled antibody for TLR4 and 
expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dotted line) compared to unconditioned control cells 
(black line) following TLR4 stimulation. Grey line represents the expression on 
unstimulated controls.  
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Figure 5.7 CD40 expression on LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Cells were then stained with a fluorescently labelled antibody for CD40 and 
expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dotted line) compared to unconditioned control cells 
(black line) following TLR4 stimulation. Grey line represents the expression on 
unstimulated controls.  
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Figure 5.8 CD80 expression on LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Cells were then stained with a fluorescently labelled antibody for CD80 and 
expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dotted line) compared to unconditioned control cells 
(black line) following TLR4 stimulation. Grey line represents the expression on 
unstimulated controls.  
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Figure 5.9 CD86 expression on LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Cells were then stained with a fluorescently labelled antibody for CD86 and 
expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dotted line) compared to unconditioned control cells 
(black line) following TLR4 stimulation. Grey line represents the expression on 
unstimulated controls.  
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Figure 5.10 IL-6 secretion from LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. **P<0.01, 
***P<0.001 as determined by unpaired t-test.  
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Figure 5.11 IL-12p40 secretion from LPS stimulated J774 macrophage 
following conditioning with fractioned MIN6 medium. J774A.1 macrophages 
were incubated with media containing 1 of 5 fractions from MIN6 conditioned 
medium (1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a 
further 24hr. Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction.*P<0.05, 
**P<0.01, ***P<0.001 as determined by unpaired t-test.  
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Figure 5.12 IL-23 secretion from LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction.*P<0.05, 
***P<0.001 as determined by unpaired t-test.  
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Figure 5.13 IL-27p28 secretion from LPS stimulated J774 macrophage 
following conditioning with fractioned MIN6 medium. J774A.1 macrophages 
were incubated with media containing 1 of 5 fractions from MIN6 conditioned 
medium (1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a 
further 24hr. Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction.*P<0.05, 
**P<0.01 as determined by unpaired t-test.  
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Figure 5.14 TNF-α secretion from LPS stimulated J774 macrophage following 
conditioning with fractioned MIN6 medium. J774A.1 macrophages were 
incubated with media containing 1 of 5 fractions from MIN6 conditioned medium 
(1-5 = A-E) for 24hr.  Cells were then stimulated with LPS (100ng/ml) for a further 
24hr. Following this supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction.*P<0.05, 
***P<0.001 as determined by unpaired t-test.  
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Figure 5.15 Clinical assessment of DSS-induced colitis. Mice were given 5% DSS 
in drinking water for 5 days, followed by water only. Mice were then sacrificed on 
day 7. Body weight change was calculated by dividing body weight on the specified 
day by starting body weight and expressed in percentage (A). Daily disease activity 
index (DDAI) scores (a combine measure of weight change, stool consistency and 
fur texture/posture) are reported for each experimental group. A higher score depicts 
a sicker animal (B). Colons were removed and length (C) and weight (D) measured. 
Data presented are mean ± SEM of n=5/early acute; 5/DSS and 5/control group. 
*P<0.05, by unpaired t-test, compared to control.  
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Figure 5.16 Histology of DSS-induced colitis. Sections of a distal colon were 
removed, paraffin embedded and stained with haematoxylin and eosin. The control is 
showing a healthy colon, while loss of crypts, the reduction of goblet cells and 
infiltration of inflammatory cells to the mucosa are visible in the DSS treated colon.  
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Figure 5.17 Expression of Cytokines in colon in DSS induced colitis. Tissue from 
each sample was homogenised using the Qiagen TissueLyser LT with stainless steel 
beads. Following homogenisation, RNA was extracted using Nucleospin RNA II kit 
(Macherey-Nagel) and quantified on the nanodrop. Equalised ammounts of RNA 
were converted into cDNA using a High Capacity cDNA Mastermix (Roche). The 
cDNA was mixed with primers for IL-1β, IFN-λ, TNF-α, IL-17 and IL-6 (all IDT) 
and analysed on the ABI Prism 7500. cDNA samples were assayed in triplicate and 
gene expression levels were normalised to endogenous control, GusB. The mean 
relative gene expression was calculated using the 2-ΔΔCt method. Results are mean 
± SEM of 5 mice/control and 5 mice/DSS *P<0.05, determined by unpaired t-test. 
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Figure 5.18 Expression of TLR4 and TLR5 in colon in DSS induced colitis. 
Tissue from each sample was homogenised using the Qiagen TissueLyser LT with 
stainless steel beads. Following homogenisation, RNA was extracted using 
Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised 
ammounts of RNA were converted into cDNA using a High Capacity cDNA 
Mastermix (Roche). The cDNA was mixed with primers for TLR4 and TLR5 (IDT) 
and analysed on the ABI Prism 7500. cDNA samples were assayed in triplicate and 
gene expression levels were normalised to endogenous control, GusB. The mean 
relative gene expression was calculated using the 2-ΔΔCt method. Results are mean 
± SEM of 5 mice/control and 5 mice/DSS **P<0.01, determined by unpaired t-test. 
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Figure 5.19 Histology of pancreas during DSS-induced colitis. Sections of a 
proximal pancreas were removed, paraffin embedded and stained with haematoxylin 
and eosin. Acinar cells appear dark pink and islets are light pink and round in 
appearance. Images were taken on a light microscope with a camera attachment. 
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Figure 5.20 F4/80 staining of Pancreas during DSS induced colitis. Sections of  
proximal pancreas were removed and paraffin embedded. 6um sections were cut and 
stained for F4/80 using the HRP-DAB SYSTEM (R&D Systems) according to 
manufacturer’s instructions. Slides were then counterstained with Harris 
Haematoxylin to allow for better contrast. F4/80 positive cells appear brown. Images 
were taken on a light microscope with a camera attachment. 
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5.4 Discussion 
 
As we had shown in Chapter 4 that culturing of J774 macrophage with MIN6 
conditioned medium exerts an overall “dampening down” of the macrophage 
immune response we thought it pertinent to investigate what may be causing this 
effect. We first had to confirm it was indeed the conditioned media that was causing 
this effect, and this was done by showing that once the J774 macrophage were 
removed from the MIN6 media they returned to a normal phenotype. When 
examined in an “ex-vivo” situation, MIN6 conditioned medium had a similar effect 
(decrease in cell-surface marker expression in following LPS stimulation) on bone 
marrow-derived macrophage. This “hyporesponsive” phenotype we are seeing in the 
macrophage following conditioning with MIN6 media is akin to the phenotype of 
certain macrophage observed in the gut (Bain et al. 2013; Bain & Mowat 2011). 
Mucosal resident macrophage, despite being actively phagocytic fail to produce an 
immune response to stimuli such as TLRs (Smythies et al. 2005; Smith et al. 2011). 
Instead they are thought to play a number of crucial homeostatic functions acting as 
non-inflammatory scavengers of bacteria, as well as assisting maintenance of 
regulatory T cells and promoting epithelial cell renewal (Hadis et al. 2011; 
Geissmann et al. 2010). Monocytes, upon entry to the mucosa immediately begin to 
undergo a process of differentiation into this hyporesponsive mature macrophage 
phenotype (Bain et al. 2013). This process was thought to be unique to the intestine, 
however recently a similar developmental process has been described in the skin 
(Tamoutounour et al. 2013). For this reason we postulate that a similar process may 
occur to resident macrophage or infiltrating monocytes in the islet, as the bodies only 
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source of insulin, surely it is a site where constant immune surveillance would be 
crucial.  
Following confirmation, that mediators in the MIN6 media that were causing this 
“anti-inflammatory” effect we next investigated what they might be. In the intestine 
it is thought that both IL-10 and TGF-β contribute to the hyporesponsive 
macrophage phenotype (Bain & Mowat 2014). However a lot remains unclear and it 
is quite likely that many factors may be needed to explain all aspects of the profile. 
We found no secretion of IL-10 or TGF-β from MIN6 cells however we have shown 
that MIN6 cells secrete IL-4. This cytokine is known to be anti-inflammatory to 
macrophage in some contexts (Takeda et al. 1996; Gordon 2003) we investigated 
whether this may be causing the observed anti-inflammatory effect of the MIN6 
media on the macrophage. However, J774 macrophage conditioned with higher 
amounts of recombinant IL-4 (2ng/ml) that those observed in MIN6 media 
(~1.5ng/ml) failed to show the same decrease in cell surface markers following LPS 
stimulation as those observed in MIN6 conditioned cells. Possibly IL-4 is not 
involved in this process or may need to work in concert with other mediators to 
produce this effect. 
 
In addition to the release of soluble mediators, epithelial cells in the gut, which are 
known to interact with resident macrophage (Peterson & Artis 2014), also release a 
wide variety of proteins, lipids, mRNAs and microRNAs contained within secreted 
nanovesicles or exosomes (Mallegol et al. 2007; van Niel et al. 2001). Exosomes, 
once thought to only be responsible for releasing a cells’ unwanted debris are now 
under investigation as major players in both local and systemic cell communication 
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(Harding et al. 2013; Raposo & Stoorvogel 2013) . With this in mind we sought to 
investigate the effect of MIN6 conditioned medium derived exosomes on 
macrophage function.  As FBS is known to contain a lot of exosomes, to be sure that 
exosomes isolated were those from MIN6 cells and not FBS, cells were cultured in 
media supplemented with exosome free FBS. This had no significant effect on cell 
viability. Subsequent hydrostatic dialysis and centrifugation steps of MIN6 
conditioned media resulted in 5 exosome fractions based on their size. As a general 
rule, when J774 macrophage were conditioned with medium containing resuspended 
exosome fractions the overall effect seen was a decreased or hyporesponsiveness of 
the macrophages to LPS stimulation when compared to control cells. This 
hyporesponsiveness included decreased immune cell surface marker expression and 
decreased pro-inflammatory cytokine secretion.  Similar finding have been reported 
elsewhere. Oral administration of OVA in mice resulted in the generation of MHC 
II
+
 vesicles in the serum that could supress OVA-specific immune responses 
(Ostman et al. 2005).  Other studies have used exosomes from mesenchymal stem 
cells (MSCs) (van Koppen et al. 2012). MSCs have been shown to confer 
immunosuppressive effects and have shown promise in clinical trials for Crohn’s 
disease, limb ischaemia and myocardial infarction. However in many of the cases 
where therapeutic effects have been observed using MSCs the stem cells have not 
been reported to persist following injection therefore it is probable the main 
immunosuppressive effect result from paracrine mechanisms mediated by secreted 
factors, including exosomes (Robbins & Morelli 2014; Caplan & Correa 2011). 
Indeed in some cases injection of conditioned media from MSC cultures has been 
confirmed to supress inflammation as effectively as injection of the stem cells 
themselves (van Koppen et al. 2012; Caplan & Correa 2011). Other tissues and cells 
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secrete exosomes bearing immunosuppressive molecules. For instance, placenta-
derived vesicles are found in the mother's blood circulation (Taylor et al. 2006) and 
women delivering at term displayed higher amounts of these vesicles, with higher 
Fas ligand (FasL)-mediated T-cell inhibiting properties than women delivering 
preterm. Prostasomes in semen (Tarazona et al. 2011) and placental explants also 
secrete exosomes that inhibit NK lymphocytes (Hedlund et al. 2009), possibly 
preventing immune attack of the foetus. Although it has not been reported elsewhere 
to date, it would make sense for islet cells to secrete mediators that allow it to 
interact and communicate with macrophage and other immune effectors most 
importantly during the setting of inflammation as typical pro-inflammatory 
mediators such as IL-1β, TNF-α and IFN-λ are known to cause β-cell death (Wachlin 
et al. 2003).   
 
An interesting observation is that although mostly decreases (or occasionally no 
change) in secretion of most cytokines is seen following conditioning of macrophage 
with exosome fractions, all but one fraction causes increased IL-27p28 secretion 
following stimulation with LPS. As mentioned previously IL-27 is known to have 
both pro and anti-inflammatory effects depending on the context (Stumhofer & 
Hunter 2008). In this context, as the increase in IL-27 is concurrent with decreases in 
other pro-inflammatory cytokines such as IL-6 and IL-12p40, and decreases in cell 
surface marker expression, we postulate that it may be exerting an anti-inflammatory 
effect. Fujimoto et al have shown that the administration of recombinant IL-27 
decreased blood glucose levels and immune cell infiltration into islets in mice treated 
with STZ (Fujimoto et al. 2011) and we ourselves showed that pre-treatment of 
MIN6 cells with recombinant IL-27 provided partial protection against STZ induced 
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cell death. It is therefore most likely beneficial for β-cells to be able to signal to 
resident or infiltrating macrophage to induce IL-27 secretion. Indeed Kalliolias et al 
have reported that IL-27 has the ability to supress cultured human macrophages 
response to the pro-inflammatory cytokines IL-1β and TNF-α (Kalliolias et al. 
2010). Although a decrease following LPS stimulation is seen surface marker 
expression of TLR2, TLR4 and CD80 in most cases following conditioning of 
macrophage with exosome fractions this is not as robust an effect as we saw when 
macrophage were conditioned with whole MIN6 conditioned medium. Further to this 
no change in expression was observed in CD40 and CD86. This suggests that it is 
likely a number of mediators released in exosomes from MIN6 cells that mediate the 
effect, as when isolated the impact on macrophage surface marker expression is 
diminished. Furthermore as this is a technique we are still working on, the efficiency 
of the purification and quantification procedure remains unknown, and it is likely 
that ultracentrifugation does not allow for 100% recovery of the vesicles secreted at 
any given time, and part of the secreted vesicles are inaccessible to purification 
because they are recaptured by cells rather than released in the culture medium or 
fluid. Taking into context the complexity of most signalling pathways within the 
cell, and our results that some fractions had a more profound effect on particular 
cytokine secretion and surface marker expression than others, it is likely that a 
combination of a number of mediators secreted by exosomes are responsible for the 
crosstalk observed between MIN6 cells and J774 macrophage. Further 
characterisation of the contents of MIN6 exosomes will be carried out in the future. 
 
It is clear from our results so far that MIN6 β-cells have the ability to interact with 
and affect macrophage phenotype and function. However it is still unclear in what 
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setting this relationship is pertinent. As mentioned previously immunohistochemical 
analysis of pancreas sections from patients with T2D, C57BL/6 mice fed a high-fat 
diet, db/db mice and Goto-Kakizaki (GK) rats all showed elevated numbers of 
macrophages within islets (Westwell-Roper et al. 2014; Richardson et al. 2009; 
Eguchi & Manabe 2013; Ehses et al. 2008; Ehses et al. 2007).  Of note is the 
observation that increased numbers of macrophages were detectable very early in 
high-fat-fed mouse islets, before the onset of diabetes. However the role for islet 
resident macrophage and what leads to infiltration of additional macrophage still 
remains unclear. If macrophage infiltrate early on before overt symptoms of diabetes 
are apparent it is likely that they contribute to the pathogenesis. The pancreas, as part 
of the gastrointestinal system is likely very influenced by the environment of the gut. 
This is clear from a number of lines of study including those that demonstrate after 
bariatric surgery, there is an almost immediate recovery from type 2 diabetes 
following the anatomical change which impacts on the connection between the gut 
and the pancreas (Rubino et al. 2006; Buchwald et al. 2009; Schauer et al. 2003; 
Dixon et al. 2008). Furthermore numerous studies have linked altered gut microbiota 
and inflammation with T2D and metabolic syndrome (Chassaing & Gewirtz 2014; 
Carvalho & Saad 2013; Ding et al. 2010). These studies clearly highlight that 
important signalling systems are in play between the gut and the pancreas. 
 
 As we have been investigating the effect of TLRs on MIN6 cells, and the crosstalk 
between these cells and J774 macrophage we posed the question – would an 
inflammatory environment in the gut, which is home to the largest compartment of 
the immune system, have the ability to induce macrophage infiltration into the 
pancreas? To answer this we used the DSS-induced model of colitis. Dextran sulfate 
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sodium induced colitis is a well appreciated and widely used model of inflammatory 
bowel disease. Colitis is induced by addition of DSS to drinking water. DSS is toxic 
to colonic epithelial cells and induces the break-down of the epithelial barrier 
function (Poritz et al. 2007) . This allows the entry of microorganisms and antigens 
from the lumen which then results in activation of immune cells and inflammation. It 
is characterised by weight loss, blood in the stool, diarrhoea and infiltration of 
immune cells into the lamina propria and submucosa (Kullmann et al. 2001). In our 
study, mice were administered DSS for 5 days followed by 2 days on water alone 
and were sacrificed for sample and tissue processing on day 7. It is clear from our 
results that a mild form of inflammation was induced in the mice fed DSS. Although 
there was no significant weight loss observed, there was a significant reduction in 
colon length, an increase (although not significant) in colon weight and an increased 
DDAI score that peaked on day 6. This was accompanied by an increased infiltration 
of inflammatory cells to the mucosa and an increase in mRNA expression of pro-
inflammatory cytokines TNF-α and IL-6. What is interesting to note is mRNA 
expression levels of TLR4 appear to be increased whereas TLR5 expression is 
significantly decreased. This once again points to TLR5 as playing a protective role 
not just in the β-cell as previously discussed but in the gut also. Indeed deletion of 
TLR5 results in the development of spontaneous colitis in mice (Vijay-Kumar et al. 
2007) and activation of TLR5 has the ability to protect against clostridium difficile 
induced colitis (Jarchum et al. 2011) . Furthermore as TLR5 deficient mice develop 
hallmark features of metabolic syndrome, including hyperlipidemia, hypertension, 
insulin resistance, and increased adiposity (Vijay-kumar et al. 2010) this highlights a 
possible role for TLR5 in the gut- pancreas axis in the context of inflammation and 
insulin signalling. It remains unclear as to how exactly activation of TLR5 may be 
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protective, however it has been shown to induce secretory interleukin-1 receptor 
antagonist (sIL-1Ra) (Carvalho et al. 2011) in both epithelial cells and macrophage. 
 
Although no obvious morphological differences were observed in pancreas sections 
stained with H&E were observed in DSS treated vs control mice, when stained with 
an antibody to the macrophage marker F4/80, DSS treated pancreas show increased 
presence of macrophage. We cannot say definitively the increased number of 
macrophage seen are a result of infiltration from the intestine to the pancreas 
however a number of ideas give weight to this as a possibility. Sections were taken 
from the head of the pancreas, which is the segment of the pancreas that is directly 
connected to both the duodenum and proximal jejunum. Both the major and minor 
papilla, which are openings that exist between the pancreas and the duodenum 
allowing for secretion of bile and other enzymes involved in digestion are located in 
this area. An increased number of macrophage and inflammatory cells are present 
during colitis (Kullmann et al. 2001) and colitis is known to result in a breakdown of 
gut barrier function and integrity (Poritz et al. 2007).  Therefore considering 
increased numbers of macrophage in the gut, breakdown of gut barrier integrity and 
the close proximity of the pancreas to the duodenum it is probable that the 
macrophage seen in the pancreas originated in the gut. Although we ourselves used 
DSS to chemically induce inflammation, a number of factors have the ability to 
contribute to gut inflammation. The foremost of these is a high-fat diet and obesity 
which is extensively linked with chronic low-grade inflammation, and T2D (Ding et 
al. 2010; Ahren & Sorhede Winzell 2004; Carvalho & Saad 2013; Cabré & 
Domènech 2012; Boni-Schnetzler et al. 2009; Weisberg et al. 2003; Donath et al. 
2013; Brestoff & Artis 2013). If during this chronic low-grade inflammation that is 
201 
 
associated with obesity, macrophage had the ability to infiltrate to the pancreas and 
perhaps the islet, this may provide an explanation for the increased numbers of 
macrophage seen is mouse models prior to the onset of overt diabetes (Ehses et al. 
2007).  
 
To summarise we have shown that MIN6 β-cells release mediators in exosomes that 
have the capability of affecting macrophage cell surface markers and cytokine 
secretion. In many cases these exosome fractions induce an almost “hyporesponsive” 
phenotype in the macrophage with reduced cell surface marker expression and 
reduced pro-inflammatory cytokine secretion. This indeed provides evidence that 
important signalling mechanisms exist between the β-cell and macrophage, however 
this likely involves a number of mediators and unfortunately was not in the scope of 
this project to further characterise what they were. Secondly we have highlighted a 
possible means by which macrophage may infiltrate the pancreas during gut 
inflammation. This is very important due to the fact that both obesity and T2D are 
intrinsically linked with low-grade inflammation. Perhaps under normal 
circumstances, any macrophage that do enter are signalled to by the β-cell to enter a 
“hyporesponsive” state to limit any potential inflammatory damage. However 
throughout the progression of T2D, the β-cell itself is overworked, trying to 
compensate for reduced insulin sensitivity by increasing its insulin output, this leads 
to β-cell exhaustion (Muoio & Newgard 2008; Ohsugi et al. 2005) and perhaps an 
inability of the β-cell to control macrophage function. Further understanding of the 
complex crosstalk that exists between β-cells and macrophage is therefore crucial, 
and may provide novel mechanisms for β-cell protection during obesity and diabetes 
associated inflammation.  
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6.1 General Discussion 
 
It is now clear from numerous lines of investigation that Type 2 Diabetes is 
inextricably linked with chronic low grade inflammation (Donath 2013; Olefsky & 
Glass 2010; Akash et al. 2013; Fresno et al. 2011; Donath & Shoelson 2011; Cruz et 
al. 2013).  Toll-like receptors (TLRs) are pattern-recognition receptors that play a 
crucial role in the innate immune system, which detects the presence and the nature 
of pathogenic microbial infection, and thus provides the first line of host defence. 
Their activation triggers a signalling cascade and ultimately the activation of 
transcription factors such as NFκB and AP-1 (Takeda et al. 2003). These 
transcription factors induce transcription of inflammatory cytokines and type I 
interferons (Kumar et al. 2009). This proinflammatory reaction is fundamental for 
the initiation of an innate immune response and subsequent adaptive responses but 
can also damage tissues. This is of particular importance when considered in the 
context of chronic inflammation whereby constitutive activation of these receptors 
may result in an overt inflammatory reaction. TLRs can also interact with ligands 
generated sites at of injury (Wagner 2006) and endogenous ligands such as oxLDL 
(oxidized LDL), HSPs (heat shock proteins) 60 and 70, fibrinogen, fibronectin and 
free-fatty acids, which are also elevated in diabetes (Wagner 2006; Osterloh & 
Breloer 2008; Chiu et al. 2009; Tsan & Gao 2004).  
 
To date the majority of research has focused on TLR4 and to a lesser extent TLR2 
and their role in the β-cell and T2D (Vives-Pi et al. 2003; Himes & Smith 2010; Yin 
et al. 2014; Ehses et al. 2010; Kiely et al. 2009; Lee 2011; Garay-malpartida et al. 
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2011; Liu et al. 2011; Li et al. 2013; Boni-Schnetzler et al. 2009; Amyot et al. 2012). 
In both cases the TLRs respond to endogenous products from cell death or increased 
levels of circulating fatty acids and accelerate the progression of the disease through 
β-cell apoptosis and inhibit islet insulin secretion (H. S. Kim et al. 2007; Schulthess 
et al. 2009). TLR activation of cells typically results in the initiation of a pro-
inflammatory reaction however in this study we have identified a novel role for 
TLR5, the receptor for bacterial flagellin, in MIN6 β-cell protection. We were 
surprised when our own investigations showed a much more profound effect on 
MIN6 β-cell function in general following TLR5 activation, than that of TLR4 or 
TLR2. Activation of all three receptors had a similar affect in that they increased 
basal insulin secretion levels but reduced glucose stimulated insulin secretion. 
However TLR2 and TLR4 activation resulted in a marked decrease in intracellular 
insulin stores. This suggests that TLR2 and TLR4 have a negative impact on insulin 
translation and synthesis but TLR5 activation may supress insulin secretion from the 
cell. TLR5 activation also resulted in a decrease in IRS1 expression levels. IRS1
–/–
 β-
cells display a reduced response to both glucose and arginine (Kulkarni et al. 1999). 
In the setting of activation of innate immunity and inflammation it may be beneficial 
for the cell to repress insulin secretion in order to ensure a sufficient supply of 
glucose to phagocytic and reparative cells. Concurrent with the decrease in IRS1 
there is an increase in IRS2 expression following TLR5 activation. Increased IRS2 
expression in β-cells may also prove protective in the setting of activation of innate 
immunity as increased numbers of apoptotic cells were found to be present within 
the β-cells of IRS2–/– mice compared with wild-type animals (Withers et al. 1998). 
Aligned with the concept of TLR5 playing a protective role in the β-cell, its 
activation resulted in decreased mRNA expression of both TLR4 and TLR5 in MIN6 
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cells, which may help to depress or limit propagation of inflammation. TLR5 
activation also decreased expression levels of the PANDER, a cytokine like protein 
produced in islets that has been shown to induce apoptosis in β-cells from mouse, 
rat, and human (Cao et al. 2003; Cao et al. 2005). Finally TLR5 activation also 
proved to be the strongest inducer of IL-27p28 secretion from MIN6 cells, a cytokine 
with both pro and anti-inflammatory effects (Hunter & Kastelein 2012). We have 
shown that both flagellin and recombinant IL-27p28 possess the ability to protect 
against STZ induced MIN6 β-cell death. This is further supported by findings that 
the administration of recombinant IL-27p28 decreased blood glucose levels, immune 
cell infiltration into islets, and IL-1β mRNA expression in the pancreas of mice 
treated with STZ (Fujimoto et al. 2011). Taken together these findings clearly point 
to a role for TLR5 induced in β-cell physiology, with an emphasis on a protective 
role.  
 
The idea of TLR5 playing a role in the β-cell and metabolism in general, although it 
is novel does not go unfounded. Mice lacking TLR5 display hallmark features of 
metabolic syndrome including hyperlipidemia, hypertension, insulin resistance, and 
increased adiposity (Vijay-kumar et al. 2010) and it has been shown that a nonsense 
polymorphism in TLR5 in humans protects from obesity but pre-disposes to T2D 
(Al-Daghri et al. 2013). Taken together with the fact that glucose itself has been 
shown to induce an up-regulation of both TLR5 mRNA and protein levels in isolated 
mouse islets (Weile et al. 2011b) this suggests TLR5 may be a key player in this 
metabolic pathway. Although there is no known endogenous ligand to TLR5 the fact 
that we have shown that activation of this receptor has robust metabolic and 
inflammatory effect on β-cells, we believe that similar to the way TLR2 and TLR4 
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respond to activation by fatty acids (Yin et al. 2014) and other endogenous 
molecules (Yu et al. 2010), there may be an endogenous mediator within this 
pathway capable of activating TLR5.  
 
Further evidence for a protective and anti-inflammatory role for TLR5 in disease 
states come from a number of studies. Deletion of TLR5 has been shown to result in 
spontaneous colitis (a form of inflammatory bowel disease) in mice (Vijay-Kumar et 
al. 2007) and administration of flagellin prior to dextran sulfate sodium in the DSS 
induced mouse model of colitis greatly abrogated disease severity with reduction of 
inflammatory markers and immune cell infiltration in the colon (Vijay-Kumar et al. 
2008). These authors also showed that pre-treatment of mice with flagellin provided 
a measure of protection against lethal doses of S. tyhpirium  and γ-irradiation (Vijay-
Kumar et al. 2008). Although it is unclear by what mechanism TLR5 activation 
plays a protective and anti-inflammatory in role in these settings it has been shown to 
induce secretory interleukin-1 receptor antagonist (sIL-1Ra) expression and secretion 
in intestinal epithelial cells and macrophages (Carvalho et al. 2011). This may 
provide a mechanistic answer to some of the anti-inflammatory properties observed 
following TLR5 activation in various models. Taken together these data certainly 
indicate a role for TLR5 activation in protective and anti-inflammatory functions in a 
wide variety of disease states. Further work must be carried out to elucidate the role 
of TLR5 signalling in β-cell physiology and metabolism as understanding of the 
signalling pathways and mediators involved in this activation may provide insight 
into novel β-cell therapeutics. 
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Another aspect of this study was to examine the crosstalk that existed between MIN6 
β-cells and J774A.1 macrophage. Macrophages, key innate immune effector cells 
best known for their role as professional phagocytes play a crucial role in innate and 
adaptive immunity and are major mediators of the inflammatory response. During 
infection, macrophage effector functions are critical for the elimination of pathogens; 
however uncontrolled inflammatory responses can induce injury of the tissue 
environment and must be repressed to allow the process of repair. Along with their 
role in the immune system macrophage also have diverse roles in tissue homeostasis, 
and glucose and lipid metabolism (Murray & Wynn 2011). To date the majority of 
research has focused on the role of the adipose tissue macrophages in the 
pathogenesis of obesity, insulin resistance and T2D. The discovery that adipose 
tissue from obese mice and humans is infiltrated with increased numbers of 
macrophages provided a major mechanistic advancement into understanding how 
obesity propagates inflammation (Weisberg et al. 2003). It is now well documented 
that there is also increased islet macrophage infiltration in patients with T2D (Ehses 
et al. 2007). Increased islet-associated immune cells were also observed in a variety 
of animal models of this disease including the GK (Goto-Kakizaki) rat (Homo-
Delarche et al 2006), the high-fat-diet fed and db/db mouse (Ehses et al. 2007) and 
the Cohen diabetic rat (Weksler-Zangen et al. 2008). As we found that MIN6 β-cell 
secretions had the capability to induce macrophage chemotaxis, we postulated that 
there must be some form of crosstalk between these two cell types. Indeed we have 
shown that when J774 macrophages are cultured in the presence of MIN6 
conditioned medium, the overall effect is to induce an anti-inflammatory phenotype 
in the macrophage. Their pro-inflammatory cytokine and chemokine secretion, cell 
surface marker expression and reactive oxygen species production is decreased 
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following TLR activation. In other words they lose their ability to respond, or 
become “inert” to inflammatory stimulus. Decreased cytokine secretion would result 
in decreased activation of inflammatory signalling cascades that activate master 
regulators such as NFκB and AP-1 (Karin & Delhase 2000). These transcription 
factors induce inflammatory cytokine and type I interferon production (Karin & 
Delhase 2000). This decrease in cytokine secretion would therefore limit propagation 
of inflammation. Aside from this is has been shown that pro-inflammatory cytokines 
can interfere with insulin signalling by phosphorylating IRS proteins downstream of 
the insulin receptor and thus are linked with the development of insulin resistance 
(Hotamisligil et al. 1994; Ueki et al. 2004). For these reasons limitation of cytokine 
secretion in the islet may prove beneficial. An interesting observation was that 
although not significant, MIN6 conditioned macrophage, stimulated with flagellin 
appear to have increased IL-27p28 secretion, which we have already shown is 
protective for β-cells. This once again highlights a potential role for TLR5 and IL-
27p28 in β-cell physiology and protection. It appears that in the presence of β-cell 
mediators, flagellin activated macrophage are driven to produce more IL-27p28 than 
control activated macrophages.  As well as decreased cytokine production there is 
decreased chemokine production from conditioned macrophage in most cases. This 
would further limit propagation of inflammation by reducing the signals for 
macrophage infiltration.  
Concurrent with this hyporesponsive phenotype, the pro-inflammatory genes 
associated with classically activated M1 type macrophage are decreased and the 
genes associated with alternatively activated M2 type macrophage are increased. 
While these conditioned macrophage do not represent the typical M2 phenotype 
(Gordon 2003) as we saw no increase in IL-10 or IL-4 production, the fact that the 
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environment of the MIN6 β-cells drives the macrophage genetically closer to that of 
an M2 macrophage is of note and may be beneficial in the context of the islet. 
Although little work has been done on the activation status of macrophage within 
islets, in adipose tissue, which is a major contributor to the metabolic setting in T2D, 
M1 macrophage have been shown to propagate inflammation and drive insulin 
resistance (Olefsky & Glass 2010). For these reasons we propose that any reduction 
in M1 type genes in macrophage that are in contact with β-cells may help protect and 
preserve insulin sensitivity. Aside from this M2 macrophages have been implicated 
in wound healing, tissue remodelling, and apoptotic cell disposal through 
phagocytosis (Gordon 2003). Interestingly, although MIN6 conditioned macrophage 
lose their responsiveness to inflammatory stimuli, they retain their phagocytic 
ability. 
 
MIN6 β-cell Conditioned macrophages display phenotypic similarities with 
populations of macrophage found in the gut. The intestine is home to the largest 
population of macrophage in the body (Hume 2006). This is no surprise as the 
intestine encounters more antigen than any other part of the body.  However, when 
inflammatory monocytes arrive at the gut, they are shaped by mediators present in 
the intestine, to undergo a phenotypic transformation that renders them inert to 
pathogenic stimuli (Bain & Mowat 2011). These macrophage retain their phagocytic 
capability however ingestion of microbes is not accompanied by the release of pro-
inflammatory mediators as is usually the case with other tissue macrophages 
(Smythies et al. 2005). This is certainly aimed at maintaining gut homeostasis as due 
to their location the macrophage are likely to come into contact with a host of 
antigenic material due to resident gut microbiota (Schenk & Mueller 2007). It is 
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thought that both IL-10 and TGF-β secretion by epithelial cells in the gut contribute 
to this hyporesponsive macrophage phenotype in the gut (Bain & Mowat 2014) 
however a lot remains unknown. Although we do not think it likely that macrophage 
in the pancreas or islets would come into contact with such amounts of antigenic 
material as those in the gut, we postulate that similar mechanisms in the islet may be 
in place to drive the phenotype of macrophage to that of a hyporesponsiveness to 
limit possible inflammation induced damage. As there was no secretion of IL-10 or 
TGF-β from MIN6 cells, we asked ourselves what could be driving this phenotype. 
Our first thought was that IL-4, which MIN6 cells secrete, and a known inducer of 
alternative macrophage activation may be playing a role. However when J774 
macrophage were conditioned with higher amounts of IL-4 than those secreted by 
MIN6 β-cells prior to activation with LPS, we did not see induction of the same 
phenotype as that observed with conditioned media. Likely due to the fact that there 
is an increase in M2 genes in the macrophage IL-4 is playing a role, but in together 
in concert with other mediators. In addition to the release of soluble mediators, 
epithelial cells in the gut, which are known to interact with resident macrophage and 
infiltrating monocytes to drive a hyporesponsive phenotype (Peterson & Artis 2014), 
also release a wide variety of proteins, lipids, mRNAs and microRNAs contained 
within secreted nanovesicles or exosomes (Mallegol et al. 2007; van Niel et al. 
2001). Although first discovered nearly 30 years ago (Johnstone et al. 1987) in 
recent years there has been a resurgence of interest in these particles. Mainly owing 
to their ability to profoundly contribute to both local and systemic cell 
communication (Harding et al. 2013; Raposo & Stoorvogel 2013) as they  have the 
ability to transfer their contents, including proteins, lipids and RNAs, between cells 
(Ratajczak et al. 2006; Valadi et al. 2007). Given the observation that cell derived 
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exosomes have been shown to have immunosuppressive effects in a number of 
different models (Wieckowski et al. 2009; S. H. Kim et al. 2007; van Koppen et al. 
2012) we investigated whether or not the observed effect on macrophage phenotype 
was being driven by mediators carried in exosomes. Exosomes were fractioned 
according to their size with the intention of identifying a particular fraction with 
immunosuppressive capability. Interestingly though, all 5 of our exosome fractions 
exerted anti-inflammatory effects on macrophage function in that they reduced 
proinflammatory cytokine secretion, and cell surface marker expression. They did 
not however, do this uniformly for example with FR1 all other cytokines tested for 
were decreased however IL-23 levels remained unchanged. FR2, 3 and 4 decreased 
IL-23 levels and with FR5 again IL-23 levels remain unchanged. The same can be 
said of surface markers with all fractions bar FR2 causing a decrease in TLR2 
expression. As we found it difficult to single out one fraction with the most profound 
immunosuppressive capability we postulate that it is likely a number of mediators 
secreted in exosomes that contribute to the overall anti-inflammatory effects of 
MIN6 β-cells. Unfortunately given that we were working with so many fractions, 
characterisation of their contents was just not in the time frame or scope of this 
project but it certainly warrants further investigation. What we do understand from 
our results however is that mediators released in exosomes from MIN6 β-cells are 
capable of exerting an anti-inflammatory action on macrophage. This is similar to 
the crosstalk that is seen between epithelial cells and macrophage in the gut. Future 
work will include characterisation of the contents of these exosomes and may lead to 
identification of novel immune modulating mechanisms for macrophage and indeed 
for limiting islet inflammation that is known to drive β-cell dysfunction. 
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To finalise our study we asked ourselves in what context would this crosstalk that we 
have described between MIN6 β-cells and macrophage be pertinent. In what setting 
do β-cells interact with macrophage? As mentioned previously there have been 
numerous reports linking T2D with macrophage infiltration of islets (Ehses et al. 
2007; Richardson et al. 2009) although it is still unknown whether or not 
macrophage infiltration is causative or a consequence of islet β-cell pathology. It is 
still unclear also as to the signals that drive macrophage infiltration of islets in the 
context of T2D. There is also a wealth of evidence linking low grade chronic 
inflammation with T2D (Donath 2013; Lee et al. 2012; Fresno et al. 2011; Cruz et al. 
2013). Inflammation that results from diet induced obesity (Ding et al. 2010), which 
has the ability to alter the microbial composition of the gut (Everard & Cani 2013; 
Shen et al. 2013; Carvalho & Saad 2013) which in turn affects the guts inflammatory 
status.  As T2D, diet induced obesity and inflammation are inextricably linked we 
asked the question whether or not inflammation in the gut may have the ability to 
affect macrophage infiltration into the pancreas, thus providing a setting where this 
cross-talk would be necessary. To address this question we used the well-studied 
model of dextran sulfate sodium (DSS) induced colitis in mice (Kullmann et al. 
2001; Poritz et al. 2007), to assess the effect of gut inflammation on the pancreas. 
Quality pancreatic RNA is notoriously difficult to isolate due to the presence of large 
quantities of RNases, DNases and proteases that initiate an autolytic process almost 
immediately upon harvest. Despite several approaches, including rapid removal of 
pancreas from the abdominal cavity, homogenizing at cold temperatures and 
inhibition of contaminating RNases through perfusion of the pancreas we were 
unable to isolate high-quality RNA. We were therefore unable to look at expression 
of inflammatory genes in the pancreas during intestinal inflammation. However we 
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were able to show increased macrophage presence in the pancreas from DSS treated 
animals compare to control animals. As discussed previously we cannot be certain 
that these macrophages originated in the intestine but there is compelling evidence in 
the literature to support this theory. Considering the increased numbers of 
macrophage in the gut (Kullmann et al. 2001), the breakdown of gut barrier integrity 
(Poritz et al. 2007) during colitis, and the close proximity of the pancreas to the 
duodenum it is probable that the macrophage seen in the pancreas originated in the 
gut.  This provides a mechanism by which inflammation in the gut has the ability to 
affect macrophage infiltration of the pancreas and also addresses the question as to 
why β-cells possess the ability to alter and control macrophage phenotype.  
Our work has highlighted that there may be a novel endogenous molecule within the 
metabolic signalling pathway that drives TLR5 activation, that may prove protective 
in the setting of islet dysfunction. This may be novel therapeutic target for islet 
protection. We have also shown that the islet is an environment similar in ways to 
the gut that has the ability to influence macrophage phenotype. This is most likely an 
effect that helps to maintain pancreatic homeostasis and dysregulation of this could 
be a driving cause in β-cell dysfunction in T2D. Finally we have shown that 
inflammation in the gut can affect infiltration of macrophage into the pancreas. 
Taking into consideration the inextricable links between low grade inflammation and 
T2D, this may be a driving force in β-cell dysfunction that leads to the onset of T2D.  
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Appendix A 
Buffers 
 
FACS buffer  
FCS     2%  
NaN3     0.05%  
Dissolve in PBS  
 
Phosphate buffered saline (PBS)  
Na2HPO4 x 2H2O   8.0 mM  
KH2PO4    1.5 mM  
NaCl     137 mM  
KCl     2.7 mM  
Dissolve in dH2O and pH to 7.4  
 
TAE buffer  
Tris     40 mM  
Acetic acid    20 mM  
EDTA    1 mM  
Dissolve in dH2O  
 
Tris buffered saline (TBS) 
NaCl     1.5 M 
Trizma Base    0.2 M 
Dissolve dH2O pH to 7.6 
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TBS-Tween 
 
Add 0.05% Tween-20 to 1x TBS 
 
Krebs Ringer Bicarbonate (KRB) 
NaCl     125 mM  
KCl     3 mM  
MgSO4    1.2 mM  
CaCl2     1.2 mM  
NaHCO3    22 mM  
Na H2PO4    1 mM 
Dissolve in dH2O and pH to 7.4 
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Appendix B 
Primer Sequences 
 
IL-1b 
Primer 1 5'-GAC CTG TTC TTT GAA GTT GAC G-3' 
Primer 2   5'-CTC TTG TTG ATG TGC TGC TG-3' 
IL-6 
Primer 1  5’-AGC CAG AGT CCT TCA GAG A-3’  
Primer 2  5’-TCC TTA GCC ACT CCT TCT GT-3’ 
TNF-α 
Primer 1  5’-TCT TTG AGA TCC ATG CCG TTG– 3’  
Primer 2  5’-AGA CCC TCA CAC TCA GAT CA– 3’ 
IFNγ 
Primer 1  5’-ATG AAC GCT ACA CAC TGC ATC-3’ 
Primer 2  5’-CCA TCC TTT TGC CAG TTC CTC -3’ 
IL-17a 
Primer 1 5’- AGA CTA CCT CAA CCG TTC CA-3’ 
Primer 2  5’- GAG CTT CCC AGA TCA CAG AG-3’ 
TLR4 
Primer 1 5'-GAA GCT TGA ATC CCT GCATAG-3' 
Primer 2  5'-AGCTCA GAT CTATGT TCTTGGTTG-3' 
TLR5 
Primer 1 5'-GGA ACATAT GCC AGA CAC ATC T-3' 
Primer 2   5'-TGA AGATCA CAC CTATGA GCA AG-3' 
INS1 
Primer 1 5'-GCC AAA CAG CAA AGT CCA G-3' 
Primer 2   5'-GCC ATG TTG AAA CAATGA CCT-3' 
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INS2 
Primer 1 5'-TTT GTC AAG CAG CAC CTT TG-3' 
Primer 2   5'-TCC ACC CAG CTC CAGTT-3' 
IRS1 
Primer 1 5'-CCA GCATCA GCT TCC AGA A-3' 
Primer 2   5'-TGT GAATTG TGA AAT AGT TCG AGT C-3' 
IRS2 
Primer 1 5'-CCT ACA CGC CTATCG CTA GA-3' 
Primer 2   5'-GTA CCT GCCTCA CCA AAGTC-3' 
IAPP 
Primer 1 5'-GCC TCG GAC CACTGA AAG-3' 
Primer 2   5'-CACTTC CGT TTG TCC ATC TGA-3' 
FAM3B 
Primer 1 5'-ACA AGT ATG CCA AGATCT GCT-3' 
Primer 2   5'-TCG CTATCA CTT TTC CTG TCT C-3' 
ARG1 
Primer 1 5'-GAATGG AAG AGT CAGTGT GGT-3' 
Primer 2  5'-AGT GTT GAT GTC AGT GTG AGC-3' 
NOS2 
Primer 1 5'-GACTGA GCT GTT AGA GAC ACT T-3' 
Primer 2   5'-CACTTC TGC TCC AAATCC AAC-3' 
MRC1 
Primer 1 5'-TAT CTC TGT CAT CCCTGT CTC T-3' 
Primer 2  5'-CAA GTT GCC GTC TGA ACT GA-3' 
ACTB 
Primer 1 5’-CGT TGA CAT CCG TAA AGA CCT-3’ 
Primer 2 5’-CTT GAT CTT CAT GGT GCT AGG AG-3’ 
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Gusb 
Primer 1  5’-CCA ATG AGC CTT CCT CTG C-3’ 
Primer 2  5’-ATC ATA TTT GGC GTT GCT CAC-3’ 
B2M 
Primer 1 5’-GGT CTT TCT GGT GCT TGT CT-3’ 
Primer 2 5’-ACG TAG CAG TTC AGT ATG TTC G-3’ 
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Endogenous controls 
 
                          
Endogenous controls testes on MIN6 and J774A.1 cell lines and colonic tissue. 
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PCR Gel 
 
 
 
 
 
DNA product analysis by gel electrophoresis DNA samples were mixed with 
loading buffer (Fermentas) and loaded onto the 2% agarose gel, together with 
GeneRuler 100bp DNA ladder (Termo-Fisher Scientific). Gels were run for 1h in 1x 
TAE buffer at 100V and visualised using the G-box imaging system (Syngene). 
 
 
 
